PT J
AU Kim, SJ
   Choung, SY
AF Kim, Sa-Jic
   Choung, Se-Young
TI Inhibitory effects of Aster spathulifolius extract on adipogenesis and lipid accumulation in 3T3-L1 preadipocytes
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
DE 3T3-L1 cells; adipogenesis; AMPK alpha; Aster spathulifolius maxim; PPAR-gamma
ID activated protein-kinase; adipocyte differentiation; transcription factors; chlorogenic acid; down-regulation; aerial parts; obesity; diet; phytochemicals; isoquercitrin
AB ObjectivesAster spathulifolius Maxim (AS), known for its anti-viral and anti-allergic activity, is also known to reduce body weight gain in high fat diet-induced obese rats. But its molecular mechanism of the anti-obesity effects is still unclear. So, we investigated the inhibitory effect of AS extract (ASE) on adipogenesis and lipid accumulation to determine the underlying cellular molecular mechanism. MethodsTo perform this study, the contents of intracellular triglyceride were analysed. Real-time polymerase chain reaction and Western blotting were carried out to investigate the expression of adipogenic transcriptional factors. Key findingsASE showed the suppression of adipogenic differentiation and the considerable reduction of the lipid accumulation in 3T3-L1 cells. Especially, ASE inhibited the early stage of differentiation via the downregulation of C/EBP- and C/EBP-, which are early adipogenic factors. Major adipogenic factors, such as PPAR- and C/EBP-, were also subsequently inhibited. These findings were supported by Oil Red O staining and intracellular triglyceride levels. A molecular mechanism liking the effect of ASE was identified through the activation of AMPK pathway. ASE increased protein levels of phosphorylated AMPK and phosphorylated ACC. ConclusionsASE showed anti-adipogenic and anti-lipogenic effects through the regulation of adipogenic factors and AMPK pathway.
C1 [Kim, Sa-Jic; Choung, Se-Young] Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci Pharm, Seoul, South Korea.
   [Choung, Se-Young] Kyung Hee Univ, Coll Pharm, Dept Prevent Pharm & Toxicol, Seoul, South Korea.
C3 Kyung Hee University; Kyung Hee University
RP Choung, SY (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci Pharm, Seoul, South Korea.
EM sychoung@khu.ac.kr
FU Kyung Hee University [KHU-20050434]; Industrial Strategic Technology Development Program - Ministry of Trade, Industry & Energy (MI, Korea) [10045257]
CR Akowuah GA, 2004, FOOD CHEM, V87, P559, DOI 10.1016/j.foodchem.2004.01.008
   Bang CY, 2014, J PHARM PHARMACOL, V66, P875, DOI 10.1111/jphp.12211
   Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701
   Choi HS, 2014, BIOCHIMIE, V104, P127, DOI 10.1016/j.biochi.2014.06.010
   Davaatseren M, 2013, FOOD CHEM TOXICOL, V58, P30, DOI 10.1016/j.fct.2013.04.023
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325
   González-Castejón M, 2014, PHYTOTHER RES, V28, P745, DOI 10.1002/ptr.5059
   González-Castejón M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI 10.1002/mnfr.200890019
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hwang JW, 2015, J FUNCT FOODS, V15, P516, DOI 10.1016/j.jff.2015.04.002
   Jang HS, 2006, THESIS KYUNG HEE U S, V0, P0
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kang YJ, 2008, DIABETES RES CLIN PR, V82, P25, DOI 10.1016/j.diabres.2008.06.012
   Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011
   Kim H, 2012, J MED FOOD, V15, P811, DOI 10.1089/jmf.2011.2126
   Kim MJ, 2015, AM. J. MOL. BIOL, V5, P32, DOI 10.4236/ajmb.2015.52004
   Kim NM, 2000, ARCH PHARM RES, V23, P237, DOI 10.1007/BF02976451
   Ko SC, 2013, ENVIRON TOXICOL PHAR, V36, P1253, DOI 10.1016/j.etap.2013.10.011
   Kong CS, 2015, J FOOD BIOCHEM, V39, P1, DOI 10.1111/jfbc.12093
   Kwak DH, 2014, MOL CELL BIOCHEM, V385, P257, DOI 10.1007/s11010-013-1834-0
   Lee E, 2013, J ETHNOPHARMACOL, V149, P148, DOI 10.1016/j.jep.2013.06.014
   Lee H, 2015, BASIC CLIN PHARMACOL, V116, P222, DOI 10.1111/bcpt.12308
   Lee JH, 2008, CLIN EXP ALLERGY, V38, P794, DOI 10.1111/j.1365-2222.2008.02936.x
   Lee SH, 2011, PHYTOTHER RES, V25, P1629, DOI 10.1002/ptr.3469
   Lee SO, 2006, ARCH PHARM RES, V29, P845, DOI 10.1007/BF02973904
   Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Lim DW, 2013, MOLECULES, V18, P9241, DOI 10.3390/molecules18089241
   Lin LZ, 2008, J AGR FOOD CHEM, V56, P10105, DOI 10.1021/jf802412m
   Lin LZ, 2010, FOOD CHEM, V120, P319, DOI 10.1016/j.foodchem.2009.09.083
   Lü H, 2009, PHYTOMEDICINE, V16, P967, DOI 10.1016/j.phymed.2009.03.024
   Luque CA, 1999, ANN PHARMACOTHER, V33, P968, DOI 10.1345/aph.18319
   Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1
   Mokdad AH, 2003, JAMA, V0, P0
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Rogerio AP, 2007, INFLAMM RES, V56, P402, DOI 10.1007/s00011-007-7005-6
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   ROSS SE, 2000, SCIENCE, V289, P950, DOI 10.1126/SCIENCE.289.5481.950
   Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Seo CR, 2014, FOOD CHEM TOXICOL, V64, P217, DOI 10.1016/j.fct.2013.11.040
   Shimoda H, 2003, BIOORG MED CHEM LETT, V13, P223, DOI 10.1016/S0960-894X(02)00889-2
   Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76
   Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Swain T, 1959, JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, V10, P63, DOI 10.1002/jsfa.2740100110
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Wan Y, 2014, EXP THER MED, V8, P79, DOI 10.3892/etm.2014.1698
   Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7
   Won JN, 2013, J MICROBIOL BIOTECHN, V23, P125, DOI 10.4014/jmb.1210.10074
   Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031
   Yang L, 2012, PHYTOTHER RES, V26, P438, DOI 10.1002/ptr.3604
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 66
TC 11
Z9 11
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JAN 15
PY 2016
VL 68
IS 1
BP 107
EP 118
DI 10.1111/jphp.12485
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DB9JH
UT WOS:000368831700011
PM 26471469
DA 2025-04-28
ER

PT J
AU Yang, CS
   Zhang, JS
   Zhang, L
   Huang, JB
   Wang, YJ
AF Yang, Chung S.
   Zhang, Jinsong
   Zhang, Le
   Huang, Jinbao
   Wang, Yijun
TI Mechanisms of body weight reduction and metabolic syndrome alleviation by tea
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
DE AMPK; Diabetes; EGCG; Obesity; Tea
ID activated protein-kinase; green tea; epigallocatechin-gallate; insulin-resistance; black-tea; coffee consumption; lipid-metabolism; polyphenol (-)-epigallocatechin-3-gallate; dietary supplementation; cardiovascular-disease
AB Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been shown to reduce body weight, alleviate metabolic syndrome, and prevent diabetes and cardiovascular diseases in animal models and humans. Such beneficial effects have generally been observed in most human studies when the level of tea consumption was three to four cups (600-900 mg tea catechins) or more per day. Green tea is more effective than black tea. In spite of numerous studies, the fundamental mechanisms for these actions still remain unclear. From a review of the literature, we propose that the two major mechanisms are: (i) decreasing absorption of lipids and proteins by tea constituents in the intestine, thus reducing calorie intake; and (ii) activating AMP-activated protein kinase by tea polyphenols that are bioavailable in the liver, skeletal muscle, and adipose tissues. The relative importance of these two mechanisms depends on the types of tea and diet consumed by individuals. The activated AMP-activated protein kinase would decrease gluconeogenesis and fatty acid synthesis and increase catabolism, leading to body weight reduction and metabolic syndrome alleviation. Other mechanisms and the health relevance of these beneficial effects of tea consumption remain to be further investigated.
C1 [Yang, Chung S.; Zhang, Le] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA.
   [Yang, Chung S.; Zhang, Jinsong; Zhang, Le; Huang, Jinbao; Wang, Yijun] Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China.
   [Zhang, Jinsong; Huang, Jinbao; Wang, Yijun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China.
C3 Rutgers University System; Rutgers University New Brunswick; Anhui Agricultural University; Anhui Agricultural University
RP Yang, CS (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA.
EM csyang@pharmacy.rutgers.edu
FU US NIH [CA122474, CA133021]; Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health; Tea Project of Anhui Provincial Agriculture Committee
CR Aggio A, 2013, EUR J NUTR, V52, P263, DOI 10.1007/s00394-012-0320-x
   Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   Axling U, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-105
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bao SQ, 2014, MOL NUTR FOOD RES, V58, P677, DOI 10.1002/mnfr.201300335
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Byun JK, 2014, IMMUNOL LETT, V157, P51, DOI 10.1016/j.imlet.2013.11.006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o
   Chang CS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038874
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/635470
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014
   Du WH, 2012, J AGR FOOD CHEM, V60, P10126, DOI 10.1021/jf302426w
   Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Ellinger S, 2011, PHYTOMEDICINE, V18, P903, DOI 10.1016/j.phymed.2011.06.006
   Everard A, 2014, MBIO, V5, P0, DOI 10.1128/mBio.01011-14
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hartley L, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD009934.pub2
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ikeda I, 2010, J AGR FOOD CHEM, V58, P8591, DOI 10.1021/jf1015285
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   James KD, 2015, FOOD CHEM TOXICOL, V76, P103, DOI 10.1016/j.fct.2014.12.009
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Ku HC, 2012, MOL NUTR FOOD RES, V56, P580, DOI 10.1002/mnfr.201100438
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Mukamal KJ, 2006, J AM COLL NUTR, V25, P472, DOI 10.1080/07315724.2006.10719561
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, PE679, DOI 10.1152/ajpendo.00377.2013
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012
   Ortsäter H, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-11
   Pae MY, 2012, J NUTR BIOCHEM, V23, P526, DOI 10.1016/j.jnutbio.2011.02.006
   Park JH, 2009, J PHYSIOL PHARMACOL, V60, P101
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pullikotil P, 2012, J NUTR BIOCHEM, V23, P1134, DOI 10.1016/j.jnutbio.2011.06.007
   Qin BL, 2010, MOL NUTR FOOD RES, V54, PS14, DOI 10.1002/mnfr.200900306
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Sesso HD, 2003, AM J CLIN NUTR, V77, P1400, DOI 10.1093/ajcn/77.6.1400
   Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tian C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053796
   Ueda M, 2012, J AGR FOOD CHEM, V60, P8917, DOI 10.1021/jf2053788
   Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301
   Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang DX, 2015, TOXICOL APPL PHARM, V283, P65, DOI 10.1016/j.taap.2014.12.018
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Wu JJ, 2014, EUR J PHARMACOL, V745, P59, DOI 10.1016/j.ejphar.2014.09.046
   Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI 10.1039/c4fo00095a
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2008, MOL NUTR FOOD RES, V52, PS139, DOI 10.1002/mnfr.200700234
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
   Zhou J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087008
NR 119
TC 276
Z9 305
U1 19
U2 424
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JAN 15
PY 2016
VL 60
IS 1
BP 160
EP 174
DI 10.1002/mnfr.201500428
PG 15
WC Food Science & Technology
SC Food Science & Technology
GA DA3WK
UT WOS:000367730800015
PM 26577614
DA 2025-04-28
ER

PT J
AU Domínguez-Avila, JA
   González-Aguilar, GA
   Alvarez-Parrilla, E
   de la Rosa, LA
AF Abraham Dominguez-Avila, J.
   Gonzalez-Aguilar, Gustavo A.
   Alvarez-Parrilla, Emilio
   de la Rosa, Laura A.
TI Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE PPAR; polyphenols; high fat; gene expression
ID proliferator-activated receptors; lipid-metabolism; gene-expression; green tea; olive oil; gamma; accumulation; alpha; acid; lipogenesis
AB Peroxisome proliferator-activated receptors (PPAR) are transcription factors that modulate energy metabolism in liver, adipose tissue and muscle. High fat diets (HFD) can negatively impact PPAR expression or activity, favoring obesity, dyslipidemia, insulin resistance and other conditions. However, polyphenols (PP) found in vegetable foodstuffs are capable of positively modulating this pathway. We therefore focused this review on the possible effects that PP can have on PPAR when administered together with HFD. We found that PP from diverse sources, such as coffee, olives, rice, berries and others, are capable of inducing the expression of genes involved in a decrease of adipose mass, liver and serum lipids and lipid biosynthesis in animal and cell models of HFD. Since cells or gut bacteria can transform PP into different metabolites, it is possible that a synergistic or antagonistic effect ultimately occurs. PP molecules from vegetable sources are an interesting option to maintain or return to a state of energy homeostasis, possibly due to an adequate PPAR expression and activity.
C1 [Abraham Dominguez-Avila, J.; Gonzalez-Aguilar, Gustavo A.] Ctr Invest Alimentac & Desarrollo AC, Coordinac Tecnol Alimentos Origen Vegetal, Carretera La Victoria Km 0-6,AP 1735, Hermosillo 83304, Sonora, Mexico.
   [Alvarez-Parrilla, Emilio; de la Rosa, Laura A.] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Anillo Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez 32310, Chihuahua, Mexico.
C3 CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Universidad Autonoma de Ciudad Juarez
RP de la Rosa, LA (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Anillo Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez 32310, Chihuahua, Mexico.
EM abrahamdominguez9@yahoo.com; gustavo@ciad.mx; ealvarez@uacj.mx; ldelaros@uacj.mx
FU National Council for Science and Technology (CONACYT); CONACYT [CB-2011-01-167164]
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Amritpal Singh Amritpal Singh, 2010, JOURNAL OF NATURAL PRODUCTS (INDIA), V3, P64
   Arabshahi-Delouee S, 2007, FOOD CHEM, V102, P1233, DOI 10.1016/j.foodchem.2006.07.013
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Awika JM, 2004, PHYTOCHEMISTRY, V65, P1199, DOI 10.1016/j.phytochem.2004.04.001
   Azuma K, 1999, J AGR FOOD CHEM, V47, P3963, DOI 10.1021/jf990347p
   Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962
   Bozan B, 2008, BIORESOURCE TECHNOL, V99, P6354, DOI 10.1016/j.biortech.2007.12.009
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2
   Caponio F, 1999, FOOD CHEM, V64, P203, DOI 10.1016/S0308-8146(98)00146-0
   Chang CJ, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/787152
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Cheng HS, 2016, NUTRITION, V0, P0, DOI DOI 10.1016/j.nut.2016.02.002
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Collins B, 2016, J NUTR BIOCHEM, V31, P150, DOI 10.1016/j.jnutbio.2015.12.021
   Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005
   Falcao SI, 2010, ANAL BIOANAL CHEM, V396, P887, DOI 10.1007/s00216-009-3232-8
   Fernández-Mar MI, 2012, FOOD CHEM, V130, P797, DOI 10.1016/j.foodchem.2011.08.023
   Frazier-Wood AC, 2013, PHARMACOGENOMICS J, V13, P312, DOI 10.1038/tpj.2012.9
   Fuentes E, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/136584
   Fukumitsu S, 2008, BRIT J NUTR, V100, P669, DOI 10.1017/S0007114508911570
   Grygiel-Górniak B, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-17
   Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392
   Hassen I, 2015, J FUNCT FOODS, V18, P926, DOI 10.1016/j.jff.2014.09.001
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Herranz-López M, 2015, PHYTOMEDICINE, V22, P605, DOI 10.1016/j.phymed.2015.03.015
   Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x
   Hillebrand S, 2004, J AGR FOOD CHEM, V52, P7331, DOI 10.1021/jf0487957
   Honda K, 2009, ANIM SCI J, V80, P562, DOI 10.1111/j.1740-0929.2009.00670.x
   Hu C, 2003, J AGR FOOD CHEM, V51, P5271, DOI 10.1021/jf034466n
   Hu Y, 2013, P NATL ACAD SCI USA, V110, P15401, DOI 10.1073/pnas.1307211110
   Ichi I, 2009, J FOOD SCI, V74, PH127, DOI 10.1111/j.1750-3841.2009.01147.x
   Ikarashi N, 2011, EVID-BASED COMPL ALT, V2011, P0, DOI 10.1093/ecam/nep24121799697
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Jang HH, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-27
   Jia YY, 2013, BBA-MOL CELL BIOL L, V1831, P698, DOI 10.1016/j.bbalip.2012.11.012
   Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l
   Kim H, 2010, J AGR FOOD CHEM, V58, P3984, DOI 10.1021/jf903230s
   Kim MS, 2014, TROP J PHARM RES, V13, P31, DOI 10.4314/tjpr.v13i1.5
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159
   Kumazawa S, 2007, J AGR FOOD CHEM, V55, P7722, DOI 10.1021/jf071187h
   Kuo DH, 2009, J ETHNOPHARMACOL, V124, P544, DOI 10.1016/j.jep.2009.05.005
   Lin YL, 2012, PLANT FOOD HUM NUTR, V67, P294, DOI 10.1007/s11130-012-0309-x
   Medina-Gomez G, 2007, PLOS GENET, V3, P0, DOI 10.1371/journal.pgen.0030064
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Ou TT, 2011, J SCI FOOD AGR, V91, P2740, DOI 10.1002/jsfa.4489
   Park JH, 2012, NUTR RES PRACT, V6, P322, DOI 10.4162/nrp.2012.6.4.322
   Pascual ME, 2001, J ETHNOPHARMACOL, V76, P201, DOI 10.1016/S0378-8741(01)00234-3
   Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, P0, DOI 10.1186/s12944-015-0087-1
   Rasouli N, 2012, PHARMACOGENET GENOM, V22, P484, DOI 10.1097/FPC.0b013e328352a72e
   Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862
   Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321
   Sugden M C, 2012, CURR MOL PHARMACOL, V5, P224
   Tian C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053796
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917
   Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001
   Wall MM, 2006, J FOOD COMPOS ANAL, V19, P655, DOI 10.1016/j.jfca.2005.12.001
   Wang L, 2011, EUR J NUTR, V50, P127, DOI 10.1007/s00394-010-0122-y
   Wang LQ, 2000, CHEM PHARM BULL, V48, P1606, DOI 10.1248/cpb.48.1606
   Wein S, 2010, EUR J PHARM SCI, V41, P16, DOI 10.1016/j.ejps.2010.05.004
   Wu LN, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26072
   Yang DJ, 2010, FOOD CHEM, V119, P1457, DOI 10.1016/j.foodchem.2009.09.027
   Yang JS, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068035
   Yang XR, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/783860
   Youssef JA, 2013, PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: DISCOVERY AND RECENT ADVANCES, V0, P33
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072
   Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6
   Zheng XK, 2011, J ETHNOPHARMACOL, V137, P662, DOI 10.1016/j.jep.2011.06.018
NR 76
TC 59
Z9 60
U1 2
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 15
PY 2016
VL 17
IS 7
BP 
EP 
DI 10.3390/ijms17071002
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DT5DK
UT WOS:000381500900017
PM 27367676
DA 2025-04-28
ER

PT J
AU Jang, YS
   Wang, ZQ
   Lee, JM
   Lee, JY
   Lim, SS
AF Jang, Young Soo
   Wang, Zhiqiang
   Lee, Jeong-Min
   Lee, Jae-Young
   Lim, Soon Sung
TI Screening of Korean Natural Products for Anti-Adipogenesis Properties and Isolation of Kaempferol-3-O-rutinoside as a Potent Anti-Adipogenetic Compound from Solidago virgaurea
SO MOLECULES
LA English
DT Article
DE obesity; screening; Solidago virgaurea; kaempferol-3-O-rutinoside
ID fatty liver-disease; 3t3-l1 adipocytes; ppar-gamma; inhibitory-activity; chlorogenic acid; obesity; extract; cells; identification; antioxidant
AB In this study, the anti-adipogenetic activity of 300 plant extracts was investigated using an Oil Red O staining assay in a 3T3-L1 cell line. Our results indicate that three plants, including the stem and leaf of Physalis angulata, the whole grass of Solidago virgaurea, and the root of Dioscorea nipponica, produced over 90% inhibition of adipogenesis. Kaempferol-3-O-rutinoside, which demonstrated a 48.2% inhibitory effect on adipogenesis without cytotoxicity, was isolated from the butanol layer of a water extract of S. virgaurea guided by the anti-adipogenesis assay in 3T3-L1. PPAR- and C/EBP expression levels were determined using western blot, and our results indicate that kaempferol-3-O-rutinoside has a strong anti-adipogenic effect in 3T3-L1 cells through the suppression of increases in PPAR- and C/EBP expression.
C1 [Jang, Young Soo; Wang, Zhiqiang; Lim, Soon Sung] Hallym Univ, Dept Food Sci & Nutr, Chunchon 200702, Gangwon Do, South Korea.
   [Lee, Jeong-Min; Lee, Jae-Young] Hallym Univ, Dept Boichem, Sch Med, Chunchon 200702, Gangwon Do, South Korea.
   [Lee, Jae-Young; Lim, Soon Sung] Hallym Univ, Inst Nat Med, Chunchon 200702, Gangwon Do, South Korea.
C3 Hallym University; Hallym University; Hallym University
RP Lim, SS (corresponding author), Hallym Univ, Dept Food Sci & Nutr, Chunchon 200702, Gangwon Do, South Korea.; Lim, SS (corresponding author), Hallym Univ, Inst Nat Med, Chunchon 200702, Gangwon Do, South Korea.
EM ggaeby77@gmail.com; wangwq01234@gmail.com; sindelela99@nate.com; jyolee@hallym.ac.kr; limss@hallym.ac.kr
FU Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through (Agri-Bioindustry Technology Development Program) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [114066-3]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2009-0094071]; Hallym University Specialization Fund [HRF-S-13]; Academy of Finland (AKA) [114066] Funding Source: Academy of Finland (AKA)
CR Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544
   Calderón-Montaño JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Christensen KB, 2010, PHYTOTHER RES, V24, PS129, DOI 10.1002/ptr.3005
   Demir H, 2009, AFR J BIOTECHNOL, V8, P274
   El-Tantawy WH, 2014, J PHYSIOL BIOCHEM, V70, P33, DOI 10.1007/s13105-013-0277-0
   Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802
   Finelli C, 2012, J GASTROINTEST LIVER, V21, P293
   Vázquez-Vela MEF, 2008, ARCH MED RES, V39, P715, DOI 10.1016/j.arcmed.2008.09.005
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Habtemariam S, 2011, NAT PROD COMMUN, V6, P201
   Jafari S, 2013, DARU, V21, P0, DOI 10.1186/2008-2231-21-37
   Jung HA, 1999, ARCH PHARM RES, V22, P213, DOI 10.1007/BF02976549
   KIM HW, 1996, THESIS PUSAN NATL U, V0, P0
   Kong CS, 2009, FOOD CHEM TOXICOL, V47, P2401, DOI 10.1016/j.fct.2009.06.010
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Kwon CS, 2003, BIOSCI BIOTECH BIOCH, V67, P1451, DOI 10.1271/bbb.67.1451
   Lahrita L, 2015, J ETHNOPHARMACOL, V168, P229, DOI 10.1016/j.jep.2015.03.082
   Lee J, 2004, THESIS KEIMYUNG U DA, V0, P0
   Lee JC, 2004, FOOD CHEM TOXICOL, V42, P1383, DOI 10.1016/j.fct.2004.03.012
   Lee TB, 1979, ILLUSTRATED FLORA KO, V0, P0
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131
   LEUSCHNER J, 1995, ARZNEIMITTELFORSCH, V45-1, P165
   Li S, 2003, COMPENDIUM MAT MEDIC, V0, P0, DOI DOI 10.1016/j.cmpb.2011.01.006
   Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040
   RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461
   Seo JB, 2011, EXP MOL MED, V43, P205, DOI 10.3858/emm.2011.43.4.025
   Takemura T, 2005, ACTA HORTIC, V0, PP487, DOI 10.17660/ActaHortic.2005.673.64
   Tarantino G, 2007, WORLD J GASTROENTERO, V13, P4669, DOI 10.3748/wjg.v13.i35.4669
   Watanabe M, 2003, BIOCHEM BIOPH RES CO, V300, P429, DOI 10.1016/S0006-291X(02)02860-7
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
NR 34
TC 38
Z9 42
U1 1
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1420-3049
EI 
J9 MOLECULES
JI Molecules
PD FEB 15
PY 2016
VL 21
IS 2
BP 
EP 
DI 10.3390/molecules21020226
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DG2KN
UT WOS:000371895900043
PM 26901177
DA 2025-04-28
ER

PT J
AU Santos, LP
   Assunçao, MCF
   Matijasevich, A
   Santos, IS
   Barros, AJD
AF Santos, Leonardo Pozza
   Formoso Assuncao, Maria Cecilia
   Matijasevich, Alicia
   Santos, Ina S.
   Barros, Aluisio J. D.
TI Dietary intake patterns of children aged 6 years and their association with socioeconomic and demographic characteristics, early feeding practices and body mass index
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Dietary intake; Principal component analysis; Cohort studies; Nutrition assessment
ID ultra-processed foods; brazil birth cohort; multivariate-analysis; european children; consumption; adolescents; health; determinants; country; obesity
AB Background: Dietary intake patterns of children from the 2004 Pelotas birth cohort study have been described at 12, 24 and 48 months of age, but there is no information about dietary patterns of these children at 6 years. Then, we aimed to identify and describe dietary intake patterns of children aged 6 years as well as to assess their association with socioeconomic and demographic characteristics, early feeding practices and BMI z-score at 6 years. Methods: We used principal components analysis to identify dietary intake patterns of 3,427 children from the 2004 Pelotas (Brazil) birth cohort study. We used multiple linear regression models to evaluate whether socioeconomic and demographic characteristics (socioeconomic position, mother's age at birth, and child's sex and skin colour), early feeding practices (exclusive breastfeeding duration and age of introduction of complementary foods), and BMI z-score at 6 years were associated with dietary intake patterns. Results: We identified seven dietary components of children's dietary intake patterns, namely: fruits and vegetables, snacks and treats, coffee and bread, milk, cheese and processed meats, rice and beans and carbohydrates. Dietary patterns were socially patterned, since six dietary components were associated with socioeconomic position. Moreover, high intake of snacks and treats and less fruits and vegetables were associated with children born to teenage mothers, with those exclusively breastfed for less than one month, and with those who started on complementary feeding before 4 months. Finally, overweight and obese children at 6 years presented lower intake of four out of seven dietary components, but we need to be cautious in interpretation due to limitations on food consumption reporting and due to possible reverse causality. Conclusion: Dietary intake patterns in children are strongly influenced by socioeconomic characteristics. Other factors such as younger maternal age at birth, and both early weaning and early introduction of complementary feeding appear to be related with 'nhealthier' patterns. Overweight and obese children presented lower intake of four out of seven dietary components, but further studies would be interesting to understand the longitudinal effect of children's feeding practices on BMI and adiposity.
C1 [Santos, Leonardo Pozza; Formoso Assuncao, Maria Cecilia; Matijasevich, Alicia; Santos, Ina S.; Barros, Aluisio J. D.] Univ Fed Pelotas, Postgrad Program Epidemiol, 1160 Marechal Deodoro St,3th Floor, BR-96020220 Pelotas, Brazil.
   [Matijasevich, Alicia] Univ Sao Paulo, Dept Prevent Med, 455 Dr Arnaldo Ave,2nd Floor, BR-01246903 Sao Paulo, Brazil.
C3 Universidade Federal de Pelotas; Universidade de Sao Paulo
RP Santos, LP (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, 1160 Marechal Deodoro St,3th Floor, BR-96020220 Pelotas, Brazil.
EM leonardo_pozza@yahoo.com.br
FU Wellcome Trust; World Health Organization; Brazilian National research Council (CNPq); Brazilian Ministry of Health
CR Aranceta J, 2003, EUR J CLIN NUTR, V57, PS40, DOI 10.1038/sj.ejcn.1601813
   Barbaresko J, 2014, BRIT J NUTR, V112, P1364, DOI 10.1017/S0007114514002098
   Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002
   Barros AJD, 2006, REV SAUDE PUBL, V40, P402, DOI 10.1590/S0034-89102006000300007
   Bielemann RM, 2015, REV SAUDE PUBL, V49, P0, DOI 10.1590/S0034-8910.2015049005572
   Biro FM, 2010, AM J CLIN NUTR, V91, P1499S, DOI 10.3945/ajcn.2010.28701B
   Canella DS, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092752
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Louzada MLD, 2015, REV SAUDE PUBL, V49, P0, DOI 10.1590/S0034-8910.2015049006132
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   Fernández-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78
   Fitzgerald A, 2010, HEALTH PROMOT INT, V25, P289, DOI 10.1093/heapro/daq021
   Gatica G, 2012, INT J BEHAV NUTR PHY, V9, P0, DOI 10.1186/1479-5868-9-43
   Green BP, 2015, J DAIRY SCI, V98, P3701, DOI 10.3168/jds.2014-9161
   Grieger JA, 2011, PUBLIC HEALTH NUTR, V14, P1939, DOI 10.1017/S1368980011001030
   Grote V, 2012, CURR OPIN CLIN NUTR, V15, P293, DOI 10.1097/MCO.0b013e328351baba
   Harris TS, 2015, APPETITE, V85, P171, DOI 10.1016/j.appet.2014.11.008
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   IBGE, 2011, PESQ ORC FAM 2008 20, V0, P0
   Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010
   Lioret S, 2015, J NUTR, V145, P775, DOI 10.3945/jn.114.201988
   Mak TN, 2013, PUBLIC HEALTH NUTR, V16, P1912, DOI 10.1017/S1368980013001912
   Mayén AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   McCourt HJ, 2014, BRIT J NUTR, V112, P1685, DOI 10.1017/S0007114514002682
   Mennella JA, 1997, PEDIATR RES, V41, P188, DOI 10.1203/00006450-199702000-00006
   Mennella JA, 2009, AM J CLIN NUTR, V90, P780S, DOI 10.3945/ajcn.2009.27462O
   Mensink GBM, 2007, BUNDESGESUNDHEITSBLA, V50, P609, DOI 10.1007/s00103-007-0222-x
   Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Mourouti N, 2015, EUR J NUTR, V54, P609, DOI 10.1007/s00394-014-0742-8
   North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896
   Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136
   Novotny R, 2003, J AM COLL NUTR, V22, P64, DOI 10.1080/07315724.2003.10719277
   Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145
   Perrine CG, 2014, PEDIATRICS, V134, PS50, DOI 10.1542/peds.2014-0646I
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ranijt N, 2015, J NUTR EDUC BEHAV, V47, P53
   RIBEIRO Adriana Bouças, 2002, REV. NUTR., V15, P239, DOI 10.1590/S1415-52732002000200012
   Santos IS, 2014, INT J EPIDEMIOL, V43, P1437, DOI 10.1093/ije/dyu144
   Shim JS, 2014, EPIDEMIOL HEALTH, V36, P0, DOI 10.4178/epih/e2014009
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Smith ADAC, 2014, FOOD NUTR RES, V58, P0, DOI 10.3402/fnr.v58.22769
   Smithers LG, 2012, EUR J CLIN NUTR, V66, P658, DOI 10.1038/ejcn.2011.219
   Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x
   Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109
   WHO, 2009, POP BAS PREV STRAT C, V0, P0
NR 48
TC 43
Z9 48
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 6
PY 2016
VL 16
IS 
BP 
EP 
DI 10.1186/s12889-016-3725-2
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX9FZ
UT WOS:000384700300003
PM 27716197
DA 2025-04-28
ER

PT J
AU Yazici-Tutunis, S
   Gurel-Gurevin, E
   Ustunova, S
   Demirci-Tansel, C
   Mericli, F
AF Yazici-Tutunis, Secil
   Gurel-Gurevin, Ebru
   Ustunova, Savas
   Demirci-Tansel, Cihan
   Mericli, Filiz
TI Possible effects of Phillyrea latifolia on weight loss in rats fed a high-energy diet
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE High-density lipoprotein; leptin; liver; low-density lipoprotein; obesity; small intestine; total cholesterol
ID high-fat diet; small-intestine; lipid-metabolism; obesity; extract; acids; constituents; leaves
AB Context Phillyrea latifolia L. (Oleaceae), commonly found in the Mediterranean region in Turkey, is used as medicinal teas for weight loss and hyperglycaemia in folk medicine. Objective The study investigated the possible effects of P. latifolia leaves aqueous extract's on weight loss and biochemical-histological changes in the rats fed a high-energy diet (HED), also isolated and determined the main phenolic compounds. Materials and methods Twenty-four male Wistar albino rats were divided into four equal groups such as the HED group fed a HED, the PLE group given only the extract of P. latifolia leaves (220 mg/kg), the HED + PLE group administrated with the extract of leaves ( 220 mg/kg) after being fed with HED and a control group fed with standard pellet diet. Results PLE administration caused a remarkable decrement of body weight in the HED + PLE group (p < 0.05). PLE showed an improved effect on structural integrity and decreased leukocyte infiltration in liver and small intestinal tissues. The blood glucose (117.3 mmol/L), leptin (5.6 ng/mL), total cholesterol (61.8 mg/dL) and LDL (9.3 mmol/L) levels were significantly increased in the HED group. PLE administration in the HED group decreased these levels. The levels of HDL (26.8 mmol/L) in the HED + PLE group were higher than both control and HED groups. Chemical composition was investigated and luteolin 7-O-glucoside and chlorogenic acid were determined for the first time in Turkish sample from the EtOAc extract of leaves. Discussion and conclusion Phillyrea latifolia leaves may have beneficial effects on obesity related cellular problems and may become a good source of antidiabetic medication.
C1 [Yazici-Tutunis, Secil] Istanbul Univ, Fac Pharm, Dept Pharmacognosy, TR-34116 Istanbul, Turkey.
   [Gurel-Gurevin, Ebru; Demirci-Tansel, Cihan] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey.
   [Ustunova, Savas] Bezmialem Vakf Univ, Fac Med, Dept Physiol, Bezmialem, Turkey.
   [Mericli, Filiz] Near East Univ, Fac Pharm, Dept Pharmacognosy & Phytopharm Phytotherapy, Nicosia, Trnc Mersin, Turkey.
C3 Istanbul University; Istanbul University; Bezmialem Vakif University; Near East University
RP Yazici-Tutunis, S (corresponding author), Istanbul Univ, Fac Pharm, Dept Pharmacognosy, TR-34116 Istanbul, Turkey.
EM secilyaz@istanbul.edu.tr
FU Research Found of the University of Istanbul [6387]
CR Altunkaynak Z, 2005, EUR J GEN MED, V2, P100, DOI 10.29333/ejgm/82319
   Ayranci E, 2013, MOLECULES, V18, P1798, DOI 10.3390/molecules18021798
   Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488
   Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107
   Davis P H, 1978, FLORA OF TURKEY AND THE EAST AEGEAN ISLANDS, Vol, P0
   de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028
   Díaz AM, 2000, BIOL PHARM BULL, V23, P1307, DOI 10.1248/bpb.23.1307
   Estadella D, 2004, NUTRITION, V20, P218, DOI 10.1016/j.nut.2003.10.008
   ESTORNELL E, 1995, J NUTR, V125, P1309
   Henning B, 2001, J AM COLL NUTR, V20, P97, DOI 10.1080/07315724.2001.10719021
   Janakat S, 2002, J ETHNOPHARMACOL, V83, P135, DOI 10.1016/S0378-8741(02)00241-6
   Lanza AMD, 2001, PLANTA MED, V67, P219, DOI 10.1055/s-2001-12004
   Meriçli AH, 2006, PHARM BIOL, V44, P643, DOI 10.1080/13880200601006830
   Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964
   Mozes S, 2004, PHYSIOL RES, V53, P177, DOI 10.33549/physiolres.930388
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pieroni A, 2000, J ETHNOPHARMACOL, V70, P213, DOI 10.1016/S0378-8741(99)00169-5
   PUGALENDHI KV, 1990, INDIAN J EXP BIOL, V28, P895
   Reuter TY, 2007, DRUG DISCOV. TODAY DIS. MODELS, V4, P3, DOI 10.1016/j.ddmod.2007.09.004
   Sefcíková Z, 2008, PHYSIOL RES, V57, P467, DOI 10.33549/physiolres.931117
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Szer U, 2006, SCI PHARM, V74, P203, DOI 10.3797/scipharm.2006.74.203
   Tomkin GeealdH, 2012, OPEN ATHEROSCLEROSIS AND THROMBOSIS JOURNAL, V5, P13, DOI 10.2174/1876506801205010013
   Tuzlac E, 2007, ISTANBULJPHARM, V39, P39, DOI 10.16883/JFPIU.37197
NR 24
TC 5
Z9 6
U1 1
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD JUN 15
PY 2016
VL 54
IS 10
BP 1991
EP 1997
DI 10.3109/13880209.2015.1137952
PG 7
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA DZ7JP
UT WOS:000386041500006
PM 26850900
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Kaats, GR
   Preuss, HG
AF Stohs, Sidney J.
   Kaats, Gilbert R.
   Preuss, Harry G.
TI Safety and Efficacy of Banaba-Moringa oleifera-Green Coffee Bean Extracts and Vitamin D3 in a Sustained Release Weight Management Supplement
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE Moringa oleifera; green coffee bean extract; Lagerstroemia speciosa (banaba); vitamin D
ID chlorogenic acid; body-weight; overweight; svetol(r); healthy
AB This 60-day, 30-subject pilot study examined a novel combination of ingredients in a unique sustained release (Carbopol matrix) tablet consumed twice daily. The product was composed of extracts of banaba leaf, green coffee bean, and Moringa oleifera leaf and vitamin D3. Safety was assessed using a 45-measurement blood chemistry panel, an 86-item self-reported Quality of Life Inventory, bone mineral density, and cardiovascular changes. Efficacy was assessed by calculating a body composition improvement index (BCI) based on changes in dual energy X-ray absorptiometry measured fat mass (FM) and fat-free mass (FFM) as well as between the study group (SG) and a historical placebo group. No changes occurred in any blood chemistry measurements. Positive changes were found in the Quality of Life (QOL) inventory composite scores. No adverse effects were observed. Decreases occurred in FM (p=0.004) and increases in FFM (p=0.009). Relative to the historical placebo group, the SG lost more FM (p<0.0001), gained more FFM (p=<0.0001), and had a negative BCI of -2.7lb. compared with a positive BCI in the SG of 3.4lb., a 6.1 discordance (p=0.0009). The data support the safety and efficacy of this unique product and demonstrate importance of using changes in body composition versus scale weight and BMI. (c) 2016 The Authors Phytotherapy Research Published by John Wiley & Sons Ltd
C1 [Stohs, Sidney J.] Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.
   [Kaats, Gilbert R.] Integrat Hlth Technol Inc, 5170 Broadway, San Antonio, TX USA.
   [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA.
C3 Creighton University; Georgetown University
RP Stohs, SJ (corresponding author), Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.
EM sid.stohs9@gmail.com
FU AdvoCare International
CR Arbeeny CM, 2004, OBES RES, V12, P1191, DOI 10.1038/oby.2004.150
   Cipriani C, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/841248
   Duffy KJ, 2011, PLOS MED, V8, P0, DOI 10.1371/Jounral.pmed.1001050
   Esteghamati A, 2015, INT J ENDOCRINOL MET, V13, P0, DOI 10.5812/ijem.19678
   Ferraro ZM, 2015, CLIN MED INSIGHTS-EN, V8, P7, DOI 10.4137/CMED.S23060
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012
   Kaats GR, 2006, J AM COLL NUTR, V25, P389, DOI 10.1080/07315724.2006.10719550
   Kaats GR, 2013, OBESITY EPIDEMIOLOGY, V0, P833
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI 10.1039/C4FO00290C
   Mbikay M, 2012, FRONT PHARMACOL, V3, P0, DOI 10.3389/fphar.2012.00024
   Nardon K, 2007, AGRO FOOD IND HI TEC, V18, P37
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Opala T, 2006, EUR J MED RES, V11, P343
   Patel C, 2008, FOOD CHEM TOXICOL, V46, P2728, DOI 10.1016/j.fct.2008.04.035
   Pathak K, 2014, OBES REV, V15, P528, DOI 10.1111/obr.12162
   Pérez-Vásquez A, 2014, J NAT PROD, V77, P516, DOI 10.1021/np400785z
   Shanmugalingam T, 2014, BMC CANCER, V14, P0, DOI 10.1186/1471-2407-14-712
   Shim KS, 2009, PHYTOTHER RES, V23, P1754, DOI 10.1002/ptr.2843
   Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Vaughan RA, 2014, ISRN NUTR, V0, P0, DOI DOI 10.1155/2014/650264
NR 23
TC 2
Z9 2
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD APR 15
PY 2016
VL 30
IS 4
BP 681
EP 688
DI 10.1002/ptr.5577
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DJ1VQ
UT WOS:000373993500018
PM 26871553
DA 2025-04-28
ER

PT J
AU Santos, RMM
   Lima, DRA
AF Santos, Roseane Maria Maia
   Andrade Lima, Darcy Roberto
TI Coffee consumption, obesity and type 2 diabetes: a mini-review
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Review
DE Coffee; Obesity; Diabetes; Chlorogenic acid; Caffeine
ID activated protein-kinase; hormone-binding globulin; to-height ratio; chlorogenic acid; insulin-resistance; decaffeinated coffee; oxidative stress; cardiovascular-disease; adiponectin receptors; waist circumference
AB Purpose The effects of regular coffee intake on weight gain and development of diabetes are reviewed. The pathophysiology of obesity and type 2 diabetes as well as the necessity of preventive options based on the increasing prevalence of these two disorders worldwide is briefly discussed. The relationship between weight gain and development of diabetes is also presented. The two major constituents in the brewed coffee, chlorogenic acids and caffeine, are responsible for many of the beneficial effects suggested by numerous epidemiological studies of coffee consumption and the development of diabetes. Methods A wide search of various databases, such as PubMed and Google Scholar, preceded the writing of this manuscript, focusing on key words that are part of the title. It was selected mainly review papers from in vivo, ex vivo, in vitro experimental studies in animals and human tissues as well as wide population-based epidemiological studies in the last 10 years. Conclusion As of today, there are mounting evidences of the reduced risk of developing type 2 diabetes by regular coffee drinkers of 3-4 cups a day. The effects are likely due to the presence of chlorogenic acids and caffeine, the two constituents of coffee in higher concentration after the roasting process.
C1 [Santos, Roseane Maria Maia] South Univ, Sch Pharm, Dept Pharmaceut Sci, 709 Mall Blvd, Savannah, GA 31419 USA.
   [Andrade Lima, Darcy Roberto] Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Botafogo, RJ, Brazil.
C3 Universidade Federal do Rio de Janeiro
RP Santos, RMM (corresponding author), South Univ, Sch Pharm, Dept Pharmaceut Sci, 709 Mall Blvd, Savannah, GA 31419 USA.
EM rsantos@southuniversity.edu
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 2012, DIAB REP CARD 2012, V0, P0
   Unknown -, 2015, COFFEE IN HEALTH AND DISEASE PREVENTION, V0, P0
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   ASTRUP A, 1993, INT J OBESITY, V17, P0
   Astrup A, 2000, OBES REV, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bailey CJ, 2011, BMJ-BRIT MED J, V342, P0, DOI 10.1136/bmj.d1996
   Barbagallo Mario, 2003, MOLECULAR ASPECTS OF MEDICINE, V24, P39, DOI 10.1016/S0098-2997(02)00090-0
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P4597, DOI 10.1021/jf8004004
   Belin RJ, 2007, MAGNESIUM RES, V20, P107
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Cavin C, 2001, FOOD CHEM TOXICOL, V39, P549, DOI 10.1016/S0278-6915(00)00168-X
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Cruz R, 2015, FOOD RES INT, V73, P190, DOI 10.1016/j.foodres.2014.11.018
   Davidson MH, 2006, AM J CARDIOL, V98, P27I, DOI 10.1016/j.amjcard.2005.12.024
   de Valk HW, 1999, NETH J MED, V54, P139, DOI 10.1016/S0300-2977(99)00005-4
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elkaim Y, 2011, NEWS STUDIES CONFIRM, V0, P0
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A, 2015, COFFEE IN HEALTH AND DISEASE PREVENTION, V0, P0
   Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, P0, DOI 10.1186/1475-2840-13-103
   Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Fumeaux R, 2010, ORG BIOMOL CHEM, V8, P5199, DOI 10.1039/c0ob00137f
   Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, PE1009, DOI 10.1152/ajpendo.90558.2008
   Goldstein E, 2010, J INT SOC SPORT NUTR, V7, P0, DOI 10.1186/1550-2783-7-18
   Goto A, 2014, CLIN CHEM, V60, P174, DOI 10.1373/clinchem.2013.207217
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Graham TE, 2001, CAN J APPL PHYSIOL, V26, PS103, DOI 10.1139/h2001-046
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016
   Hamer M, 2008, BRIT J NUTR, V100, P1046, DOI 10.1017/S0007114508944135
   HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   Hiltunen LA, 2006, EUR J CLIN NUTR, V60, P1222, DOI 10.1038/sj.ejcn.1602441
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   International Diabetes F, 2013, 66 WORLD HLTH ASS, V0, P0
   International Diabetes F, 2013, IDF ATL, V0, P0
   Jia HJ, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0389-3
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x
   Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892
   Kodiha M, 2011, TARGETING AMPK THERA, V1, P0
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   LARSSON B, 1984, BMJ-BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401
   Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343
   Leong KS, 1999, BEST PRACT RES CL EN, V13, P221, DOI 10.1053/beem.1999.0017
   Lopaschuk GD, 2008, INT J OBESITY, V32, PS29, DOI 10.1038/ijo.2008.120
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Malloy MJ, 2015, BASIC CLIN PHARM, V0, P0
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Monente C, 2015, J AGR FOOD CHEM, V63, P4327, DOI 10.1021/acs.jafc.5b01619
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Morisco F, 2014, J CLIN GASTROENTEROL, V48, PS87, DOI 10.1097/MCG.0000000000000240
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   NAISMITH DJ, 1970, NUTR METAB, V12, P144
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   NEHLIG A, 1994, INT J SPORTS MED, V15, P215, DOI 10.1055/s-2007-1021049
   Nuhu Abdulmumin A, 2014, ISRN NUTR, V2014, P384230, DOI 10.1155/2014/384230
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Paluska Scott A, 2003, CURR SPORTS MED REP, V2, P213, DOI 10.1249/00149619-200308000-00008
   PAOLISSO G, 1990, DIABETOLOGIA, V33, P511, DOI 10.1007/BF00404136
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Pincock S, 2006, LANCET, V368, P1643, DOI 10.1016/S0140-6736(06)69682-7
   Redeuil K, 2011, J CHROMATOGR A, V1218, P4678, DOI 10.1016/j.chroma.2011.05.050
   Rivera J, 2014, UNLOCKING COFFEES 1, V0, P0
   Robinson K, 2011, CRIT CARE, V15, P0, DOI 10.1186/cc10021
   Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x
   Rustenbeck I, 2014, NUTR DIABETES, V4, P0, DOI 10.1038/nutd.2014.19
   Santos RM, 2009, UNASHAMED DEFENSE CO, V0, P0
   Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220
   Serafini M, 2009, CLIN DERMATOL, V27, P225, DOI 10.1016/j.clindermatol.2008.04.007
   Slow S, 2004, EUR J CLIN NUTR, V58, P1253, DOI 10.1038/sj.ejcn.1601957
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   SPRIET LL, 1995, INT J SPORT NUTR, V5, PS84, DOI 10.1123/ijsn.5.s1.s84
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Takahashi S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091134
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Troup GJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122834
   van Dam R M, 2006, NED TIJDSCHR GENEESKD, V150, P1821
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2006, ANN INTERN MED, V145, P634, DOI 10.7326/0003-4819-145-8-200610170-00018
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wu X, 1997, MUTAT RES-GEN TOX EN, V391, P171, DOI 10.1016/S1383-5718(97)00065-X
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Zanotti I, 2015, FOOD FUNCT, V6, P13, DOI 10.1039/c4fo00670d
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 125
TC 118
Z9 127
U1 2
U2 80
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN 15
PY 2016
VL 55
IS 4
BP 1345
EP 1358
DI 10.1007/s00394-016-1206-0
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DM6UN
UT WOS:000376488200003
PM 27026242
DA 2025-04-28
ER

PT J
AU Pan, MH
   Tung, YC
   Yang, GL
   Li, SM
   Ho, CT
AF Pan, Min-Hsiung
   Tung, Yen-Chen
   Yang, Guliang
   Li, Shiming
   Ho, Chi-Tang
TI Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee
SO FOOD & FUNCTION
LA English
DT Review
ID pu-erh tea; green tea; body-weight; adipose-tissue; gut microbiota; black tea; adipocyte differentiation; phenolic-compounds; glucose-tolerance; physical-activity
AB Obesity is a serious health problem in adults and children worldwide. However, the basic strategies for the management of obesity (diet, exercise, drugs and surgery) have limitations and side effects. Therefore, many researchers have sought to identify bioactive components in food. Tea and coffee are the most frequently consumed beverages in the whole world. Their health benefits have been studied for decades, especially those of green tea. The anti-obesity effect of tea and coffee has been studied for at least ten years. The results have shown decreased lipid accumulation in cells via the regulation of the cell cycle during adipogenesis, changes in transcription factors and lipogenesis-related proteins in the adipose tissue of animal models, and decreased body weight and visceral fat in humans. Tea and coffee also influence the gut microbiota in obese animals and humans. Although the anti-obesity mechanism of tea and coffee still needs further clarification, they may have potential as a new strategy to prevent or treat obesity.
C1 [Pan, Min-Hsiung; Yang, Guliang; Li, Shiming] Huanggang Normal Univ, Hubei Collaborat Innovat Ctr the Characterist Res, AHubei Key Lab Econ Forest Germplasm Improvement, Huanggang, Hubei, Peoples R China.
   [Pan, Min-Hsiung; Tung, Yen-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
C3 Huanggang Normal University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Rutgers University System; Rutgers University New Brunswick
RP Pan, MH (corresponding author), Huanggang Normal Univ, Hubei Collaborat Innovat Ctr the Characterist Res, AHubei Key Lab Econ Forest Germplasm Improvement, Huanggang, Hubei, Peoples R China.; Pan, MH; Tung, YC (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
EM mhpan@ntu.edu.tw; emjine@gmail.com
CR Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 2014, ECONOMIC RESEARCH SERVICE: DATASET ON INTERNATIONAL AGRICULTURAL PRODUCTIVITY, V0, P0
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Axling U, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-105
   Baothman OA, 2016, LIPIDS HEALTH DIS, V15, P0, DOI 10.1186/s12944-016-0278-4
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bjorndal B, 2011, J OBES, V2011, P0, DOI 10.1155/2011/490650
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Caesar R, 2008, J LIPID RES, V49, P1588, DOI 10.1194/jlr.D800013-JLR200
   Cao ZH, 2013, PHYTOTHER RES, V27, P1193, DOI 10.1002/ptr.4831
   Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247
   Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   DESALVO KB, 2016, JAMA-J AM MED ASSOC, V315, P457, DOI 10.1001/JAMA.2015.18396
   Dou JP, 2007, J AGR FOOD CHEM, V55, P7462, DOI 10.1021/jf0718603
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   French S, 2003, CURR OPIN CLIN NUTR, V6, P629, DOI 10.1097/00075197-200311000-00004
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130
   GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Harrold JA, 2000, J NEUROCHEM, V74, P1224
   Haslam E, 2003, PHYTOCHEMISTRY, V64, P61, DOI 10.1016/S0031-9422(03)00355-8
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200
   Huang YW, 2009, J FUNCT FOODS, V1, P304, DOI 10.1016/j.jff.2009.06.002
   Ito Y, 2008, BIOMED RES-TOKYO, V29, P27, DOI 10.2220/biomedres.29.27
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jeong JY, 2015, CELL TISSUE RES, V362, P87, DOI 10.1007/s00441-015-2191-y
   Jeong JY, 2015, CELL BIOL INT, V39, P52, DOI 10.1002/cbin.10343
   Jéquier E, 2002, INT J OBESITY, V26, PS12, DOI 10.1038/sj.ijo.0802123
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Karagozian R, 2014, METABOLISM, V63, P607, DOI 10.1016/j.metabol.2014.01.011
   Kemperman RA, 2013, FOOD RES INT, V53, P659, DOI 10.1016/j.foodres.2013.01.034
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kopelman PG, 2004, GUT, V53, P1044, DOI 10.1136/gut.2003.021816
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kromhout D, 2016, EUR J CLIN NUTR, V70, P869, DOI 10.1038/ejcn.2016.52
   Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Lai CS, 2015, CURR OPIN FOOD SCI, V2, P9, DOI 10.1016/j.cofs.2014.11.008
   Lao WG, 2015, AM J CHINESE MED, V43, P1177, DOI 10.1142/S0192415X15500676
   Lee H, 2013, J NUTR BIOCHEM, V24, P1232, DOI 10.1016/j.jnutbio.2012.09.007
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Monteiro R, 2008, J NUTR, V138, P2156, DOI 10.1093/jn/138.11.2156
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x
   Ogden CL, 2015, NCHS DATA BRIEF, V0, PP1, DOI 10.1017/S1368980017000088
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   OSullivan MG, 2016, ENCYCLOPEDIA OF FOOD AND HEALTH, V0, P571
   Park B, 2016, ARCH PHARM RES, V39, P310, DOI 10.1007/s12272-015-0674-8
   Portune KJ, 2017, MOL NUTR FOOD RES, V61, P0, DOI 10.1002/mnfr.201600252
   Preedy VR, 2014, COFFEE IN HEALTH AND DISEASE, V0, P0
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Saris W H M, 2003, OBES REV, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x
   Sarjeant K, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a008417
   Schneeberger M, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep16643
   Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720
   Seo DB, 2015, J MED FOOD, V18, P549, DOI 10.1089/jmf.2014.3265
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Stern J S, 1995, OBES RES, V3, P591
   Symonds ME, 2011, ADIPOSE TISSUE BIOLOGY, V0, P0
   Takahashi M, 1999, J NUTR SCI VITAMINOL, V45, P583, DOI 10.3177/jnsv.45.583
   Tanaka T, 2005, ACS SYM SER, V99, P188
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tian C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053796
   Trigueros L, 2013, CRIT REV FOOD SCI, V53, P929, DOI 10.1080/10408398.2011.574215
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Vermaak I, 2011, NAT PROD REP, V28, P1493, DOI 10.1039/c1np00035g
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   WEERAWATANAKORN M, 2015, FOOD SCIENCE AND HUMAN WELLNESS, V4, P133, DOI 10.1016/J.FSHW.2015.10.002
   Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P1, DOI 10.1038/sj.ijo.0800536
   WILLIAMSON DF, 1993, INT J OBESITY, V17, P279
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI 10.1039/c4fo00095a
   Yan JQ, 2013, SCI CHINA LIFE SCI, V56, P804, DOI 10.1007/s11427-013-4512-2
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang Y, 2015, FITOTERAPIA, V104, P45, DOI 10.1016/j.fitote.2015.05.007
   Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005
   Zhang X, 2014, J AGR FOOD CHEM, V62, P10046, DOI 10.1021/jf5016335
   Zhang Y, 2012, J FUNCT FOODS, V4, P315, DOI 10.1016/j.jff.2011.12.010
   Zheng GD, 2004, IN VIVO, V18, P55
NR 104
TC 84
Z9 85
U1 4
U2 100
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 15
PY 2016
VL 7
IS 11
BP 4481
EP 4491
DI 10.1039/c6fo01168c
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA EC8AT
UT WOS:000388363000001
PM 27722362
DA 2025-04-28
ER

PT J
AU Amarra, MSV
   Khor, GL
   Chan, P
AF Amarra, Maria Sofia V.
   Khor, Geok Lin
   Chan, Pauline
TI Intake of added sugar in Malaysia: a review
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Review
DE sugar; intake; added sugars; sources; Malaysia
ID risk-factors; fructose; nutrition; obesity; energy
AB The term 'added sugars' refers to sugars and syrup added to foods during processing or preparation, and sugars and syrups added at the table. Calls to limit the daily intakes of added sugars and its sources arose from evidence analysed by WHO, the American Heart Association and other organizations. The present review examined the best available evidence regarding levels of added sugar consumption among different age and sex groups in Malaysia and sources of added sugars. Information was extracted from food balance sheets, household expenditure surveys, nutrition surveys and published studies. Varying results emerged, as nationwide information on intake of sugar and foods with added sugar were obtained at different times and used different assessment methods. Data from the 2003 Malaysian Adult Nutrition Survey (MANS) using food frequency questionnaires suggested that on average, Malaysian adults consumed 30 grams of sweetened condensed milk (equivalent to 16 grams sugar) and 21 grams of table sugar per day, which together are below the WHO recommendation of 50 grams sugar for every 2000 kcal/day to reduce risk of chronic disease. Published studies suggested that, for both adults and the elderly, frequently consumed sweetened foods were beverages (tea or coffee) with sweetened condensed milk and added sugar. More accurate data should be obtained by conducting population-wide studies using biomarkers of sugar intake (e.g. 24-hour urinary sucrose and fructose excretion or serum abundance of the stable isotope C-13) to determine intake levels, and multiple 24 hour recalls to identify major food sources of added sugar.
C1 [Amarra, Maria Sofia V.; Chan, Pauline] Int Life Sci Inst Southeast Asia Reg ILSI SEA, Sci Programs, 9 Mohamed Sultan Rd 02-01, Singapore 238959, Singapore.
   [Khor, Geok Lin] Int Med Univ, Sch Hlth Sci, Kuala Lumpur 57000, Malaysia.
C3 International Medical University Malaysia
RP Amarra, MSV (corresponding author), Int Life Sci Inst Southeast Asia Reg ILSI SEA, Sci Programs, 9 Mohamed Sultan Rd 02-01, Singapore 238959, Singapore.
EM sofiaamarra@ilsisea.org.sg
FU International Life Sciences Institute Southeast Asia Region
CR Unknown -, 1997, NUTR COMPOSITION MAL, V0, P0
   Unknown -, 2013, WORLD HEALTH STATISTICS 2013: A WEALTH OF INFORMATION ON GLOBAL PUBLIC HEALTH, V0, P0
   Unknown -, 2005, DIET REF INT EN CARB, V0, P0
   Unknown -, 2010, REPORT OF THE DIETARY GUIDELINES ADVISORY COMMITTEE ON THE DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Bellisle F, 2012, J NUTR, V142, P1149S, DOI 10.3945/jn.111.149583
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866
   Boo NY, 2010, SINGAP MED J, V51, P126
   Boon TeoYee Boon TeoYee, 2012, AMERICAN JOURNAL OF FOOD AND NUTRITION, V2, P69, DOI 10.5251/ajfn.2012.2.3.69.77
   Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Chan TF, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0082004
   Gan W Y, 2011, MALAYS J NUTR, V17, P213
   Hedrick VE, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-109
   Huat F L, 2006, MALAYS J NUTR, V12, P11
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814
   Khitan Z, 2013, J NUTR METAB, V2013, P0, DOI 10.1155/2013/682673
   Manaf ZA, 2012, MALAYS J MED SCI, V19, P56
   Mann J, 2007, EUR J CLIN NUTR, V61, PS132, DOI 10.1038/sj.ejcn.1602943
   Mirnalini K Jr, 2008, MALAYS J NUTR, V14, P1
   Moher D, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.i4086
   Morenga LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.e7492
   Moynihan P, 2004, PUBLIC HEALTH NUTR, V7, P201, DOI 10.1079/PHN2003589
   Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954
   Nash SH, 2014, EUR J CLIN NUTR, V68, P91, DOI 10.1038/ejcn.2013.230
   Nurul-Fadhilah A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059297
   Saw WS, 2012, PAKISTAN JOURNAL OF NUTRITION, V11, P1066
   Shahar S, 2000, ASIA PAC J CLIN NUTR, V9, P122, DOI 10.1046/j.1440-6047.2000.00147.x
   Shahril MR, 2013, J NUTR METAB, V2013, P0, DOI 10.1155/2013/658642
   Shanita Nik S, 2012, MALAYS J NUTR, V18, P283
   Sigman-Grant M, 2003, AM J CLIN NUTR, V78, P815S, DOI 10.1093/ajcn/78.4.815S
   Smith LC, 2007, MEASURING FOOD SECURITY USING HOUSEHOLD EXPENDITURE SURVEYS, V0, P0, DOI DOI 10.2499/0896297675
   Tappy L, 2012, BMC BIOL, V10, P0, DOI 10.1186/1741-7007-10-42
   Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009
   Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827
   Van Horn Linda, 2010, CIRCULATION, V122, P2470, DOI 10.1161/CIR.0b013e3181ffdcb0
   WHO, 2003, WHO TECHN REP SER, V0, P0
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
   Zahara A M Jr, 2010, MALAYS J NUTR, V16, P83
   Zaini M Z Anuar, 2005, ASIA PAC J PUBLIC HEALTH, V17, P71, DOI 10.1177/101053950501700203
NR 55
TC 40
Z9 43
U1 2
U2 13
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PD JUN 15
PY 2016
VL 25
IS 2
BP 227
EP 240
DI 10.6133/apjcn.2016.25.2.13
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DN4PZ
UT WOS:000377051000002
PM 27222405
DA 2025-04-28
ER

PT J
AU Ezoe, M
   Wakamatsu, JI
   Takahata, Y
   Hasegawa, T
   Morimatsu, F
   Nishimura, T
AF Ezoe, Misako
   Wakamatsu, Jun-ichi
   Takahata, Yoshihisa
   Hasegawa, Takanori
   Morimatsu, Fumiki
   Nishimura, Takanori
TI Diet-Induced Thermogenesis and Expression Levels of Thyroid Hormone Target Genes and Their Products in Rats Differ between Meat Proteins
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE meat protein; diet-induced thermogenesis; brown adipose tissue; thyroid hormone target gene; UCP1
ID brown adipose-tissue; bioactive peptides; fat thermogenesis; molecular-basis; green tea; caffeine; obesity
AB We compared the effects of purified meat proteins on postprandial thermogenesis and on the secretion of and responsiveness to thyroid hormones (THs) in rats. Body temperatures at 2 h after feeding were significantly higher in the chicken and mutton protein groups than in the other groups, and these proteins seem to have a strong thermogenic effect. There were no significant differences in plasma TH concentrations among the groups, but levels of TH-responsive Spot 14 protein in the liver and brown adipose tissue were significantly higher in the chicken and mutton protein groups than in the other groups. Levels of malic enzyme 1 protein in the liver and brown adipose tissue were significantly higher in the chicken protein group than in the other groups except for the mutton protein group. Furthermore, levels of uncoupling protein 1 were higher in the chicken and mutton protein groups than in the other groups. The results suggest that the difference in postprandial thermogenesis of meat is strongly dependent on meat proteins; chicken and mutton proteins are strong promoters of postprandial thermogenesis, and THs may contribute to this effect. Since strong postprandial thermogenesis and high expression levels of TH target genes and their products were not observed in the amino acid group, chicken and mutton proteins or their digested peptides might contribute to these effects.
C1 [Ezoe, Misako; Wakamatsu, Jun-ichi; Nishimura, Takanori] Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.
   [Ezoe, Misako; Takahata, Yoshihisa; Hasegawa, Takanori; Morimatsu, Fumiki] Nippon Meat Packer Inc, R&D Ctr, 3-3 Midorigahara, Tsukuba, Ibaraki 3002646, Japan.
C3 Hokkaido University; NH Foods Ltd.
RP Wakamatsu, JI (corresponding author), Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.
EM jwaka@anim.agr.hokudai.ac.jp
CR BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6
   Branco M, 1999, AM J PHYSIOL-ENDOC M, V276, PE179, DOI 10.1152/ajpendo.1999.276.1.E179
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Carlson GL, 1997, BAILLIERE CLIN ENDOC, V11, P603, DOI 10.1016/S0950-351X(97)80878-6
   Collin A, 2005, DOMEST ANIM ENDOCRIN, V29, P78, DOI 10.1016/j.domaniend.2005.02.007
   Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947
   Fitzgerald RJ, 2006, INT J DAIRY TECHNOL, V59, P118, DOI 10.1111/j.1471-0307.2006.00250.x
   Gabarrou JF, 1997, BRIT J NUTR, V78, P963, DOI 10.1079/BJN19970212
   GALTON VA, 1991, ENDOCRINOLOGY, V128, P1717, DOI 10.1210/endo-128-4-1717
   Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   GLICK Z, 1989, PHYSIOL BEHAV, V45, P243, DOI 10.1016/0031-9384(89)90125-X
   Jequier E, 1983, EXPERIENTIA SUPPL, V44, P26
   Kagawa Y, 2011, STANDARD TABLES FOOD, V0, P0
   KARST H, 1984, ANN NUTR METAB, V28, P245, DOI 10.1159/000176811
   Kastner J, 2009, CHINESE NUTRITION THERAPY: DIETETICS IN TRADITIONAL CHINESE MEDICINE (TCM), Vsecond, P0
   Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266
   Kodera T, 2006, J FOOD SCI, V71, PC164, DOI 10.1111/j.1365-2621.2006.tb15612.x
   Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012
   LIAW CW, 1984, J BIOL CHEM, V259, P7253
   Nihon chui shokuyo gakkai, 2009, YAK ZEN HDB, V0, P0
   OBREGON MJ, 1989, AM J PHYSIOL, V257, PE625, DOI 10.1152/ajpendo.1989.257.5.E625
   Obregon MJ, 1996, ENDOCRINOLOGY, V137, P4721, DOI 10.1210/en.137.11.4721
   RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003
   Rizzello CG, 2005, J DAIRY SCI, V88, P2348, DOI 10.3168/jds.S0022-0302(05)72913-1
   ROTHWELL NJ, 1983, HORM METAB RES, V15, P394, DOI 10.1055/s-2007-1018733
   Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40
   Scott CB, 2005, NUTRITION, V21, P874, DOI 10.1016/j.nut.2004.12.010
   Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005
   SILVA JE, 1988, MOL ENDOCRINOL, V2, P706, DOI 10.1210/mend-2-8-706
   Wakamatsu J, 2013, J NUTR SCI VITAMINOL, V59, P516, DOI 10.3177/jnsv.59.516
   Wakamatsu J, 2013, ANIM SCI J, V84, P416, DOI 10.1111/asj.12013
   Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x
   Westerterp Klaas R, 2004, NUTR METAB (LOND), V1, P5
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097
NR 39
TC 6
Z9 7
U1 0
U2 7
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD APR 15
PY 2016
VL 62
IS 2
BP 93
EP 100
DI 
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DL1AE
UT WOS:000375363500004
PM 27264093
DA 2025-04-28
ER

PT J
AU Cheng, DM
   Roopchand, DE
   Poulev, A
   Kuhn, P
   Armas, I
   Johnson, WD
   Oren, A
   Ribnicky, D
   Zelzion, E
   Bhattacharya, D
   Raskin, I
AF Cheng, Diana M.
   Roopchand, Diana E.
   Poulev, Alexander
   Kuhn, Peter
   Armas, Isabel
   Johnson, William D.
   Oren, Andrew
   Ribnicky, David
   Zelzion, Ehud
   Bhattacharya, Debashish
   Raskin, Ilya
TI High phenolics Rutgers Scarlet Lettuce improves glucose metabolism in high fat diet-induced obese mice
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Bioaccessibility; Gut microbiota; Lettuce; Metabolic syndrome; Phenolics
ID green coffee extract; chlorogenic acid; alpha-glucosidase; cinnamon extract; caffeic acid; polyphenols; quercetin; bioavailability; inflammation; cholesterol
AB Scope: The ability of high phenolic Rutgers Scarlet Lettuce (RSL) to attenuate metabolic syndrome and gut dysbiosis was studied in very high fat diet (VHFD)-fed mice. Phenolic absorption was assessed in vivo and in a gastrointestinal tract model. Methods and results: Mice were fed VHFD, VHFD supplemented with RSL (RSL-VHFD) or store-purchased green lettuce (GL-VHFD), or low-fat diet (LFD) for 13 weeks. Compared to VHFD or GL-VHFD-fed groups, RSL-VHFD group showed significantly improved oral glucose tolerance (p<0.05). Comparison of VHFD, RSL-VHFD, and GL-VHFD groups revealed no significant differences with respect to insulin tolerance, hepatic lipids, body weight gain, fat mass, plasma glucose, triglycerides, free fatty acid, and lipopolysaccharide levels, as well as relative abundances of major bacterial phyla from 16S rDNA amplicon data sequences (from fecal and cecal samples). However, RSL and GL-supplementation increased abundance of several taxa involved in plant polysaccharide degradation/fermentation. RSL phenolics chlorogenic acid, quercetin-3-glucoside, and quercetin-malonyl-glucoside were bioaccessible in the TIM-1 digestion model, but had relatively low recovery. Conclusions: RSL phenolics contributed to attenuation of post-prandial hyperglycemia. Changes in gut microbiota were likely due to microbiota accessible carbohydrates in RSL and GL rather than RSL phenolics, which may be metabolized, absorbed, or degraded before reaching the colon.
C1 [Cheng, Diana M.; Roopchand, Diana E.; Poulev, Alexander; Kuhn, Peter; Armas, Isabel; Oren, Andrew; Ribnicky, David; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.
   [Zelzion, Ehud; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA.
   [Johnson, William D.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers University System; Rutgers University New Brunswick; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center
RP Raskin, I (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.
EM raskin@aesop.rutgers.edu
FU National Center for Complementary and Alternative Medicine (NCCAM) [P50AT002776-01]; Office of Dietary Supplements (ODS); National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940];  [R01 AT 008618-01]
CR Adisakwattana S, 2011, PLANT FOOD HUM NUTR, V66, P143, DOI 10.1007/s11130-011-0226-4
   Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Blum J, 2007, NUTRAFOODS, V6, P13
   Bouayed J, 2012, FOOD CHEM, V131, P1466, DOI 10.1016/j.foodchem.2011.10.030
   Cheng DM, 2014, NUTRITION, V30, PS52, DOI 10.1016/j.nut.2014.02.022
   Cheng DM, 2012, FOOD CHEM, V135, P2994, DOI 10.1016/j.foodchem.2012.06.117
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   DArchivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   DuPont MS, 2002, J NUTR, V132, P172, DOI 10.1093/jn/132.2.172
   Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Finucane MM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084689
   Gannon NP, 2015, MOL NUTR FOOD RES, V59, P48, DOI 10.1002/mnfr.201400414
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Gonzales GB, 2016, FOOD RES INT, V88, P342, DOI 10.1016/j.foodres.2015.12.023
   Hassellund SS, 2013, J HUM HYPERTENS, V27, P100, DOI 10.1038/jhh.2012.4
   Karlsen A, 2007, J NUTR, V137, P1951
   Kaulmann A, 2016, FOOD CHEM, V197, P325, DOI 10.1016/j.foodchem.2015.10.049
   Kawabata K, 2015, FOOD FUNCT, V6, P1399, DOI 10.1039/C4FO01178C
   Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lila MA, 2012, J AGR FOOD CHEM, V60, P5763, DOI 10.1021/jf203526h
   Manach C, 2005, AM J CLIN NUTR, V81, P230S, DOI 10.1093/ajcn/81.1.230S
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Morand C, 2000, BIOFACTORS, V12, P169, DOI 10.1002/biof.5520120127
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   Nieman DC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072215
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Ou KQ, 2014, J FUNCT FOODS, V7, P43, DOI 10.1016/j.jff.2013.08.004
   Pfeuffer M, 2013, NUTR METAB CARDIOVAS, V23, P403, DOI 10.1016/j.numecd.2011.08.010
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075
   Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916
   Roopchand DE, 2013, PHARMACOL RES, V68, P59, DOI 10.1016/j.phrs.2012.11.008
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   Segata N, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-6-r60
   Shihabudeen HMS, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-46
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tang Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0073402
   Vital M, 2014, MBIO, V5, P0, DOI 10.1128/mBio.00889-14
   Williamson G, 2005, AM J CLIN NUTR, V81, P243S, DOI 10.1093/ajcn/81.1.243S
   Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511
NR 47
TC 14
Z9 16
U1 1
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD NOV 15
PY 2016
VL 60
IS 11
BP 2367
EP 2378
DI 10.1002/mnfr.201600290
PG 12
WC Food Science & Technology
SC Food Science & Technology
GA ED8PU
UT WOS:000389134200005
PM 27529448
DA 2025-04-28
ER

PT J
AU Wu, CH
   Pan, CH
   Lee, CK
   Sheu, MJ
   Liu, FC
   Wang, GJ
   Wu, CH
AF Wu, Chi-Han
   Pan, Chun-Hsu
   Lee, Ching-Kuo
   Sheu, Ming-Jyh
   Liu, Fon-Chang
   Wang, Guei-Jane
   Wu, Chieh-Hsi
TI Antiobesity and antihyperlipidaemic effects of Yan-Sheng-Yin in animals and humans
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Adipocyte differentiation; Atherogenesis; Hyperlipidaemia; Obesity; Yan-Sheng-Yin
ID activated protein-kinase; adipose-specific protein; hibiscus-sabdariffa l.; high-fat diet; protocatechuic acid; adipocyte differentiation; rat-liver; plasma-concentrations; insulin sensitivity; chlorogenic acid
AB Yan-Sheng-Yin (YSY), a Chinese natural dietary supplement that promotes good health, is entirely composed of natural foods. Whether YSY is a potential adjuvant intervention for reducing hyperlipidaemia, atherogenesis, or obesity is unclear. This study evaluated the inhibitory effects and mechanisms of YSY for hyperlipidaemia, atherogenesis, and obesity. Experimental results showed that YSY reduced body weight, hyperlipidaemia, fatty liver, and atherogenesis in hyperlipidaemic mice. In addition, YSY promoted lipid metabolism by inducing adiponectin secretion and activation (phosphorylation) of 5' adenosine monophosphate-activated protein kinase (AMPK) and by suppressing the activation of acetylCoA carboxylase (ACC) and HMG-CoA reductase (HMGCR). Moreover, YSY inhibited adipocyte differentiation by suppressing peroxisome proliferator-activated receptor gamma (PPAR-gamma) and CCAAT/enhancer-binding proteins (C/EBPs). Furthermore, the antihyperlipidaemic effect of YSY was observed in the clinical trial. Our findings suggest that YSY is an adjuvant intervention for treating and preventing hyperlipidaemia, atherogenesis, and obesity. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Wu, Chi-Han; Sheu, Ming-Jyh; Liu, Fon-Chang; Wu, Chieh-Hsi] China Med Univ, Sch Pharm, Taichung 40402, Taiwan.
   [Pan, Chun-Hsu; Lee, Ching-Kuo; Wu, Chieh-Hsi] Taipei Med Univ, Dept Pharm, 250 Wu Hsing St, Taipei 11031, Taiwan.
   [Wang, Guei-Jane] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.
C3 China Medical University Taiwan; Taipei Medical University; China Medical University Taiwan
RP Wu, CH (corresponding author), Taipei Med Univ, Dept Pharm, 250 Wu Hsing St, Taipei 11031, Taiwan.
EM chhswu@tmu.edu.tw
FU Taipei Medical University [TMU102-AE1-B15]; Ministry of Science and Technology, Taiwan [MOST 104-2320-B-038-026]
CR Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Aziz Z, 2013, J ETHNOPHARMACOL, V150, P442, DOI 10.1016/j.jep.2013.09.042
   BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6
   Beltrán-Debón R, 2010, PHYTOMEDICINE, V17, P186, DOI 10.1016/j.phymed.2009.08.006
   Bisen PS, 2010, CURR MED CHEM, V17, P2419, DOI 10.2174/092986710791698495
   Bjomtorp P, 1974, HORMONE METABOLIC S, V4, P77
   CARLSON CA, 1973, J BIOL CHEM, V248, P378
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi SW, 2007, J MICROBIOL BIOTECHN, V17, P1970
   CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x
   Cui T, 2006, J AGR FOOD CHEM, V54, P4574, DOI 10.1021/jf060310m
   FAUST IM, 1978, AM J PHYSIOL, V235, PE279, DOI 10.1152/ajpendo.1978.235.3.E279
   Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200
   Fukushima M, 2001, EXP BIOL MED, V226, P758, DOI 10.1177/153537020222600808
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064
   Harini R, 2010, REDOX REP, V15, P71, DOI 10.1179/174329210X12650506623285
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Jose Jimmy, 2014, OMAN MED J, V29, P351, DOI 10.5001/omj.2014.93
   Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103
   Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002
   Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063
   Lin MC, 2015, J AGR FOOD CHEM, V63, P235, DOI 10.1021/jf505303s
   Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094
   Mallamaci F, 2002, J NEPHROL, V15, P507
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Mosshammer D, 2014, BRIT J CLIN PHARMACO, V78, P454, DOI 10.1111/bcp.12360
   Mottaghi A, 2014, SCAND J IMMUNOL, V80, P151, DOI 10.1111/sji.12190
   Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200
   Okabe Y, 2014, PHYTOMEDICINE, V21, P800, DOI 10.1016/j.phymed.2014.01.014
   Olvera-García V, 2008, J FOOD SCI, V73, PT75, DOI 10.1111/j.1750-3841.2008.00781.x
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pan CH, 2013, J SCI FOOD AGR, V93, P1278, DOI 10.1002/jsfa.5882
   Rogge BP, 2013, J AM COLL CARDIOL, V62, P1683, DOI 10.1016/j.jacc.2013.04.081
   Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120
   Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461
   Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200
   Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432
   TSI D, 1995, PLANTA MED, V61, P18, DOI 10.1055/s-2006-957990
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang DL, 2010, J AGR FOOD CHEM, V58, P12722, DOI 10.1021/jf103427j
   Wang XS, 1999, CHIN J CHIN MAT MED, V24, P739
   Wu CM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095452
   Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zeng F, 2013, J FOOD SCI, V78, PH1470, DOI 10.1111/1750-3841.12226
   Zhang JY, 2013, J ETHNOPHARMACOL, V148, P563, DOI 10.1016/j.jep.2013.04.053
NR 49
TC 1
Z9 1
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN 15
PY 2016
VL 24
IS 
BP 173
EP 182
DI 10.1016/j.jff.2016.04.004
PG 10
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA DP3BJ
UT WOS:000378367100018
DA 2025-04-28
ER

PT J
AU Hao, S
   Xiao, Y
   Lin, Y
   Mo, ZT
   Chen, Y
   Peng, XF
   Xiang, CH
   Li, YQ
   Li, WN
AF Hao, Shun
   Xiao, Yuan
   Lin, Yan
   Mo, Zhentao
   Chen, Yang
   Peng, Xiaofeng
   Xiang, Canhui
   Li, Yiqi
   Li, Wenna
TI Chlorogenic acid-enriched extract from Eucommia ulmoides leaves inhibits hepatic lipid accumulation through regulation of cholesterol metabolism in HepG2 cells
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE ABCA1; AMPK; chlorogenic acid; CYP7A1; HMGCR; lipid accumulation; SREBP2
ID hypolipidemic action; obesity; simvastatin; expression; hamsters; receptor; rats
AB Context: Eucommia ulmoides Oliver (Eucommiaceae) leaf exhibits beneficial lipid-lowering and anti-obesity effects. However, the mechanisms remain unknown.Objective: The objective of this study is to investigate the lipid-lowering effects of chlorogenic acid (CGA)-enriched extract from this plant (CAEF) in human hepatoma HepG2 cells, focusing on cholesterol metabolism.Materials and methods: HepG2 cells were treated with CAEF (10, 20, 25, 40, 60, and 80mg/L), CGA (0.3, 3, 30, 300, and 600mol/L), and simvastatin (0.1, 1, 10, 50, and 100mol/L) for 24 or 48h. The cytotoxicity, Oil red O staining, total cholesterol, and triacylglycerol in supernatants were determined. The mRNA expression of genes involved in cholesterol metabolism was determined with RT-PCR. The protein expression of HMG-CoA reductase (HMGCR) was examined by immunocytochemistry and western-blot.Results: The IC50 values were 59.2mg/L for CAEF, 335.9mol/L for CGA, and 10.5mol/L for simvastatin. By treating cells with CAEF (25mg/L), CGA (30mol/L), or simvastatin (10mol/L) for 48h, the efflux of total cholesterol and triacylglycerol was increased (CAEF, 4.06- and 31.00-folds; CGA, 2.94- and 2.17-folds; and simvastatin, 3.94- and 24.67-folds), and the cellular lipid droplets were reduced in Oil red O staining. CAEF and CGA increased mRNA expression of ABCA1, CYP7A1, and AMPK2, while CAEF and simvastatin decreased SREBP2. However, their effects on LXR mRNA expression were variable. Importantly, all drugs significantly inhibited protein expression of HMGCR at mRNA and protein levels.Discussion and conclusion: CAEF is a promising dietary supplement to prevent obesity and dyslipidemia and the effects appear to be due, at least in part, to regulating cholesterol metabolism through inhibition of HMGCR in HepG2 cells.
C1 [Hao, Shun; Lin, Yan; Mo, Zhentao; Chen, Yang; Peng, Xiaofeng; Xiang, Canhui; Li, Yiqi; Li, Wenna] Zunyi Med Univ, Zhuhai 519041, Guangdong, Peoples R China.
   [Xiao, Yuan] Guizhou Prov Peoples Hosp, Pharmaceut Preparat Sect, Guiyang, Guizhou, Peoples R China.
C3 Zunyi Medical University
RP Li, WN (corresponding author), Zunyi Med Univ, Zhuhai Campus, Zhuhai 519041, Guangdong, Peoples R China.
EM lielizabeth@126.com
FU Guizhou Provincial Modernization of Traditional Chinese Medicine Foundation of China [QKHZY [2013] 3018]; Project Natural Science Foundation of China [21162046]; Research Funds of Department of Education of Guizhou Province of China [QKJ 2010042]
CR Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004
   Borthwick F, 2014, ATHEROSCLEROSIS, V232, P141, DOI 10.1016/j.atherosclerosis.2013.10.031
   Chinese Pharmacopoeia Commission, 2005, CHIN PHARM, V0, P0
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606
   Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Hao L, 2011, INT J ENDOCRINOL MET, V31, P368, DOI 10.3760/cma.j.issn.1673-4157.2011.06.003
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Horii Y, 2010, NEUROSCI LETT, V479, P181, DOI 10.1016/j.neulet.2010.05.030
   Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689
   Kobayashi Y, 2012, J SCI FOOD AGR, V92, P358, DOI 10.1002/jsfa.4586
   Lao XQ, 2015, INT J OBESITY, V39, P288, DOI 10.1038/ijo.2014.95
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Li W, 2012, ZHONG YAO XIN YAO YU, V22, P30
   [李文娜 Li Wenna], 2012, 食品工业科技 SCIENCE & TECHNOLOGY OF FOOD INDUSTRY, V33, P137
   Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-67
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Murase T, 2010, AM J PHYSIOL-ENDOC M, V299, PE266, DOI 10.1152/ajpendo.00774.2009
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Pan CH, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/436786
   Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034
   Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005
   Shi XD, 2011, DIABETES RES CLIN PR, V91, P389, DOI 10.1016/j.diabres.2010.11.002
   Shin DJ, 2008, J BIOL CHEM, V283, P15089, DOI 10.1074/jbc.M710452200
   Spencer-Jones NJ, 2006, J MED GENET, V43, P936, DOI 10.1136/jmg.2006.041988
   Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang LL, 2014, CHINESE MED J-PEKING, V127, P218, DOI 10.3760/cma.j.issn.0366-6999.20131591
   Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645
   Yuan Tian-Yi, 2013, ZHONGGUO ZHONG YAO ZA ZHI, V38, P781
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhang XP, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061922
   Zhong D, 2013, LIPIDS HEALTH DIS, V12, P0, DOI 10.1186/1476-511X-12-32
NR 35
TC 67
Z9 72
U1 3
U2 93
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD FEB 1
PY 2016
VL 54
IS 2
BP 251
EP 259
DI 10.3109/13880209.2015.1029054
PG 9
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA CY2OG
UT WOS:000366247400009
PM 25845641
DA 2025-04-28
ER

PT J
AU Voerman, E
   Jaddoe, VWV
   Gishti, O
   Hofman, A
   Franco, OH
   Gaillard, R
AF Voerman, Ellis
   Jaddoe, Vincent W. V.
   Gishti, Olta
   Hofman, Albert
   Franco, Oscar H.
   Gaillard, Romy
TI Maternal Caffeine Intake During Pregnancy, Early Growth, and Body Fat Distribution at School Age
SO OBESITY
LA English
DT Article
ID birth-weight; coffee consumption; risk; adiposity; childhood; exposure; obesity; update; length; index
AB Objective: The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined. Methods: In a population-based birth cohort among 7,857 mothers and their children, maternal caffeine intake during pregnancy was assessed by questionnaires. Growth characteristics were measured from birth onward. At 6 years, body fat and insulin levels were measured. Results: Compared to children whose mothers consumed <2 units of caffeine per day during pregnancy (1 unit of caffeine is equivalent to 1 cup of coffee (90 mg caffeine)), those whose mothers consumed >= 6 units of caffeine per day tended to have a lower weight at birth, higher weight gain from birth to 6 years, and higher body mass index from 6 months to 6 years. Both children whose mothers consumed 4-5.9 and >= 6 units of caffeine per day during pregnancy tended to have a higher childhood body mass index and total body fat mass. Only children whose mothers consumed >= 6 units of caffeine per day had a higher android/gynoid fat mass ratio. Conclusions: These results suggest that high levels of maternal caffeine intake during pregnancy are associated with adverse offspring growth patterns and childhood body fat distribution.
C1 [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Generat Study Grp R, Rotterdam, Netherlands.
   [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Hofman, Albert; Franco, Oscar H.; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.
   [Voerman, Ellis; Jaddoe, Vincent W. V.; Gishti, Olta; Gaillard, Romy] Erasmus MC, Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC
RP Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Generat Study Grp R, Rotterdam, Netherlands.; Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.; Gaillard, R (corresponding author), Erasmus MC, Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands.
EM r.gaillard@erasmusmc.nl
FU Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development; Netherlands Organization for Health Research and Development (NWO) [ZonMw-VIDI 016.136.361]; European Research Council [ERC-2014-CoG-648916]; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; European Union [289346]
CR Unknown -, 2013, VOEDINGSCENTRUM, V0, P0
   Unknown -, 2006, NEVO TAB 20006 DUTCH, V0, P0
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Boylan S, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a2332
   Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288
   Chen LW, 2014, BMC MED, V12, P0, DOI 10.1186/s12916-014-0174-6
   Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006
   Gishti O, 2015, PEDIATR RES, V77, P710, DOI 10.1038/pr.2015.29
   GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5
   Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7
   Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071
   Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Ibáñez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778
   Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2015, EPIDEMIOLOGY, V26, P185, DOI 10.1097/EDE.0000000000000220
   Kruithof CJ, 2014, EUR J EPIDEMIOL, V29, P911, DOI 10.1007/s10654-014-9980-6
   Li DK, 2014, INT J OBES LOND, V39, P658
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002
   NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891
   Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037
   Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b2393
   SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V
   Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044497
NR 40
TC 30
Z9 33
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD MAY 15
PY 2016
VL 24
IS 5
BP 1170
EP 1177
DI 10.1002/oby.21466
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA DO1DU
UT WOS:000377519500024
PM 27015969
DA 2025-04-28
ER

PT J
AU Aragonès, G
   Ardid-Ruiz, A
   Ibars, M
   Suárez, M
   Bladé, C
AF Aragones, Gerard
   Ardid-Ruiz, Andrea
   Ibars, Maria
   Suarez, Manuel
   Blade, Cinta
TI Modulation of leptin resistance by food compounds
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
DE Agouti-related peptide; Megalin; Proopiomelanocortin; Protein tyrosine phosphatase 1B
ID high-fat-diet; endoplasmic-reticulum stress; phosphatase 1b ptp1b; beta/nf-kappa-b; insulin-resistance; lipid-metabolism; gene-expression; weight-gain; signal-transduction; inhibitory-activity
AB Leptin is mainly secreted by white adipose tissue and regulates energy homeostasis by inhibiting food intake and stimulating energy expenditure through its action in neuronal circuits in the brain, particularly in the hypothalamus. However, hyperleptinemia coexists with the loss of responsiveness to leptin in common obese conditions. This phenomenon has been defined as leptin resistance and the restoration of leptin sensitivity is considered to be a useful strategy to treat obesity. This review summarizes the existing literature on potentially valuable nutrients and food components to reverse leptin resistance. Notably, several food compounds, such as teasaponins, resveratrol, celastrol, caffeine, and taurine among others, are able to restore the leptin signaling in neurons by overexpressing anorexigenic peptides (proopiomelanocortin) and/or repressing orexigenic peptides (neuropeptide Y/agouti-related peptide), thus decreasing food intake. Additionally, some nutrients, such as vitamins A and D, can improve leptin transport through the blood-brain barrier. Therefore, food components can improve leptin resistance by acting at different levels of the leptin pathway; moreover, some compounds are able to target more than one feature of leptin resistance. However, systematic studies are necessary to define the actual effectiveness of each compound.
C1 [Aragones, Gerard; Ardid-Ruiz, Andrea; Ibars, Maria; Suarez, Manuel; Blade, Cinta] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, Tarragona, Spain.
C3 Universitat Rovira i Virgili
RP Bladé, C (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, Tarragona, Spain.
EM mariacinta.blade@urv.cat
FU Spanish Government [AGL2013-40707-R]
CR Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200
   Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, PE24, DOI 10.1152/ajpendo.00121.2014
   Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3
   Belury MA, 2003, J NUTR, V133, P257S, DOI 10.1093/jn/133.1.257S
   Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093
   Bjorbæk C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Bjorbæk C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305
   Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009
   Boado RJ, 1998, J NEUROCHEM, V71, P1761
   Boonloh K, 2015, NUTRIENTS, V7, P6313, DOI 10.3390/nu7085292
   Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280
   Byun K, 2014, EMBO REP, V15, P801, DOI 10.15252/embr.201338317
   Cabezas F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016794
   Çakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343
   Camargo RL, 2015, AMINO ACIDS, V47, P2419, DOI 10.1007/s00726-015-2035-9
   Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X
   Choi HN, 2014, NUTR RES PRACT, V8, P544, DOI 10.4162/nrp.2014.8.5.544
   Clarke SD, 2001, J NUTR, V131, P1129, DOI 10.1093/jn/131.4.1129
   Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757
   Crujeiras AB, 2015, LIFE SCI, V0, P0
   de Git KCG, 2015, OBES REV, V16, P207, DOI 10.1111/obr.12243
   Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178
   Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008
   Domínguez-Avila JA, 2015, FOOD CHEM, V168, P529, DOI 10.1016/j.foodchem.2014.07.092
   Eo H, 2015, J AGR FOOD CHEM, V63, P349, DOI 10.1021/jf502830b
   Erranz B, 2004, J LIPID RES, V45, P2185, DOI 10.1194/jlr.M400235-JLR200
   EscobarMorreale HF, 1997, ENDOCRINOLOGY, V138, P4485, DOI 10.1210/en.138.10.4485
   Fang LL, 2014, J FUNCT FOODS, V9, P264, DOI 10.1016/j.jff.2014.04.017
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y
   Franco JG, 2016, EUR J NUTR, V55, P601, DOI 10.1007/s00394-015-0880-7
   Häkansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392
   Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775
   Hoek-van den Hil EF, 2015, GENES NUTR, V10, P0, DOI 10.1007/s12263-015-0469-z
   Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070
   Hosoi T, 2015, J NEUROCHEM, V133, P343, DOI 10.1111/jnc.13057
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Indra Mochamad Rasjad, 2013, BMC RES NOTES, V6, P275, DOI 10.1186/1756-0500-6-275
   Jia S, 2015, FOOD FUNCT, V6, P878, DOI 10.1039/c4fo00993b
   Jiang CS, 2012, ACTA PHARMACOL SIN, V33, P1217, DOI 10.1038/aps.2012.90
   Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019
   Kim SJ, 2010, ARCH PHARM RES, V33, P775, DOI 10.1007/s12272-010-0518-5
   Kim SW, 2014, EXP MOL MED, V46, P0, DOI 10.1038/emm.2014.10
   Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Kowalska K, 2015, FOOD CHEM, V185, P383, DOI 10.1016/j.foodchem.2015.03.152
   Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6
   Lima ND, 2014, LIFE SCI, V115, P29, DOI 10.1016/j.lfs.2014.09.003
   Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011
   Liu W, 1998, EUR J CLIN INVEST, V28, P100
   Lynn RB, 1996, BIOCHEM BIOPH RES CO, V219, P884, DOI 10.1006/bbrc.1996.0328
   Maeda A, 2014, MOL NUTR FOOD RES, V58, P1177, DOI 10.1002/mnfr.201300675
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129
   Luvizotto RDM, 2013, BRIT J NUTR, V110, P1803, DOI 10.1017/S0007114513001256
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   Mnafgui K, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/620384
   Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071
   Muradian K, 2015, NUTR METAB CARDIOVAS, V25, P891, DOI 10.1016/j.numecd.2015.05.010
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Myoung HJ, 2010, ARCH PHARM RES, V33, P1741, DOI 10.1007/s12272-010-1105-5
   Noratto G, 2015, J NUTR BIOCHEM, V26, P633, DOI 10.1016/j.jnutbio.2014.12.014
   Oh-I S, 2005, CELL METAB, V1, P331, DOI 10.1016/j.cmet.2005.04.004
   Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004
   Palou M, 2015, MOL NUTR FOOD RES, V59, P2022, DOI 10.1002/mnfr.201500292
   Pan HT, 2014, PHYSIOL BEHAV, V130, P157, DOI 10.1016/j.physbeh.2014.04.003
   Panariello F, 2012, J OBES, V2012, P0, DOI 10.1155/2012/572848
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Park CH, 2015, ARCH PHARM RES, V38, P1270, DOI 10.1007/s12272-014-0457-7
   Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004
   Park Hyeong-Kyu, 2014, F1000PRIME REP, V6, P73, DOI 10.12703/P6-73
   Park YK, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109344
   Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822
   Rao PS, 2012, BIOINFORMATION, V8, P834, DOI 10.6026/97320630008834
   Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9
   Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172
   SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Saravanan S, 2015, EUR J PHARMACOL, V761, P279, DOI 10.1016/j.ejphar.2015.05.034
   Sasaki T, 2015, FRONT ENDOCRINOL, V6, P0, DOI 10.3389/fendo.2015.00109
   Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5
   Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589
   Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025
   Suhitha S, 2012, BIOINFORMATION, V8, P1125, DOI 10.6026/97320630081125
   Susanti VY, 2014, OBESITY, V22, P2115, DOI 10.1002/oby.20838
   Takahashi N, 2011, MOL NUTR FOOD RES, V55, P1791, DOI 10.1002/mnfr.201100401
   Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002
   Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551
   Tang YC, 2009, ENDOCRINOLOGY, V150, P3011, DOI 10.1210/en.2008-1601
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Quang TH, 2015, MOLECULES, V20, P11173, DOI 10.3390/molecules200611173
   Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190
   Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279
   van der Stelt I, 2015, J FUNCT FOODS, V14, P702, DOI 10.1016/j.jff.2015.02.040
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293
   Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679
   Whang WK, 2005, EXP MOL MED, V37, P436, DOI 10.1038/emm.2005.54
   White CL, 2009, AM J PHYSIOL-ENDOC M, V296, PE291, DOI 10.1152/ajpendo.90513.2008
   Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194
   Wu YZ, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092618
   Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315
   Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yu YH, 2013, ENDOCRINOLOGY, V154, P3130, DOI 10.1210/en.2013-1218
   Yuan XW, 2015, FOOD NUTR RES, V59, P0, DOI 10.3402/fnr.v59.27373
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
   Zhang J, 2010, FOOD CHEM, V119, P1491, DOI 10.1016/j.foodchem.2009.09.031
   Zhang Q, 2015, MOL MED REP, V11, P603, DOI 10.3892/mmr.2014.2708
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885
   Zulet MA, 2014, PHYTOMEDICINE, V21, P1162, DOI 10.1016/j.phymed.2014.04.027
NR 119
TC 49
Z9 52
U1 0
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD AUG 15
PY 2016
VL 60
IS 8
BP 1789
EP 1803
DI 10.1002/mnfr.201500964
PG 15
WC Food Science & Technology
SC Food Science & Technology
GA DV5JV
UT WOS:000382964200004
PM 26842874
DA 2025-04-28
ER

PT J
AU Ríos-Hoyo, A
   Gutiérrez-Salmeán, G
AF Rios-Hoyo, Alejandro
   Gutierrez-Salmean, Gabriela
TI New Dietary Supplements for Obesity: What We Currently Know
SO CURRENT OBESITY REPORTS
LA English
DT Article
DE Dietary supplements; Obesity; Weight loss
ID aurantium bitter orange; body-weight reduction; oat beta-glucan; citrus-aurantium; blood-pressure; double-blind; raspberry ketone; hoodia-gordonii; synephrine alkaloids; hydroxycitric acid
AB Obesity and its associated cardiometabolic alterations currently are considered an epidemic; thus, their treatment is of major importance. The cornerstone for such treatment involves therapeutic lifestyle changes; however, the vast majority of cases fail and/or significant weight loss is maintained only in the short term because of lack of compliance. The popularity of dietary supplements for weight management has increased, and a wide variety of these products are available over the counter. However, the existing scientific evidence is insufficient to recommend their safe use. Hence, the purpose of this article is to review the clinical effects, proposed mechanism of action, and safety profile of some of the new dietary supplements, including white bean extract, Garcinia cambogia, bitter orange, Hoodia gordonii, forskolin, green coffee, glucomannan, beta-glucans, chitosan, guar gum, and raspberry ketones.
C1 [Rios-Hoyo, Alejandro; Gutierrez-Salmean, Gabriela] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Ave Univ Anahuac 46, Huixquilucan 52786, Estado De Mexic, Mexico.
C3 Universidad Anahuac
RP Gutiérrez-Salmeán, G (corresponding author), Univ Anahuac Mexico Norte, Fac Ciencias Salud, Ave Univ Anahuac 46, Huixquilucan 52786, Estado De Mexic, Mexico.
EM gabrielasalmean@yahoo.com
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Allison DB, 2005, INT J OBESITY, V29, P443, DOI 10.1038/sj.ijo.0802879
   Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Arogba SS, 2014, NIGERIAN FOOD JOURNAL, V32, P62, DOI 10.1016/S0189-7241(15)30097-7
   Astell KJ, 2013, COMPLEMENT THER MED, V21, P407, DOI 10.1016/j.ctim.2013.05.007
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Beppu F, 2012, LIPIDS HEALTH DIS, V11, P0, DOI 10.1186/1476-511X-11-112
   Blom WAM, 2011, AM J CLIN NUTR, V94, P1171, DOI 10.3945/ajcn.111.020321
   Bradley J, 2015, NUTR BUS J, V0, P0
   Bredsdorff L, 2015, REGUL TOXICOL PHARM, V73, P196, DOI 10.1016/j.yrtph.2015.06.022
   Celleno Leonardo, 2007, INT J MED SCI, V4, P45
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cloetens L, 2012, NUTR REV, V70, P444, DOI 10.1111/j.1753-4887.2012.00494.x
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   DOrazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604
   DallAlba V, 2013, BRIT J NUTR, V110, P1601, DOI 10.1017/S0007114513001025
   Dave V, 1997, J ENVIRON POLYM DEGR, V5, P237
   Davy BM, 2002, J NUTR, V132, P394, DOI 10.1093/jn/132.3.394
   de Lira-García Cynthia, 2008, REV. SALUD PÚBLICA, V10, P818
   El Khoury D, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/703490
   Ernst E, 1998, PERFUSION, V11, P461
   Farah Adriana, 2006, BRAZ. J. PLANT PHYSIOL., V18, P23, DOI 10.1590/S1677-04202006000100003
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Food and Drug Administration, 2015, WHAT IS DIET SUPPL, V0, P0
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gammone MA, 2015, MAR DRUGS, V13, P2196, DOI 10.3390/md13042196
   Geller AI, 2015, NEW ENGL J MED, V373, P1531, DOI 10.1056/NEJMsa1504267
   Godard MP, 2005, OBES RES, V13, P1335, DOI 10.1038/oby.2005.162
   Guerciolini R, 2001, OBES RES, V9, P364, DOI 10.1038/oby.2001.47
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Henderson Shonteh, 2005, J INT SOC SPORTS NUTR, V2, P54, DOI 10.1186/1550-2783-2-2-54
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Hu XJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P59, DOI 10.1016/j.abb.2012.01.011
   Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883
   Kaats GR, 2013, FOOD CHEM TOXICOL, V55, P358, DOI 10.1016/j.fct.2013.01.013
   Kabir M, 2002, METABOLISM, V51, P819, DOI 10.1053/meta.2002.33345
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kang SI, 2011, BIOCHEM BIOPH RES CO, V409, P769, DOI 10.1016/j.bbrc.2011.05.086
   Kavitha C, 2010, J MED PLANTS RES, V4, P278
   Keithley J, 2005, ALTERN THER HEALTH M, V11, P30
   Keithley JK, 2013, J OBES, V2013, P0, DOI 10.1155/2013/610908
   Kim GS, 2012, BMC COMPLEM ALTERN M, V12, P0, DOI 10.1186/1472-6882-12-31
   Kim H, 2006, CEREAL FOOD WORLD, V51, P29, DOI 10.1094/CFW-51-0029
   Kim KY, 2008, BIOSCI BIOTECH BIOCH, V72, P1772, DOI 10.1271/bbb.80072
   Kim YJ, 2013, WORLD J GASTROENTERO, V19, P4689, DOI 10.3748/wjg.v19.i29.4689
   Le Nevé B, 2010, AM J PHYSIOL-GASTR L, V299, PG1368, DOI 10.1152/ajpgi.00135.2010
   Lobb A, 2009, WORLD J GASTROENTERO, V15, P1786, DOI 10.3748/wjg.15.1786
   Lyly M, 2010, FOOD NUTR RES, V54, P0, DOI 10.3402/fnr.v54i0.2149
   Lyly M, 2009, EUR J NUTR, V48, P251, DOI 10.1007/s00394-009-0009-y
   MacLean DB, 2004, BRAIN RES, V1020, P1, DOI 10.1016/j.brainres.2004.04.041
   Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002
   Maki KC, 2007, EUR J CLIN NUTR, V61, P786, DOI 10.1038/sj.ejcn.1602562
   Márquez F, 2012, CRIT REV FOOD SCI, V52, P585, DOI 10.1080/10408398.2010.500551
   Mattes RD, 2007, PHYSIOL BEHAV, V90, P705, DOI 10.1016/j.physbeh.2006.12.009
   Mhurchu CN, 2004, INT J OBESITY, V28, P1149, DOI 10.1038/sj.ijo.0802693
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x
   Mullin GE, 2015, NUTR CLIN PRACT, V30, P311, DOI 10.1177/0884533615572655
   Ngondi Judith L, 2005, LIPIDS HEALTH DIS, V4, P12, DOI 10.1186/1476-511X-4-12
   Oben JE, 2008, LIPIDS HEALTH DIS, V7, P0, DOI 10.1186/1476-511X-7-12
   Oben JE, 2008, LIPIDS HEALTH DIS, V7, P0, DOI 10.1186/1476-511X-7-44
   Onakpoya I, 2014, J AM COLL NUTR, V33, P70, DOI 10.1080/07315724.2014.870013
   Onakpoya Igho, 2013, JOURNAL OF DIETARY SUPPLEMENTS, V10, P29, DOI 10.3109/19390211.2012.760508
   Onakpoya I, 2011, BRIT J NUTR, V106, P196, DOI 10.1017/S0007114511001516
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Park KS, 2015, PHARM BIOL, V53, P870, DOI 10.3109/13880209.2014.946059
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Pasman WJ, 1997, INT J OBESITY, V21, P548, DOI 10.1038/sj.ijo.0800439
   Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806
   Pereira A, 2009, ARQ BRAS CARDIOL, V93, P253, DOI 10.1590/S0066-782X2009000900009
   Peters HPF, 2009, AM J CLIN NUTR, V89, P58, DOI 10.3945/ajcn.2008.26701
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Pittler MH, 2001, AM J MED, V110, P724, DOI 10.1016/S0002-9343(01)00702-1
   Queenan KM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-6
   Ribeiro SMR, 2008, FOOD CHEM, V110, P620, DOI 10.1016/j.foodchem.2008.02.067
   Russell PJ, 2012, FOOD CHEM TOXICOL, V50, PS6, DOI 10.1016/j.fct.2011.02.020
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schiller RN, 2001, J AM NUTRACEUT ASS, V4, P42
   Semwal RB, 2015, FITOTERAPIA, V102, P134, DOI 10.1016/j.fitote.2015.02.012
   Smith C, 2014, J ETHNOPHARMACOL, V155, P987, DOI 10.1016/j.jep.2014.06.033
   Sood N, 2008, AM J CLIN NUTR, V88, P1167, DOI 10.1093/ajcn/88.4.1167
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Stohs SJ, 2010, J FUNCT FOODS, V2, P235, DOI 10.1016/j.jff.2010.10.003
   Synytsya A, 2009, CARBOHYD POLYM, V76, P548, DOI 10.1016/j.carbpol.2008.11.021
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   van Bennekum AM, 2005, BRIT J NUTR, V94, P331, DOI 10.1079/BJN20051498
   van Heerden FR, 2008, J ETHNOPHARMACOL, V119, P434, DOI 10.1016/j.jep.2008.08.023
   Vinson JA, 2009, THE OPEN NUTRACEUTICALS JOURNAL, V2, P88, DOI 10.2174/1876396000902010088
   Willis HJ, 2009, NUTR RES, V29, P100, DOI 10.1016/j.nutres.2009.01.004
   Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108
   Yamoneka J, 2015, LWT-FOOD SCI TECHNOL, V64, P989, DOI 10.1016/j.lwt.2015.06.035
NR 93
TC 81
Z9 85
U1 3
U2 99
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2162-4968
EI 
J9 CURR OBES REP
JI Curr. Obes. Rep.
PD JUN 15
PY 2016
VL 5
IS 2
BP 262
EP 270
DI 10.1007/s13679-016-0214-y
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA EB0ST
UT WOS:000387056600012
PM 27053066
DA 2025-04-28
ER

PT J
AU Zhou, Y
   Ruan, Z
   Wen, YM
   Yang, YH
   Mi, SM
   Zhou, LL
   Wu, X
   Ding, S
   Deng, ZY
   Wu, GY
   Yin, YL
AF Zhou, Yan
   Ruan, Zheng
   Wen, Yanmei
   Yang, Yuhui
   Mi, Shumei
   Zhou, Lili
   Wu, Xin
   Ding, Sheng
   Deng, Zeyuan
   Wu, Guoyao
   Yin, Yulong
TI Chlorogenic acid from honeysuckle improves hepatic lipid dysregulation and modulates hepatic fatty acid composition in rats with chronic endotoxin infusion
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE chlorogenic acid; lipid metabolism; fatty acids; AMP-activated protein kinase
ID diet-induced obesity; insulin-resistance; skeletal-muscle; lonicera-japonica; adipose-tissue; protein-kinase; liver; mice; increases; accumulation
AB Chlorogenic acid as a natural hydroxycinnamic acid has protective effect for liver. Endotoxin induced metabolic disorder, such as lipid dysregulation and hyperlipidemia. In this study, we investigated the effect of chlorogenic acid in rats with chronic endotoxin infusion. The Sprague-Dawley rats with lipid metabolic disorder (LD group) were intraperitoneally injected endotoxin. And the rats of chlorogenic acid-LD group were daily received chlorogenic acid by intragastric administration. In chlorogenic acid-LD group, the area of visceral adipocyte was decreased and liver injury was ameliorated, as compared to LD group. In chlorogenic acid-LD group, serum triglycerides, free fatty acids, hepatic triglycerides and cholesterol were decreased, the proportion of C20:1, C24:1 and C18:3n-6, Delta 9-18 and Delta 6-desaturase activity index in the liver Were decreased, and the proportion of C18:3n-3 acid was increased, compared to the LD group. Moreover, levels of phosphorylated AMP-activated protein kinase, carnitine palmitoyltransferase-I, and fatty acid beta-oxidation were increased in chlorogenic acid-LD group compared to LD rats, whereas levels of fatty acid synthase and acetyl-CoA carboxylase were decreased. These findings demonstrate that chlorogenic acid effectively improves hepatic lipid dysregulation in rats by regulating fatty acid metabolism enzymes, stimulating AMP-activated protein kinase activation, and modulating levels of hepatic fatty acids.
C1 [Zhou, Yan; Ruan, Zheng; Wen, Yanmei; Yang, Yuhui; Mi, Shumei; Zhou, Lili; Wu, Xin; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Peoples R China.
   [Zhou, Yan; Ruan, Zheng; Wen, Yanmei; Yang, Yuhui; Mi, Shumei; Zhou, Lili; Wu, Xin; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, Coll Food Sci, Nanchang 330047, Peoples R China.
   [Wu, Xin; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China.
   [Ding, Sheng] Ctr Dis Control & Prevent Jiangxi Prov, Inst Nutr & Food Safety, Nanchang 330029, Peoples R China.
   [Wu, Guoyao] Texas A&M Univ, Fac Nutr, Dept Anim Sci, College Stn, TX 77843 USA.
C3 Nanchang University; Nanchang University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Texas A&M University System; Texas A&M University College Station
RP Ruan, Z (corresponding author), Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Peoples R China.; Ruan, Z (corresponding author), Nanchang Univ, Coll Food Sci, Nanchang 330047, Peoples R China.
EM ruanzheng@ncu.edu.cn
FU National Natural Science Foundation of China [31360552]; Natural Science Foundation of Jiangxi Province [20151BAB204036]; Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201414]
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Brun P, 2007, AM J PHYSIOL-GASTR L, V292, PG518, DOI 10.1152/ajpgi.00024.2006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286
   FEINGOLD KR, 1992, J LIPID RES, V33, P1765
   FRIEDMAN MI, 1986, BRAIN RES BULL, V17, P855, DOI 10.1016/0361-9230(86)90099-7
   Ginsberg HN, 2006, OBESITY, V14, P41S, DOI 10.1038/oby.2006.281
   GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946
   Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Khan M, 2000, J ENDOTOXIN RES, V6, P41, DOI 10.1177/09680519000060010601
   Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007
   Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197
   Lazarow P B, 1981, METHODS ENZYMOL, V72, P315
   Leung HWC, 2008, FOOD CHEM TOXICOL, V46, P3389, DOI 10.1016/j.fct.2008.08.022
   Mai K, 2012, METABOLISM, V61, P108, DOI 10.1016/j.metabol.2011.05.018
   Mason KE, 2008, ARCH BIOCHEM BIOPHYS, V469, P151, DOI 10.1016/j.abb.2007.10.018
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2005, BBA-MOL CELL BIOL L, V1733, P224, DOI 10.1016/j.bbalip.2004.12.015
   NOLAN JP, 1989, HEPATOLOGY, V10, P887, DOI 10.1002/hep.1840100523
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Orellana-Gavaldà JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140
   Park JW, 2013, BRIT J NUTR, V109, P283, DOI 10.1017/S0007114512001122
   Porta F, 2009, INFLAMMATION, V32, P315, DOI 10.1007/s10753-009-9138-y
   Suh SJ, 2006, J CELL BIOCHEM, V99, P1298, DOI 10.1002/jcb.20912
   Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Uchiumi D, 2004, J PERIODONTAL RES, V39, P120, DOI 10.1111/j.1600-0765.2004.00716.x
   Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023
   Warensjö E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wu CH, 2010, J AGR FOOD CHEM, V58, P7075, DOI 10.1021/jf101415v
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557
   Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991
   Zhou YL, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/979414
NR 53
TC 21
Z9 26
U1 2
U2 44
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD MAR 1
PY 2016
VL 58
IS 2
BP 146
EP 155
DI 10.3164/jcbn.14-138
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DI8LJ
UT WOS:000373752200009
PM 27013782
DA 2025-04-28
ER

PT J
AU Ogura, K
   Ogura, M
   Shoji, T
   Sato, Y
   Tahara, Y
   Yamano, G
   Sato, H
   Sugizaki, K
   Fujita, N
   Tatsuoka, H
   Usui, R
   Muka, E
   Fujimoto, S
   Inagaki, N
   Nagashima, K
AF Ogura, Kasane
   Ogura, Masahito
   Shoji, Toshihiko
   Sato, Yuichi
   Tahara, Yumiko
   Yamano, Gen
   Sato, Hiroki
   Sugizaki, Kazu
   Fujita, Naotaka
   Tatsuoka, Hisato
   Usui, Ryota
   Muka, Eri
   Fujimoto, Shimpei
   Inagaki, Nobuya
   Nagashima, Kazuaki
TI Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE apple procyanidins; insulin resistance; inflammation; ob/ob mouse
ID beta-cell function; high-fat; glucose-production; oxidative stress; chlorogenic acid; gene-expression; disease; mechanisms; obesity; rats
AB Procyanidins, the main ingredient of apple polyphenols, are known to possess antioxidative and anti-inflammatory effects associated closely with the pathophysiology of insulin resistance and type 2 diabetes. We investigated the effects of orally administered apple procyanidins (APCs) on glucose metabolism using diabetic ob/ob mice. We found no difference in body weight or body composition between mice treated with APCs and untreated mice. A 4 week oral administration of APCs containing water [0.5% (w/v)] ameliorated glucose tolerance, insulin resistance, and hepatic gluconeogenesis in ob/ob mice. APCs also suppressed the increase in the level of the pancreatic beta-cell. Insulin-stimulated Akt phosphorylation was significantly enhanced; pro-inflammatory cytokine expression levels were significantly decreased, and c-Jun N-terminal kinase phosphorylation was downregulated in the liver of those mice treated with APCs. In conclusion, APCs ameliorate insulin resistance by improving hepatic insulin signaling through suppression Of hepatic inflammation in ob/ob mice, which may be a mechanism with possible beneficial health effects of APCs in disturbed glucose metabolism.
C1 [Ogura, Kasane; Ogura, Masahito; Sato, Yuichi; Tahara, Yumiko; Yamano, Gen; Sato, Hiroki; Sugizaki, Kazu; Fujita, Naotaka; Tatsuoka, Hisato; Usui, Ryota; Inagaki, Nobuya; Nagashima, Kazuaki] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto 6068507, Japan.
   [Shoji, Toshihiko] NARO, Inst Fruit Tree & Tea Sci, 2-1 Fujimoto, Tsukuba, Ibaraki 3058605, Japan.
   [Muka, Eri] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Lab Med Physiol & Metab, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.
   [Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, 185-1 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan.
C3 Kyoto University; National Agriculture & Food Research Organization - Japan; Ritsumeikan University; Kochi University
RP Nagashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto 6068507, Japan.
EM nagasima@kuhp.kyoto-u.ac.jp
FU Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan
CR Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019
   Bagdas D, 2015, FOOD CHEM TOXICOL, V81, P54, DOI 10.1016/j.fct.2015.04.001
   Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1
   Brun P, 2007, AM J PHYSIOL-GASTR L, V292, PG518, DOI 10.1152/ajpgi.00024.2006
   Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026
   Espley RV, 2014, J NUTR, V144, P146, DOI 10.3945/jn.113.182659
   Floyel T, 2014, P NATL ACAD SCI USA, V111, P10305, DOI 10.1073/pnas.1402571111
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Jung M, 2009, MOL NUTR FOOD RES, V53, P1263, DOI 10.1002/mnfr.200800575
   KAHN BB, 1991, J CLIN INVEST, V87, P561, DOI 10.1172/JCI115031
   Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1
   Kuroda N, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092884
   Lapidot T, 2002, J AGR FOOD CHEM, V50, P3156, DOI 10.1021/jf011522g
   Lee YA, 2007, J AGR FOOD CHEM, V55, P9395, DOI 10.1021/jf071523u
   Leontowicz H, 2002, J NUTR BIOCHEM, V13, P603, DOI 10.1016/S0955-2863(02)00206-1
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Masumoto S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31208
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Mlinar B, 2007, CLIN CHIM ACTA, V375, P20, DOI 10.1016/j.cca.2006.07.005
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ou KQ, 2014, MOL NUTR FOOD RES, V58, P2196, DOI 10.1002/mnfr.201400243
   Perseghin G, 2009, DIABETES CARE, V32, PS164, DOI 10.2337/dc09-S303
   Qin Bolin, 2010, J DIABETES SCI TECHNOL, V4, P685
   Robertson K, 2008, AM J PHYSIOL-ENDOC M, V294, PE928, DOI 10.1152/ajpendo.00606.2007
   Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, PG583, DOI 10.1152/ajpgi.00422.2005
   Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184
   Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006
   Vayndorf EM, 2013, J FUNCT FOODS, V5, P1235, DOI 10.1016/j.jff.2013.04.006
   Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806
   Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095
   Yanagida A, 2000, J CHROMATOGR A, V890, P251, DOI 10.1016/S0021-9673(00)00614-2
   Yoshioka Y, 2008, INT IMMUNOPHARMACOL, V8, P1802, DOI 10.1016/j.intimp.2008.08.021
NR 45
TC 46
Z9 56
U1 1
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD NOV 23
PY 2016
VL 64
IS 46
BP 8857
EP 8865
DI 10.1021/acs.jafc.6b03424
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA ED5SU
UT WOS:000388913400017
PM 27792335
DA 2025-04-28
ER

PT J
AU An, RP
AF An, Ruopeng
TI Beverage Consumption in Relation to Discretionary Food Intake and Diet Quality among US Adults, 2003 to 2012
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Beverages; Snacks; Energy intake; Diet quality; 24-Hour dietary recall
ID sugar-sweetened beverages; body-weight; metabolic syndrome; snacking; patterns; energy; risk; metaanalysis; americans; children
AB Background A majority of Americans consume beverages and discretionary foods - foods that are typically low in nutrient value but high in sugar, sodium, fats, and cholesterol-as part of their daily diet, which profoundly impacts their energy balance and nutritional status. Objective This study examined consumption of different types of beverages in relation to discretionary food intake and diet quality among US adults. Methods Nationally representative sample of 22,513 adults from the National Health and Nutrition Examination Survey 2003 to 2012 waves were analyzed. The discretionary food category identifies energy-dense, nutrient-poor food products that do not necessarily provide essential nutrients that the human body needs, but can add variety. First-difference estimator addressed confounding bias from time-invariant unobservables (eg, eating habits, taste preferences) by using within-individual variations in diet and beverage consumption between 2 nonconsecutive 24-hour dietary recalls. Results Approximately 21.7%, 42.9%, 52.8%, 26.3%, and 22.2% of study participants consumed diet beverage, sugar-sweetened beverage (SSB), coffee, tea, and alcohol, respectively, and 90.1% consumed discretionary foods on any given day. Across beverage types, alcohol (384.8 kcal) and SSB (226.2 kcal) consumption was associated with the largest increase in daily total calorie intake; coffee (60.7 kcal) and diet-beverage (48.8 kcal) consumption was associated with the largest increase in daily calorie intake from discretionary foods, and SSB consumption was associated with the largest reduction in daily overall diet quality measured by the Healthy Eating Index 2010. The impact of beverage consumption on daily calorie intake (overall and from discretionary foods) and diet quality differed across individual sociodemographics and body-weight status. The incremental daily calorie intake from discretionary foods associated with diet-beverage consumption was highest in obese adults, and that associated with SSB was highest in normal-weight adults. Conclusions Interventions to promote healthy eating should assess beverage consumption in the context of overall dietary behavior.
C1 [An, Ruopeng] Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP An, RP (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, 1206 South 4th St, Champaign, IL 61820 USA.
EM ran5@illinois.edu
CR Unknown -, 2013, AUSTR DIET GUID, V0, P0
   Unknown -, 2010, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Appleton KM, 2001, APPETITE, V37, P225, DOI 10.1006/appe.2001.0435
   Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649
   Binkley J, 2007, APPETITE, V49, P561, DOI 10.1016/j.appet.2007.03.225
   Bleich SN, 2014, AM J PUBLIC HEALTH, V104, PE72, DOI 10.2105/AJPH.2013.301556
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Bowman SA, 2008, MYPYRAMID EQUIVALENT, V0, P0
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Drummond S, 1996, EUR J CLIN NUTR, V50, P779
   Fakhouri Tala H I, 2012, NCHS DATA BRIEF, V0, P1
   FDA (Food and Drug Administration), 2013, GUID IND FOOD LAB GU, V0, P127
   Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016
   Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x
   Holt SHA, 2000, INT J FOOD SCI NUTR, V51, P59, DOI 10.1080/096374800100912
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Keast DR, 2010, AM J CLIN NUTR, V92, P428, DOI 10.3945/ajcn.2009.28421
   Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045
   Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826
   Larson MR, 2000, INT J OBESITY, V24, P663, DOI 10.1038/sj.ijo.0801233
   Leblanc V, 2015, J HUM NUTR DIET, V28, P37, DOI 10.1111/jhn.12213
   Lucan SC, 2010, AM J PUBLIC HEALTH, V100, P631, DOI 10.2105/AJPH.2009.172692
   Malik AH, 2014, AM J CARDIOL, V113, P1574, DOI 10.1016/j.amjcard.2014.01.437
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x
   Morley JE, 2001, J GERONTOL A-BIOL, V56, P81, DOI 10.1093/gerona/56.suppl_2.81
   National Cancer Institute, 2014, HEI TOOLS RES, V0, P0
   Ogden Cynthia L, 2011, NCHS DATA BRIEF, V0, P1
   Park S, 2014, PREV CHRONIC DIS, V11, P0, DOI 10.5888/pcd11.130304
   Piernas C, 2010, HEALTH AFFAIR, V29, P398, DOI 10.1377/hlthaff.2009.0666
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   US National Cancer Institute, 2005, SOURC BEV INT US POP, V0, P0
NR 35
TC 57
Z9 61
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD JAN 15
PY 2016
VL 116
IS 1
BP 28
EP 37
DI 10.1016/j.jand.2015.08.009
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CZ3MV
UT WOS:000367009100005
PM 26372338
DA 2025-04-28
ER

PT J
AU Ohara, T
   Muroyama, K
   Yamamoto, Y
   Murosaki, S
AF Ohara, Tatsuya
   Muroyama, Koutarou
   Yamamoto, Yoshihiro
   Murosaki, Shinji
TI Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Glucosyl hesperidin; Caffeine; Obesity; Body fat; Body mass index
ID subcutaneous adipose-tissue; serum triglyceride level; metabolic syndrome; body-fat; cardiovascular-disease; citric-acid; hepg2 cells; kk mice; osteoarthritis; lipoprotein
AB Background: We have previously shown that a combination of glucosyl hesperidin (G-hesperidin) plus caffeine reduces accumulation of body fat, whereas G-hesperidin or caffeine alone shows little effect on high-fat diet-induced obesity in mice. The aim of this study is to evaluate the anti-obesity effect of G-hesperidin plus caffeine on body fat and serum TG in healthy subjects with moderately high body mass index (BMI) and serum TG. Since we considered that there are individual differences in caffeine sensitivity, we conducted dose-finding study of caffeine combined with G-hesperidin. Methods: Seventy-five healthy subjects with moderately high BMI (24-30 kg/m(2)) and serum TG (100-250 mg/dl) were divided and assigned to 12-week intervention with daily intakes of 500 mg of G-hesperidin with or without 25, 50, or 75 mg of caffeine, or placebo in a randomized double-blind placebo-controlled design. Results: After intervention, decreases in abdominal fat area (AFA), especially subcutaneous fat area (SFA), were significantly greater in the G-hesperidin with 50-mg caffeine group (AFA:-8.4 +/- 21.9 v. s. 16.3 +/- 34.1 cm(2); p < 0.05, SFA: -9.3 +/- 17.1 v.s. 11.2 +/- 18.3 cm(2); p < 0.01) and in the G-hesperidin with 75-mg caffeine group (AFA:-17.0 +/- 31.4 v.s. 16.3 +/- 34.1 cm(2); p < 0.01, SFA: -12.4 +/- 18.7 v. s. 11.2 +/- 18.3 cm(2); p < 0.01) than in the placebo group. Fat-decreasing effects of G-hesperidin were enhanced dose-dependently by caffeine addition. BMI decreases were significantly greater in the G-hesperidin with 75-mg caffeine group than in the placebo group (-0.56 +/- 0.74 v. s. -0.02 +/- 0.58 kg/m(2); p < 0.05). G-hesperidin with/without caffeine had no effect on serum TG (p > 0.05 v. s. placebo). Conclusions: These data suggested that a combination of 500-mg G-hesperidin with 50- or 75-mg caffeine may be useful for the prevention or treatment of obesity.
C1 [Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan.
RP Ohara, T (corresponding author), House Wellness Foods Corp, Inst Res & Dev, 3-20 Imoji, Itami, Hyogo 6640011, Japan.
EM Ohara_Tatsuya@house-wf.co.jp
FU House Wellness Foods Corporation
CR Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bissonnette S, 2013, J LIPID RES, V54, P1466, DOI 10.1194/jlr.P023176
   Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892
   CORREA H, 1978, AM J CLIN NUTR, V31, P1431, DOI 10.1093/ajcn/31.8.1431
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Gormsen LC, 2009, AM J PHYSIOL-ENDOC M, V296, PE165, DOI 10.1152/ajpendo.90675.2008
   Hanawa M, 2008, J NUTR FOOD, V11, P1
   HART DJ, 1993, J RHEUMATOL, V20, P331
   Hijiya H, 1991, EUROPEAN PATENT, V0, Patent No. 0402049A2
   Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9
   HY-YA M, 2011, JPN PHARMACOL THER, V39, P727
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   LEWIS GF, 1993, DIABETES, V42, P833, DOI 10.2337/diabetes.42.6.833
   LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835
   Manek NJ, 2003, ARTHRITIS RHEUM-US, V48, P1024, DOI 10.1002/art.10884
   MITCHELL GW, 1953, NEW ENGL J MED, V249, P835, DOI 10.1056/NEJM195311192492102
   Miwa Y, 2005, J NUTR SCI VITAMINOL, V51, P460, DOI 10.3177/jnsv.51.460
   Miwa Y, 2004, J NUTR SCI VITAMINOL, V50, P211, DOI 10.3177/jnsv.50.211
   Miwa Y, 2006, J NUTR SCI VITAMINOL, V52, P223, DOI 10.3177/jnsv.52.223
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56, DOI 10.3177/jnsv.49.56
   Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325
   Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642
   Ohara T, 2015, PHYTOTHER RES, V29, P310, DOI 10.1002/ptr.5258
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rowland AS, 2002, EPIDEMIOLOGY, V13, P668, DOI 10.1097/00001648-200211000-00011
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
NR 37
TC 39
Z9 39
U1 0
U2 20
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
EI 
J9 NUTR J
JI Nutr. J.
PD JAN 19
PY 2016
VL 15
IS 
BP 
EP 
DI 10.1186/s12937-016-0123-7
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DB1IX
UT WOS:000368263000001
PM 26786000
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Yoon, BK
   Park, H
   Seok, JW
   Choi, H
   Yu, JH
   Choi, Y
   Song, SJ
   Kim, A
   Kim, JW
AF Kim, Hyo Jung
   Yoon, Bo Kyung
   Park, Hyounkyoung
   Seok, Jo Woon
   Choi, Hyeonjin
   Yu, Jung Hwan
   Choi, Yoonjeong
   Song, Su Jin
   Kim, Ara
   Kim, Jae-woo
TI Caffeine inhibits adipogenesis through modulation of mitotic clonal expansion and the AKT/GSK3 pathway in 3T3-L1 adipocytes
SO BMB REPORTS
LA English
DT Article
DE Adipogenesis; AKT; Caffeine; Glycogen synthase kinase; Mitotic clonal expansion
ID glycogen-synthase kinase-3-beta; transcription factor; binding proteins; differentiation; insulin; cells; phosphorylation; kinase; proliferation; activation
AB Caffeine has been proposed to have several beneficial effects on obesity and its related metabolic diseases; however, how caffeine affects adipocyte differentiation has not been elucidated. In this study, we demonstrated that caffeine suppressed 3T3-L1 adipocyte differentiation and inhibited the expression of CCAAT/enhancer binding protein (C/EBP). and peroxisome proliferator-activated receptor (PPAR)., two main adipogenic transcription factors. Anti-adipogenic markers, such as preadipocyte secreted factor (Pref)-1 and Kruppel-like factor 2, remained to be expressed in the presence of caffeine. Furthermore, 3T3-L1 cells failed to undergo typical mitotic clonal expansion in the presence of caffeine. Investigation of hormonal signaling revealed that caffeine inhibited the activation of AKT and glycogen synthase kinase (GSK) 3 in a dose-dependent manner, but not extracellular signal-regulated kinase (ERK). Our data show that caffeine is an anti-adipogenic bioactive compound involved in the modulation of mitotic clonal expansion during adipocyte differentiation through the AKT/GSK3 pathway.
C1 [Kim, Hyo Jung; Park, Hyounkyoung; Seok, Jo Woon; Choi, Hyeonjin; Yu, Jung Hwan; Choi, Yoonjeong; Song, Su Jin; Kim, Ara; Kim, Jae-woo] Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul 03722, South Korea.
   [Yoon, Bo Kyung] Yonsei Univ, Coll Med, Seoul 03722, South Korea.
   [Seok, Jo Woon; Yu, Jung Hwan; Choi, Yoonjeong; Song, Su Jin; Kim, Ara; Kim, Jae-woo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
   [Kim, Jae-woo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 03722, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System
RP Kim, JW (corresponding author), Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul 03722, South Korea.; Kim, JW (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.; Kim, JW (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 03722, South Korea.
EM japol13@yuhs.ac
FU National Research Foundation of Korea (NRF) [2011-0030086, 2015R1A2A2A01004345, 2013R1A1A1059527]; Korea government, Ministry of Science, ICT and Future Planning (MSIP)
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   de Leon J, 2003, PROG NEURO-PSYCHOPH, V27, P165, DOI 10.1016/S0278-5846(02)00348-2
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563
   Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453
   Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983
   Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885
   Lee H, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052474
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X
   Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Ross SE, 1999, MOL CELL BIOL, V19, P8433
   Sinchai T, 2011, NEUROSCI LETT, V502, P65, DOI 10.1016/j.neulet.2011.07.026
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015
   Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102
   Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200
NR 31
TC 56
Z9 62
U1 3
U2 17
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG, KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
EI 1976-670X
J9 BMB REP
JI BMB Rep.
PD FEB 15
PY 2016
VL 49
IS 2
BP 111
EP 115
DI 10.5483/BMBRep.2016.49.2.128
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DH8QE
UT WOS:000373059500008
PM 26350746
DA 2025-04-28
ER

PT J
AU Cho, IJ
   Choung, SY
   Hwang, YC
   Ahn, KJ
   Chung, HY
   Jeong, IK
AF Cho, In-Jin
   Choung, Se Young
   Hwang, You-Cheol
   Ahn, Kyu Jeung
   Chung, Ho Yeon
   Jeong, In-Kyung
TI Aster spathulifolius Maxim extract reduces body weight and fat mass in obese humans
SO NUTRITION RESEARCH
LA English
DT Article
DE Aster spathulifolius; Obesity; Weight loss; Fat mass
ID uncoupling protein-2; dietary-supplements; insulin-resistance; chlorogenic acid; in-vitro; overweight; korea; gene; mice; sphathulifolius
AB Aster spathulifolius Maxim (AS), a perennial herb of the genus Aster within the family Asteraceae, induced weight loss in a rat model of diet-induced obesity. We hypothesized that AS could also reduce body weight in obese humans. Therefore, we performed a randomized, double-blind, placebo-controlled clinical trial in Korea to evaluate the effect of AS extract (ASE) on body weight and fat mass and its safety in obese humans. Forty-four obese participants (body mass index [BMI], 25-30 kg/m(2)) aged >= 20 years were randomly assigned to the placebo or ASE group (700 mg/d of ASE) and were instructed to take a once-daily pill for 12 weeks. Weight, BMI, waist circumference, fat mass (measured using bioimpedance, dual-energy X-ray absorptiometry, and computed tomography), and laboratory tests were assessed at baseline and at 12 weeks. Body weight significantly decreased after 12 weeks of treatment in the ASE group (placebo vs ASE: -0.08 +/- 2.11 kg vs -3.30 +/- 3.15 kg, P < .05), and so did body fat mass (placebo vs ASE; bioimpedance method: -0.51 +/- 1.89 kg vs -2.38 +/- 2.30 kg, P < .05; dual-energy X-ray absorptiometry: 0.38 +/- 1.59 kg vs -2.26 +/- 2.37 kg, P < .05). Changes in lipid profiles, fasting plasma glucose, and hemoglobin A1c did not differ between the 2 groups. No drug-related adverse events were observed during the study. In conclusion, ASE significantly decreases body weight and fat mass in obese humans, suggesting that ASE may be a potential therapeutic candidate for reducing obesity. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Cho, In-Jin] Kyung Hee Univ, Grad Sch, Dept Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   [Choung, Se Young] Kyung Hee Univ, Dept Prevent Pharm & Toxicol, Dept Life & Nanopharmaceut Sci Pharm, Coll Pharm, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   [Hwang, You-Cheol; Ahn, Kyu Jeung; Chung, Ho Yeon; Jeong, In-Kyung] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, 892 Dongnam Ro, Seoul 05278, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital
RP Jeong, IK (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol & Metab, 892 Dongnam Ro, Seoul 05278, South Korea.
EM jik1016@naver.com
FU Newtree Co, Ltd, of the Republic of Korea; Kyung Hee University [KHU-20071482]; Technology Innovation Program of the Industrial Strategic Technology Development Program [10045275]; Ministry of Trade, Industry & Energy, Republic of Korea
CR Unknown -, 2000, ASIA PACIFIC PERSPEC, V0, P0
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   Drent ML, 1995, OBES RES, V3, PS623, DOI 10.1002/j.1550-8528.1995.tb00236.x
   Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   Ghadieh HE, 2015, NUTR METAB, V12, P0, DOI 10.1186/s12986-015-0014-5
   Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35
   Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x
   Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405
   Kim SJ, 2015, J MED FOOD IN PRESS, V0, P0
   Kim SJ, 2015, J PHARM PHARM, V0, P0
   Kim TJ, 1996, WILD FLOWERS KOREA, V0, P0
   Kushner RF, 2014, JAMA-J AM MED ASSOC, V312, P943, DOI 10.1001/jama.2014.10432
   Lee CB, 1999, ILLUSTRATED FLORA OF KOREA, V0, P0
   Lee SO, 2005, J NAT PROD, V68, P1471, DOI 10.1021/np058044e
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Manore MM, 2012, INT J SPORT NUTR EXE, V22, P139, DOI 10.1123/ijsnem.22.2.139
   Martinez-Saez N, 2014, FOOD CHEM, V150, P227, DOI 10.1016/j.foodchem.2013.10.100
   Nordfors L, 1998, DIABETOLOGIA, V41, P935, DOI 10.1007/s001250051010
   Oberkofler H, 1998, DIABETOLOGIA, V41, P940, DOI 10.1007/s001250051011
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561
   Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726
   안인정, 2012, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION 한국식품영양과학회지, V41, P584
   Park JH, 2006, INT J OBESITY, V30, P1661, DOI 10.1038/sj.ijo.0803321
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, V0, P1
   Won JN, 2013, J MICROBIOL BIOTECHN, V23, P125, DOI 10.4014/jmb.1210.10074
   Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361
   Yin XF, 2015, FOOD SCI BIOTECHNOL, V24, P301, DOI 10.1007/s10068-015-0040-0
   Yin X, 2015, J MED FOOD, V18, P987, DOI 10.1089/jmf.2014.3416
   Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679
NR 35
TC 11
Z9 13
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 
J9 NUTR RES
JI Nutr. Res.
PD JUL 15
PY 2016
VL 36
IS 7
BP 671
EP 678
DI 10.1016/j.nutres.2016.03.001
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DQ3LI
UT WOS:000379103400006
PM 27333958
DA 2025-04-28
ER

PT J
AU Bertoia, ML
   Rimm, EB
   Mukamal, KJ
   Hu, FB
   Willett, WC
   Cassidy, A
AF Bertoia, Monica L.
   Rimm, Eric B.
   Mukamal, Kenneth J.
   Hu, Frank B.
   Willett, Walter C.
   Cassidy, Aedin
TI Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124 086 US men and women followed for up to 24 years
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID high-fat diet; green tea; body-weight; glucose-uptake; risk; supplementation; consumption; overweight; caffeine; gain
AB OBJECTIVE To examine whether dietary intake of specific flavonoid subclasses (including flavonols, flavones, flavanones, flavan-3-ols, anthocyanins, and flavonoid polymers) is associated with weight change over time. DESIGN Three prospective cohort studies. SETTING Health professionals in the United States. PARTICIPANTS 124 086 men and women participating in the Health Professionals Follow-up Study (HPFS), Nurses' Health Study (NHS), and Nurses' Health Study II (NHS II). MAIN OUTCOME MEASURE Self reported change in weight over multiple four year time intervals between 1986 and 2011. RESULTS Increased consumption of most flavonoid subclasses, including flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers, was inversely associated with weight change over four year time intervals, after adjustment for simultaneous changes in other lifestyle factors including other aspects of diet, smoking status, and physical activity. In the pooled results, the greatest magnitude of association was observed for anthocyanins (-0.23 (95% confidence interval -0.30 to -0.15) lbs per additional standard deviation/day, 10 mg), flavonoid polymers (-0.18 (-0.28 to -0.08) lbs per additional SD/day, 138 mg), and flavonols (-0.16 (-0.26 to -0.06) lbs per additional SD/day, 7 mg). After additional adjustment for fiber intake, associations remained significant for anthocyanins, proanthocyanidins, and total flavonoid polymers but were attenuated and no longer statistically significant for other subclasses. CONCLUSIONS Higher intake of foods rich in flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers may contribute to weight maintenance in adulthood and may help to refine dietary recommendations for the prevention of obesity and its potential consequences.
C1 [Bertoia, Monica L.; Rimm, Eric B.; Mukamal, Kenneth J.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.
   [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.
   [Cassidy, Aedin] Univ E Anglia, Norwich Med Sch, Dept Nutr, Norwich NR4 7TJ, Norfolk, England.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center; University of East Anglia
RP Bertoia, ML (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.
EM mbertoia@hsph.harvard.edu
FU National Institutes of Health [P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, UM1 CA176726, R01 CA67262, UM1 CA167552, R01 HL35464, UM1 CA186107]; Biotechnology, Biological Sciences Research Council (BBSRC), UK [BB/J004545/1]; Danish Council for Strategic Research (Innovation Fund Denmark) [0603-00488B]; project "Diet and prevention of ischemic heart disease: a translational approach" (DIPI)
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   Unknown -, 2004, USDA DAT PROANTH CON, V0, P0
   Unknown -, 2010, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001
   Bertoia ML, 2015, PLOS MED, V12, P0, DOI 10.1371/journal.pmed.1001878
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059
   de Kleijn MJJ, 2001, J NUTR, V131, P1826
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   HOLBROOK TL, 1989, INT J OBESITY, V13, P723
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Kimmons Joel, 2009, MEDSCAPE J MED, V11, P26
   Komatsu Tatsushi, 2003, JOURNAL OF MEDICAL INVESTIGATION, V50, P170
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Panico S, 2008, PREV MED, V47, P53, DOI 10.1016/j.ypmed.2008.01.023
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X
   Rimm E B, 1990, EPIDEMIOLOGY, V1, P466, DOI 10.1097/00001648-199011000-00009
   RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
   Setchell KDR, 1999, J NUTR, V129, P758S, DOI 10.1093/jn/129.3.758S
   Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703
   US Departament of Agriculture, 2007, USDA DAT FLAV CONT S, V0, P0
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
NR 39
TC 140
Z9 148
U1 1
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
EI 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 28
PY 2016
VL 352
IS 
BP 
EP 
DI 10.1136/bmj.i17
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC6EX
UT WOS:000369313700002
PM 26823518
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Samavat, H
   Espejo, L
   Arikawa, AY
   Stendell-Hollis, NR
   Kurzer, MS
AF Dostal, Allison M.
   Samavat, Hamed
   Espejo, Luis
   Arikawa, Andrea Y.
   Stendell-Hollis, Nicole R.
   Kurzer, Mindy S.
TI Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women
SO JOURNAL OF NUTRITION
LA English
DT Article
DE green tea extract; obesity; postmenopausal women; insulin; adiponectin
ID breast-cancer; metabolic syndrome; body-weight; risk; glucose; comt; supplementation; biomarkers; parameters; resistance
AB Background: Green tea consumption has been associated with favorable changes in body weight and obesity-related hormones, although it is not known whether these changes result from green tea polyphenols or caffeine. Objective: We examined the impact of decaffeinated green tea extract (GTE) containing 843 mg of (-)-epigallocatechin-3-gallate on anthropometric variables, obesity-associated hormones, and glucose homeostasis. Methods: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial of 937 healthy postmenopausal women assigned to either decaffeinated GTE (1315 mg total catechins/d) or a placebo, stratified by catechol-O-amethyltransferase (COM7) genotype. This study was conducted in a subset of 237 overweight and obese participants [body mass index (BMI) >= 25 kg/m(2)]. Results: No changes in energy intake, body weight, BMI, or waist circumference (WC) were observed over 12 mo in women taking GTE In = 117) or placebo In = 120). No differences were seen in circulating leptin, ghrelin, adiponectin, or glucose concentrations at month 12. Participants randomly assigned to GTE with baseline insulin >= 10 mu U/mL (n= 23) had a decrease in fasting serum insulin from baseline to month 12 (-1.43 +/- 0.59 plU/mL), whereas those randomly assigned to placebo with baseline insulin >= 10 mu IU/mL In = 19) had an increase in insulin over 12 mo (0.55 +/- 0.641.1 mu IU/mL, P< 0.01). Participants with the homozygous high-activity (G/G) form of COMT had significantly lower adiponectin (5.97 +/- 0.50 compared with 7.58 +/- 0.53 mu g/mL, P = 0.03) and greater insulin concentrations (7.63 +/- 0.53 compared with 6.18 +/- 0.36 mu lU/mL, P = 0.02) at month 12 compared with those with the low-activity (NA) genotype, regardless of treatment group. Conclusions: Decaffeinated GTE was not associated with reductions in body weight, BMI, or WC and did not alter energy intake or mean hormone concentrations in healthy postmenopausal women over 12 mo. GTE decreased fasting insulin concentrations in those with elevated baseline fasting concentrations. The high-activity form of the COMT enzyme may be associated with elevations in insulin and a reduction in adiponectin concentrations over time. This trial was registered at http://www.clinicaltrials.gov as NCT00917735.
C1 [Dostal, Allison M.; Samavat, Hamed; Espejo, Luis; Kurzer, Mindy S.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
   [Arikawa, Andrea Y.] Univ N Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Stendell-Hollis, Nicole R.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, Ellensburg, WA USA.
C3 University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of North Florida; Central Washington University
RP Kurzer, MS (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.
EM mkurzer@umn.edu
FU NIH/National Cancer Institute [R01 CA127236]; National Cancer Institute [T32CA132670]; Department of Defense/US Army Medical Research and Materiel Command [W81XWH-11-1-0013]; University of Minnesota graduate school doctoral dissertation fellowship; University of Minnesota Agricultural Experiment Station [MIN-18-103]; National Center for Advancing Translational Sciences of the NIH [UL1TR000114]
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bhagwat S, 2014, USDA DATABASE FLAVON, V0, P0
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Dawling S, 2001, CANCER RES, V61, P6716
   Dostal AM, 2015, FOOD CHEM TOXICOL, V83, P26, DOI 10.1016/j.fct.2015.05.019
   Gao H, 2013, DIABETES, V62, P1338, DOI 10.2337/db12-0935
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Hursel R, 2013, AM J CLIN NUTR, V98, P1682S, DOI 10.3945/ajcn.113.058396
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Jurgens TM, 2012, COCHRANE DB SYST REV, V12, P12
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   KARHUNEN T, 1994, J HISTOCHEM CYTOCHEM, V42, P1079, DOI 10.1177/42.8.8027527
   Kring SII, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006696
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890
   Mather KJ, 2014, BEST PRACT RES CL EN, V28, P107, DOI 10.1016/j.beem.2013.06.008
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   National Institutes of Health [NIH], 2007, DIET HIST QUEST VERS, V0, P0
   NIH, 2009, COMM TERM CRIT ADV E, V0, P0
   Ortsäter H, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-11
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534
   Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699
   Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6
   Swarbrick Michael M, 2008, METABOLIC SYNDROME AND RELATED DISORDERS, V6, P87, DOI 10.1089/met.2007.0029
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   U.S. Department of Agriculture (USDA 2000) Human Nutrition Research Center, 2000, CONT SURV FOOD INT I, V0, P0
   Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x
   Wang JP, 2002, CLIN EXP PHARMACOL P, V29, P419, DOI 10.1046/j.1440-1681.2002.03673.x
   Wannamethee SG, 2007, INT J OBESITY, V31, P1089, DOI 10.1038/sj.ijo.0803544
   Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu AH, 2003, CANCER RES, V63, P7526
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yang J, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2014-005632
   Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945
   Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252
NR 46
TC 66
Z9 66
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JAN 15
PY 2016
VL 146
IS 1
BP 38
EP 45
DI 10.3945/jn.115.222414
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DA3MF
UT WOS:000367701100006
PM 26581683
DA 2025-04-28
ER

PT J
AU Lean, MEJ
   Te Morenga, L
AF Lean, Michael E. J.
   Te Morenga, Lisa
TI Sugar and Type 2 diabetes
SO BRITISH MEDICAL BULLETIN
LA English
DT Review
DE diet; soda; body mass index; diabetes; evidence; beliefs
ID sweetened beverage consumption; life-style intervention; glycemic index; food-consumption; vegetarian diets; fructose intake; blood-pressure; weight-loss; risk; glucose
AB Background: Consumption of sugar, specifically sugar-sweetened beverages, has been widely held responsible by the media for the global rise in Type 2 diabetes (T2DM). Sources of data: Systematic reviews and dietary guidelines relating dietary sugars to T2DM. Areas of agreement: Weight gain and T2DM incidence are associated with diet and lifestyle patterns characterized by high consumptions of any sweetened beverages. High sugar intakes impair risk factors for macrovascular complications of T2DM. Areas of controversy: Much of the association between sugars and T2DM is eliminated by adjusting data for body mass index (BMI). However, BMI adjustment does not fully account for adiposity (r(2)=0.65-0.75). Excess sugar can promote weight gain, thus T2DM, through extra calories, but has no unique diabetogenic effect at physiological levels. Growing points: Ethical concerns about caffeine added to sweetened beverages, undetectable by consumers, to increase consumption. Areas timely for developing research: Evidence needed for limiting dietary sugar below 10% energy intake.
C1 [Lean, Michael E. J.] Univ Glasgow, Dept Human Nutr, Sch Med, Glasgow Royal Infirm, Level 2,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.
   [Te Morenga, Lisa] Univ Otago, Dept Human Nutr, Dunedin 9016, New Zealand.
   [Te Morenga, Lisa] Univ Otago, Edgar Inst Diabet & Obes Res, Dunedin 9016, New Zealand.
C3 University of Glasgow; University of Otago; University of Otago
RP Lean, MEJ (corresponding author), Univ Glasgow, Dept Human Nutr, Sch Med, Glasgow Royal Infirm, Level 2,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.
EM Mike.Lean@glasgow.ac.uk
CR Al-Gindan YY, 2015, BRIT J NUTR, V114, P1852, DOI 10.1017/S0007114515003670
   Unknown -, 1998, LANCET, V0, P0
   BANTLE JP, 1983, NEW ENGL J MED, V309, P7, DOI 10.1056/NEJM198307073090102
   Barclay AW, 2007, DIABETES CARE, V30, P2811, DOI 10.2337/dc07-0784
   Basu S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057873
   Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158
   Cheungpasitporn W, 2014, NEPHROLOGY, V19, P791, DOI 10.1111/nep.12343
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Franz MJ, 2015, J ACAD NUTR DIET, V115, P1447, DOI 10.1016/j.jand.2015.02.031
   Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002
   Ha V, 2012, HYPERTENSION, V59, P787, DOI 10.1161/HYPERTENSIONAHA.111.182311
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701
   Huang C, 2014, ATHEROSCLEROSIS, V234, P11, DOI 10.1016/j.atherosclerosis.2014.01.037
   Imamura F, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h3576
   Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033
   Karamanou M, 2014, HORM-INT J ENDOCRINO, V13, P296, DOI 10.1007/BF03401345
   Knowler William C, 2002, N ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Lara JJ, 2004, J HUM NUTR DIET, V17, P209, DOI 10.1111/j.1365-277X.2004.00520.x
   Lê KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336
   Lean M, 2011, CLIN OBES, V1, P41, DOI 10.1111/j.1758-8111.2010.00007.x
   Lean M E, 1985, DIABET MED, V2, P117
   Lindström J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230
   Livesey G, 2008, AM J CLIN NUTR, V88, P1419, DOI 10.3945/ajcn.2007.25700
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Meni ACS, 2015, DIABETOLOGIA, V58, P2455, DOI 10.1007/s00125-015-3694-5
   Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Morenga LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.e7492
   OSEI K, 1989, DIABETIC MED, V6, P506, DOI 10.1111/j.1464-5491.1989.tb01218.x
   Raatz SK, 2015, J NUTR, V145, P2265, DOI 10.3945/jn.115.218016
   Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492
   Shridhar K, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-55
   Sievenpiper JL, 2009, DIABETES CARE, V32, P1930, DOI 10.2337/dc09-0619
   Sluijs I, 2010, AM J CLIN NUTR, V92, P905, DOI 10.3945/ajcn.2010.29620
   Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Tanamas SK, 2016, QJM-INT J MED, V109, P443, DOI 10.1093/qjmed/hcv201
   Tappy L, 2015, CURR DIABETES REP, V15, P0, DOI 10.1007/s11892-015-0627-0
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004
   Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang DD, 2012, J NUTR, V142, P916, DOI 10.3945/jn.111.151951
   WOLEVER TMS, 1995, AM J CLIN NUTR, V62, P212S, DOI 10.1093/ajcn/62.1.212S
   World Health Organization, 2015, GUID SUG INT AD CHIL, V0, P0
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 50
TC 47
Z9 54
U1 5
U2 67
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD DEC 15
PY 2016
VL 120
IS 1
BP 43
EP 53
DI 10.1093/bmb/ldw037
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA EI8CX
UT WOS:000392733700006
PM 27707695
DA 2025-04-28
ER

PT J
AU Park, S
   Blanck, HM
   Dooyema, CA
   Ayala, GX
AF Park, Sohyun
   Blanck, Heidi M.
   Dooyema, Carrie A.
   Ayala, Guadalupe X.
TI Association Between Sugar-Sweetened Beverage Intake and Proxies of Acculturation Among US Hispanic and Non-Hispanic White Adults
SO AMERICAN JOURNAL OF HEALTH PROMOTION
LA English
DT Article
DE sugar-sweetened beverages; hispanic; acculturation; language; birthplace; prevention research
ID coronary-heart-disease; caloric beverages; united-states; consumption; risk; obesity; questionnaire; children; weight; energy
AB Purpose: This study examined associations between sugar-sweetened beverage (SSB) intake and acculturation among a sample representing civilian noninstitutionalized U.S. adults. Design: Quantitative, cross-sectional study. Setting: National. Subjects: The 2010 National Health Interview Survey data for 17,142 Hispanics and U.S.-born non-Hispanic whites (>= 18 years). Measures: The outcome variable was daily SSB intake (nondiet soda, fruit drinks, sports drinks, energy drinks, and sweetened coffee/tea drinks). Exposure variables were Hispanic ethnicity and proxies of acculturation (language of interview, birthplace, and years living in the United States). Analysis: We used multivariate logistic regression to estimate adjusted odds ratios (ORs) for the exposure variables associated with drinking SSB >= 1 time/d after controlling for covariates. Results: The adjusted odds of drinking SSB >= 1 time/d was significantly higher among Hispanics who completed the interview in Spanish (OR = 1.65) than U.S.-born non-Hispanic whites. Compared with those who lived in the United States for < 5 years, the adjusted odds of drinking SSB >= 1 time/d was higher among adults who lived in the United States for 5 to < 10 years (OR = 2.72), those who lived in the United States for 10 to < 15 years (OR = 2.90), and those who lived in the United States for >= 15 years (OR = 2.41). However, birthplace was not associated with daily SSB intake. Conclusion: The acculturation process is complex and these findings contribute to identifying important subpopulations that may benefit from targeted intervention to reduce SSB intake.
C1 [Park, Sohyun; Blanck, Heidi M.; Dooyema, Carrie A.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE,Mailstop F77, Atlanta, GA 30341 USA.
   [Ayala, Guadalupe X.] San Diego State Univ, Div Hlth Promot & Behav Sci, Inst Behav & Community Hlth, San Diego, CA 92182 USA.
   [Ayala, Guadalupe X.] San Diego Prevent Res Ctr, San Diego, CA USA.
C3 Centers for Disease Control & Prevention - USA; California State University System; San Diego State University
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE,Mailstop F77, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR Unknown -, 2010, DIET GUID AM 2010, V0, P0
   Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205
   Brener N, 2011, MMWR-MORBID MORTAL W, V60, P778
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU, V0, P0
   Clark SE, 2012, INT J OCCUP ENV HEAL, V18, P53, DOI 10.1179/1077352512Z.0000000007
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Himmelgreen DA, 2005, ECOL FOOD NUTR, V44, P105, DOI 10.1080/03670240590923514
   Kim H, 2010, WATER CONDITIONING P, V52, P42
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kumar GS, 2014, MMWR-MORBID MORTAL W, V63, P686
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002
   Novotny R, 2009, J AM DIET ASSOC, V109, P1712, DOI 10.1016/j.jada.2009.07.013
   rodwan John g, 2012, BOTTLED WATER 2011: THE RECOVERY CONTINUES, V0, P0
   Satia-Abouta J, 2002, J AM DIET ASSOC, V102, P1105, DOI 10.1016/S0002-8223(02)90247-6
   Sharkey JR, 2011, FOOD NUTR RES, V55, P0, DOI 10.3402/fnr.v55i0.5819
   Sharkey JR, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-101
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, PE1596, DOI 10.1210/jc.2011-1251
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Sukalakamala S, 2006, J AM DIET ASSOC, V106, P103, DOI 10.1016/j.jada.2005.09.050
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
NR 34
TC 28
Z9 39
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0890-1171
EI 2168-6602
J9 AM J HEALTH PROMOT
JI Am. J. Health Promot.
PD MAY-JUN 15
PY 2016
VL 30
IS 5
BP 357
EP 364
DI 10.1177/0890117116646343
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM4GG
UT WOS:000376304300007
PM 27404644
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Menichini, Francesco
   Conforti, Filomena
TI Hypolipidemic and Antioxidant Properties of Hot Pepper Flower (Capsicum annuum L.)
SO PLANT FOODS FOR HUMAN NUTRITION
LA English
DT Article
DE Capsicum annuum; Pancreatic lipase; Phenolic composition; Antioxidant; Obesity
ID dietary plants; lipase; inhibition; obesity; fruits; cells
AB At present, the various medical treatments of obesity involve side effects. The aim of the research is therefore to find natural compounds that have anti-obesity activity with minimum disadvantages. In this study, the hypolipidemic effect of hydroalcoholic extract of flowers from Capsicum annuum L. was examined through the evaluation of inhibition of pancreatic lipase. Antioxidant activity was assessed using different tests: 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide ((NO)-N-center dot) and lipid peroxidation inhibition assays. Phytochemical analysis indicated that total phenolic and flavonoid content in the extract was 128.7 +/- 4.5 mg chlorogenic acid equivalent/g of crude extract and 17.66 +/- 0.11 mg of quercetin equivalent/g of crude extract, respectively. The extract inhibited pancreatic lipase with IC50 value equal to 3.54 +/- 0.18 mg/ml. It also inhibited lipid peroxidation with IC50 value of 27.61 +/- 2.25 mu g/ml after 30 min of incubation and 41.69 +/- 1.13 mu g/ml after 60 min of incubation. The IC50 value of radical scavenging activity was 51.90 +/- 2.03 mu g/ml. The extract was also able to inhibit NO production (IC50 = of 264.3 +/- 7.98 mu g/ml) without showing any cytotoxic effect.
C1 [Marrelli, Mariangela; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
C3 University of Calabria
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
CR Araniti F, 2014, PHYTOCHEM LETT, V8, P179, DOI 10.1016/j.phytol.2013.08.019
   Araniti F, 2013, NAT PROD RES, V27, P880, DOI 10.1080/14786419.2012.691491
   Bray MS, 2000, J APPL PHYSIOL, V88, P788, DOI 10.1152/jappl.2000.88.2.788
   Conforti F, 2007, FOOD CHEM, V102, P1096, DOI 10.1016/j.foodchem.2006.06.047
   Conforti F, 2012, NAT PROD RES, V26, P1594, DOI 10.1080/14786419.2011.585988
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   Heo M, 2011, OBESITY FACTS, V4, P449, DOI 10.1159/000335279
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Marrelli M, 2015, FOOD CHEM TOXICOL, V86, P16, DOI 10.1016/j.fct.2015.09.011
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Marrelli M, 2012, FOOD CHEM TOXICOL, V50, P726, DOI 10.1016/j.fct.2011.12.025
   Menichini G, 2013, CELL PROLIFERAT, V46, P193, DOI 10.1111/cpr.12020
   Menichini G, 2012, ANTI-CANCER AGENT ME, V12, P959, DOI 10.2174/187152012802649987
   Sosnowska D, 2015, PLANT FOOD HUM NUTR, V70, P344, DOI 10.1007/s11130-015-0501-x
   Szajdek A, 2008, PLANT FOOD HUM NUTR, V63, P147, DOI 10.1007/s11130-008-0097-5
   Zhang WL, 2014, OBES REV, V15, P957, DOI 10.1111/obr.12228
NR 16
TC 25
Z9 25
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-9668
EI 1573-9104
J9 PLANT FOOD HUM NUTR
JI Plant Food Hum. Nutr.
PD SEP 15
PY 2016
VL 71
IS 3
BP 301
EP 306
DI 10.1007/s11130-016-0560-7
PG 6
WC Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Plant Sciences; Chemistry; Food Science & Technology; Nutrition & Dietetics
GA EA8MA
UT WOS:000386887700012
PM 27372805
DA 2025-04-28
ER

PT J
AU Munsell, CR
   Harris, JL
   Sarda, V
   Schwartz, MB
AF Munsell, Christina R.
   Harris, Jennifer L.
   Sarda, Vishnudas
   Schwartz, Marlene B.
TI Parents' beliefs about the healthfulness of sugary drink options: opportunities to address misperceptions
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sugary beverages; Food beliefs; Parents; Children
ID sweetened beverages; childhood obesity; metabolic syndrome; consumption; risk; nutrition
AB Objective: To assess potential misperceptions among parents regarding the healthfulness of sugary drinks for their children. Design: Online survey of parents. Participants identified the categories and specific brands of sugary drinks they provided for their children. They also indicated their perceptions of sugary drink categories and brands as healthy options for children, perceived importance of on-package claims in purchase decisions and their concerns about common sugary drink ingredients. Setting: Online market research panel. Subjects: Parents (n 982) of 2- to 17-year-olds, 46 % non-white or Hispanic. Results: Ninety-six per cent of parents provided on average 2.9 different categories of sugary drinks for their children in the past month. Flavoured waters, fruit drinks and sports drinks were rated as the healthiest sugary drink categories. Across all categories and brands, parents who purchased specific products rated them as significantly healthier than those who did not (P < 0.05). Over half of parents reported concern about caffeine, sugar and artificial sweeteners in sugary drinks that their children consume and approximately one-third reported that on-package ingredient claims were important in their purchase decisions. Conclusions: Nearly all parents provide sugary drinks for their children and many believe that some sugary drinks are healthy options for children, particularly flavoured waters, fruit drinks and sports drinks. Furthermore, many parents rely upon on-package claims in their purchase decisions. Given excessive consumption of added sugar by children in the home, there is a continuing need to address parents' misperceptions about the healthfulness of many sugary drink products.
C1 [Munsell, Christina R.; Harris, Jennifer L.; Sarda, Vishnudas; Schwartz, Marlene B.] Yale Univ, Rudd Ctr Food Policy & Obes, 309 Edwards St, New Haven, CT 06511 USA.
   [Sarda, Vishnudas] Boston Childrens Hosp, Boston, MA USA.
C3 Yale University; Harvard University; Harvard University Medical Affiliates; Boston Children's Hospital
RP Harris, JL (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, 309 Edwards St, New Haven, CT 06511 USA.
EM jennifer.harris@yale.edu
FU Robert Wood Johnson Foundation; Rudd Foundation
CR Aaker D A, 2012, MARKETING RESEARCH, V11th, P0
   American Academy of Pediatrics Committee on School Health, 2014, PEDIATRICS, V113, P152
   Andreyeva T, 2011, ECON HUM BIOL, V9, P221, DOI 10.1016/j.ehb.2011.02.004
   Unknown -, 2010, DIET GUID AM 2010, V0, P0
   Unknown -, 2004, GLOB STRAT DIET PHYS, V0, P0
   Barlow SE, 2007, PEDIATRICS, V120, PS164, DOI 10.1542/peds.2007-2329C
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Biro FM, 2010, AM J CLIN NUTR, V91, P1499S, DOI 10.3945/ajcn.2010.28701B
   Centers for Disease Control and Prevention (CDC), 2005, MMWR MORB MORTAL WKLY REP, V54, P1
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harris JL, 2011, PUBLIC HEALTH NUTR, V14, P2207, DOI 10.1017/S1368980011001741
   Harris JL, 2011, SUGARY DRINK FACTS: EVALUATING SUGARY DRINK NUTRITION AND MARKETING TO YOUTH, V0, P0
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Jordan A, 2012, ANN AM ACAD POLIT SS, V640, P118, DOI 10.1177/0002716211425656
   Leibowitz J, 2012, A REVIEW OF FOOD MARKETING TO CHILDREN AND ADOLESCENTS: FOLLOW-UP REPORT, V0, P0
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   National Diabetes Information Clearinghouse, 2011, NAT DIAB STAT 2011, V0, P0
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.39
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Pollock NK, 2012, J NUTR, V142, P251, DOI 10.3945/jn.111.150219
   Robert Wood Johnson Foundation, 2012, RES REV, V0, P0
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Simmons K, 2013, FASEB J, V27, P0
   Stallings VA, 2007, NUTR STANDARDS FOODS, V0, P0
   Stevens RE, 2011, ESSENTIALS MARKETING, V0, P0
   Sun SS, 2008, J PEDIATR-US, V152, P191, DOI 10.1016/j.jpeds.2007.07.055
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
NR 33
TC 79
Z9 89
U1 0
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JAN 15
PY 2016
VL 19
IS 1
BP 46
EP 54
DI 10.1017/S1368980015000397
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA DH2UH
UT WOS:000372641600006
PM 25757372
DA 2025-04-28
ER

PT J
AU Ma, R
   Weng, HB
   Liang, JY
AF Ma, Rui
   Weng, Hongbo
   Liang, Jianying
TI Screening of lipase inhibitors in Folium Mori with lipase-linked magnetic microspheres by high-performance liquid chromatography and evaluation in diabetic mice
SO JOURNAL OF SEPARATION SCIENCE
LA English
DT Article
DE Astragalin; Folium Mori; High-performance liquid chromatography; Immobilized enzymes; Lipase inhibitors
ID mulberry leaf; mass-spectrometry; mellitus; extract; complications; type-2; rutin; rats; obesity
AB A new method for the screening of compounds with hypoglycemic effect from traditional Chinese medicines employing high-performance liquid chromatography and lipase-linked magnetic microspheres has been proposed. We hypothesized that the interaction of traditional Chinese medicine extracts with lipase-linked magnetic microspheres should decrease the concentration of compounds with hypoglycemic effect. Using this approach, the potential lipase inhibitors in Folium Mori extract were investigated. First, lipase was immobilized on magnetic microspheres by a chemical method. Then, by comparing the chromatograms of samples before and after the interaction with lipase-linked magnetic microspheres, seven compounds of Folium Mori extract were identified. It was found that protocatechuic acid, chlorogenic acid, protocatechualdehyde, rutin, isoquercitrin, astragalin, and dicaffeoylquinic acid B had evident combination with lipase-linked magnetic microspheres. Their hypoglycemic effects were verified in streptozocin-induced diabetic mice. In the present study, astragalin was verified to improve the glucose tolerance and lower the level of glucose in streptozocin-induced diabetic mice, which indicated that astragalin might be a new highly efficient lipase inhibitor. Based on these significant results, this method could be a convenient approach to screen potential lipase inhibitors from traditional Chinese medicines. Meanwhile, it also could be expanded to screen other active compounds in traditional Chinese medicines.
C1 [Ma, Rui; Liang, Jianying] Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Lecturer Room 521,Res Bldg,826 Zhangheng Rd, Shanghai 201203, Peoples R China.
   [Weng, Hongbo] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Liang, JY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Lecturer Room 521,Res Bldg,826 Zhangheng Rd, Shanghai 201203, Peoples R China.; Weng, HB (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.
EM hbweng@fudan.edu.cn; jyliang@shmu.edu.cn
FU Shanghai Committee of Science and Technology, China [14431904900]
CR Amutha A, 2016, J DIABETES COMPLICAT, V30, P951, DOI 10.1016/j.jdiacomp.2016.02.009
   Araujo CM, 2015, FOOD FUNCT, V6, P3490, DOI 10.1039/c5fo00474h
   Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, P0, DOI 10.1186/2193-1801-3-549
   Buchholz T, 2016, PHYTOTHER RES, V30, P260, DOI 10.1002/ptr.5525
   Ding D, 2015, DIABETES RES CLIN PR, V108, P306, DOI 10.1016/j.diabres.2015.02.002
   Dugo P, 2009, J SEP SCI, V32, P3627, DOI 10.1002/jssc.200900348
   Foster-Schubert KE, 2006, ENDOCR REV, V27, P779, DOI 10.1210/er.2006-0041
   Habtemariam S, 2015, MINI-REV MED CHEM, V15, P524, DOI 10.2174/138955751507150424103721
   Hsu CY, 2014, MOL NUTR FOOD RES, V58, P1168, DOI 10.1002/mnfr.201300691
   Hu FL, 2008, J AM SOC MASS SPECTR, V19, P865, DOI 10.1016/j.jasms.2008.02.016
   Huang Shiang-Suo, 2014, J TRADIT COMPLEMENT MED, V4, P162, DOI 10.4103/2225-4110.131639
   Hunyadi A, 2013, PHYTOTHER RES, V27, P847, DOI 10.1002/ptr.4803
   Hunyadi A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050619
   Kim JY, 2015, J MED FOOD, V18, P306, DOI 10.1089/jmf.2014.3160
   Kimura T, 2004, J AGR FOOD CHEM, V52, P1415, DOI 10.1021/jf0306901
   Kowluru RA, 2007, EXP DIABETES RES ANN, V0, P0
   Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y
   Niture NT, 2014, INDIAN J EXP BIOL, V52, P720
   Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586
   Pan LY, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133212
   Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525
   Pospiskova K, 2013, CARBOHYD POLYM, V96, P545, DOI 10.1016/j.carbpol.2013.04.014
   Sayyid RK, 2016, TRENDS ENDOCRIN MET, V27, P249, DOI 10.1016/j.tem.2016.02.006
   Shaefer C, 2016, CURR MED RES OPIN, V32, P1479, DOI 10.1185/03007995.2016.1163255
   Sharma SB, 2010, J PHARM PHARMACOL, V62, P247, DOI 10.1211.jpp/62.02.0013
   Van Gaal L, 2015, DIABETES CARE, V38, P1161, DOI 10.2337/dc14-1630
   Yang L, 2016, J SEP SCI, V39, P38, DOI 10.1002/jssc.201500899
   Yang SJ, 2014, NUTR RES PRACT, V8, P613, DOI 10.4162/nrp.2014.8.6.613
   Zhang LL, 2014, J SEP SCI, V37, P1265, DOI 10.1002/jssc.201301267
NR 30
TC 14
Z9 16
U1 2
U2 39
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1615-9306
EI 1615-9314
J9 J SEP SCI
JI J. Sep. Sci.
PD DEC 15
PY 2016
VL 39
IS 23
BP 4474
EP 4483
DI 10.1002/jssc.201600924
PG 10
WC Chemistry, Analytical
SC Chemistry
GA EJ2HG
UT WOS:000393030100002
PM 27687881
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Arikawa, A
   Espejo, L
   Kurzers, MS
AF Dostal, Allison M.
   Arikawa, Andrea
   Espejo, Luis
   Kurzers, Mindy S.
TI Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women
SO JOURNAL OF NUTRITION
LA English
DT Article
DE green tea; obesity; body composition; bone health; postmenopausal women
ID catechol-o-methyltransferase; breast-cancer risk; body-mass index; weight-loss; fat mass; osteoporosis; health; adiponectin; caffeine; comt
AB Background: Green tea extract (GTE) consumption has been linked to favorable changes in adiposity and bone mineral density (BMD), although it is unknown if these effects are due to green tea catechins or caffeine. The catechol-O-methyltransferase (COM7) genotype may also modify these associations. Objective: We examined the impact of decaffeinated GTE on body composition (using dual-energy X-ray absorptiometry) and obesity-associated hormones. Methods: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial in 937 postmenopausal women (aged 50-70 y) assigned to receive either GTE containing 843 mg (-)-epigallocatechin-3-gallate or placebo. This substudy was conducted in 121 overweight/obese participants [body mass index (BMI) (kg/m(2)) Results: There were no differences in changes in BMI (-0.13 +/- 0.11 compared with -0.05 +/- 0.11; P= 0.61), total fat mass (-0.30 +/- 0.16 compared with -0.12 +/- 0.15 kg; P = 0.40), percentage of body fat (-0.15% +/- 0.17% compared with -0.15% +/- 0.16%; P = 0.99), or BMD (-0.006 +/- 0.002 compared with -0.003 +/- 0.002 g/cm(2); P = 0.49) over 12 mo between women taking GTE (n = 61) and those taking a placebo (n = 60). Interactions were observed between treatment and time for gynoid percentage of fat (%fat) and tissue %fat. Gynoid %fat increased from baseline to month 12 in the placebo group as baseline BMI increased and decreased over time as baseline BMI increased in the GTE group (P-interaction = 0.02). Tissue %fat increased from baseline to month 12 in the placebo group as baseline BMI increased. In the GTE group, tissue %fat decreased during the intervention as baseline BMI increased (P-interaction = 0.04). No changes were seen in circulating leptin, ghrelin, adiponectin, or insulin concentrations. COMT genotype did not modify the effect of GTE on any variable. Conclusions: Decaffeinated GTE was not associated with overall reductions in adiposity or improvements in BMD in overweight/obese postmenopausal women. However, GTE may be beneficial for reduction in tissue and gynoid %fat in individuals with higher BMI. This clinical trial was registered at www.clinicaltrials.gov as NCT00917735.
C1 [Dostal, Allison M.; Espejo, Luis; Kurzers, Mindy S.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
   [Arikawa, Andrea] Univ N Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
C3 University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of North Florida
RP Kurzers, MS (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
EM mkurzer@umn.edu
FU NIH/National Cancer Institute [R01 CA127236]; National Cancer Institute [T32CA132670]; University of Minnesota Agricultural Experiment Station project [MIN-18-103]; National Center for Advancing Translational Sciences of the NIH [UL1TR000114]
CR Alissa EM, 2014, J AM COLL NUTR, V33, P206, DOI 10.1080/07315724.2013.866528
   Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bhagwat S, 2014, 3 USDA, V0, P0
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Dawling S, 2001, CANCER RES, V61, P6716
   Dostal AM, 2015, FOOD CHEM TOXICOL, V83, P26, DOI 10.1016/j.fct.2015.05.019
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117
   Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Kriska AM, 2002, MED SCI SPORTS MED, V29, P0
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Lorenz M, 2014, EUR J PHARMACOL, V740, P645, DOI 10.1016/j.ejphar.2014.06.014
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Metz JA, 2000, ARCH INTERN MED, V160, P2150, DOI 10.1001/archinte.160.14.2150
   MIKSICEK RJ, 1993, MOL PHARMACOL, V44, P37
   Mohiti-Ardekani J, 2014, J BONE MINER METAB, V32, P400, DOI 10.1007/s00774-013-0511-4
   Muraki S, 2007, J ORTHOP SCI, V12, P317, DOI 10.1007/s00776-007-1143-0
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ong T, 2014, BONE, V59, P207, DOI 10.1016/j.bone.2013.11.024
   Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Shen CL, 2012, OSTEOPOROSIS INT, V23, P1541, DOI 10.1007/s00198-011-1731-x
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   SUZUKI N, 1995, MATURITAS, V22, P9, DOI 10.1016/0378-5122(95)00902-W
   Suzuki T, 1997, BONE, V21, P461, DOI 10.1016/S8756-3282(97)00179-8
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630
   U.S. Department of Agriculture (USDA 2000) Human Nutrition Research Center, 2000, CONT SURV FOOD INT I, V0, P0
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639
   Wongdee K, 2015, WORLD J DIABETES, V6, P673, DOI 10.4239/wjd.v6.i5.673
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yuan JM, 2013, AM J CLIN NUTR, V98, P1676S, DOI 10.3945/ajcn.113.058271
   Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/jbmr.070813
   Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572
NR 53
TC 63
Z9 63
U1 0
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD FEB 15
PY 2016
VL 146
IS 2
BP 256
EP 264
DI 10.3945/jn.115.219238
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DC9RD
UT WOS:000369557800011
PM 26701796
DA 2025-04-28
ER

PT J
AU Mayén, AL
   Stringhini, S
   Ford, ND
   Martorell, R
   Stein, AD
   Paccaud, F
   Marques-Vidal, P
AF Mayen, Ana-Lucia
   Stringhini, Silvia
   Ford, Nicole D.
   Martorell, Reynaldo
   Stein, Aryeh D.
   Paccaud, Fred
   Marques-Vidal, Pedro
TI Socioeconomic predictors of dietary patterns among Guatemalan adults
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Socioeconomic; Diet patterns; Guatemala; Expenditures
ID nutrition transition; income; associations; reduction; adherence; education; obesity; foods; women
AB We aimed to assess the associations of socioeconomic factors with dietary patterns in a Guatemalan population. Cross-sectional data of 1076 participants (42 % men, mean age 32.6 +/- A 4.2 years) collected between 2002 and 2004 in four rural villages in Guatemala. Dietary patterns were derived using principal component analysis. Chi-square and Poisson regression models were used to assess associations between socioeconomic factors and dietary patterns. Three dietary patterns were identified: "Western" (high in processed foods), "traditional" (high in traditional foods) and "coffee and sugar", explaining 11, 7 and 6 % of the variance, respectively. Annual expenditures were associated with a higher adherence to the "Western" pattern: prevalence ratios [(PR) (95 % confidence interval)] 1.92 (1.17-3.15) for the highest vs. lowest expenditure group in men and 8.99 (3.57-22.64) in women. A borderline significant (p = 0.06) negative association was found between the "traditional" pattern and higher household expenditures [0.71 (0.49-1.02) in men] and with schooling [0.23 (0.05-1.02)] in women (p = 0.05). Dietary patterns in Guatemala are predicted by socioeconomic factors. In particular, high annual expenditures are associated with a more westernized, less traditional diet.
C1 [Mayen, Ana-Lucia; Stringhini, Silvia; Paccaud, Fred] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.
   [Ford, Nicole D.] Emory Univ, Laney Grad Sch, Nutr & Hlth Sci, Atlanta, GA 30322 USA.
   [Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Marques-Vidal, Pedro] Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Emory University; Emory University; Rollins School Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)
RP Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland.
EM Ana-Lucia.Mayen-Chacon@chuv.ch; Silvia.Stringhini@chuv.ch; ndionne@emory.edu; rmart77@emory.edu; aryeh.stein@emory.edu; Fred.Paccaud@chuv.ch; Pedro-Manuel.Marques-Vidal@chuv.ch
FU US National Institutes of Health [R01 TW-05598]; Swiss Excellence Government scholarship; Swiss National Science Foundation (SNSF) [PZ00P3_147998]
CR Araujo MC, 2014, PUBLIC HEALTH NUTR, V17, P2740, DOI 10.1017/S1368980013003005
   Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096
   Barros Aluisio J D, 2003, BMC MED RES METHODOL, V3, P21, DOI 10.1186/1471-2288-3-21
   Blouin C, 2009, LANCET, V373, P502, DOI 10.1016/S0140-6736(08)61777-8
   Campos-Ortiz F, 2013, STUDY ON THE COMPETITIVENESS OF THE MEXICAN SUGAR INDUSTRY, V0, P0
   Cardoso I, 2013, EUR J CLIN NUTR, V67, P135, DOI 10.1038/ejcn.2012.199
   Central Bank of Guatemala, 2014, CENTR BANK GUAT MONT, V0, P0
   Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107
   Dekker LH, 2015, FOOD NUTR RES, V59, P0, DOI 10.3402/fnr.v59.26317
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0
   Fernández-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78
   Ferrante D, 2011, REV PANAM SALUD PUBL, V29, P69, DOI 10.1590/S1020-49892011000200001
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003
   Grajeda Ruben, 2005, FOOD AND NUTRITION BULLETIN, V26, P0
   Howe LD, 2008, EMERG THEMES EPIDEMI, V5, P0, DOI 10.1186/1742-7622-5-3
   Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978
   Kline RB, 1994, EASY GUIDE FACTOR AN, V0, P0
   Lako JV, 2001, ASIA PAC J CLIN NUTR, V10, P188, DOI 10.1046/j.1440-6047.2001.00255.x
   Luger E, 2016, PUBLIC HEALTH NUTR, V19, P1211, DOI 10.1017/S1368980015002852
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-654
   Maluccio John A, 2005, FOOD AND NUTRITION BULLETIN, V26, P0
   Maluccio John A, 2005, FOOD AND NUTRITION BULLETIN, V26, P0
   Mayén AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   Menchu MT, 2012, TABLA DE COMPOSICION DE ALIMENTOS DE CENTROAMERICA, V0, P0
   Ministerio de Salud Publica y Asistencia Social Instituto Nacional de Estadistica Universidad del V, 2011, 5 ENC NAC SAL MAT IN, V0, P0
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127
   Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742
   Noel SE, 2009, J NUTR, V139, P1360, DOI 10.3945/jn.109.105874
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Perez-Grovas Victor, 2001, CASE STUDY OF THE COFFEE SECTOR IN MEXICO, V0, P0
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Public Health Ministry, 2009, GUAT REPR HLTH SURV, V0, P0
   Sofianou A, 2011, J AM DIET ASSOC, V111, P1563, DOI 10.1016/j.jada.2011.07.005
   de Castro MBT, 2016, PUBLIC HEALTH NUTR, V19, P1245, DOI 10.1017/S1368980015002700
   USDA Foreign Agricultural Service GAIN, 2013, GUAT MY 2012 2013 SU, V0, P0
   Waterlander WE, 2013, INT J BEHAV NUTR PHY, V10, P0, DOI 10.1186/1479-5868-10-59
   Winham DM, 2009, AM J LIFESTYLE MED, V3, P64S, DOI 10.1177/1559827609335552
NR 39
TC 14
Z9 16
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1661-8556
EI 1661-8564
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD DEC 15
PY 2016
VL 61
IS 9
BP 1069
EP 1077
DI 10.1007/s00038-016-0863-3
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ED3HA
UT WOS:000388739000010
PM 27421467
DA 2025-04-28
ER

PT J
AU Sui, ZX
   Zheng, MB
   Zhang, M
   Rangan, A
AF Sui, Zhixian
   Zheng, Miaobing
   Zhang, Man
   Rangan, Anna
TI Water and Beverage Consumption: Analysis of the Australian 2011-2012 National Nutrition and Physical Activity Survey
SO NUTRIENTS
LA English
DT Article
DE water intake; dietary pattern; drinking water; diet quality; adults; children
ID sugar-sweetened beverages; dietary energy density; hydration biomarkers; plain water; children; obesity; dehydration; performance; quality; health
AB Background: Water consumption as a vital component of the human diet is under-researched in dietary surveys and nutrition studies. Aim: To assess total water and fluid intakes and examine demographic, anthropometric, and dietary factors associated with water consumption in the Australian population. Methods: Dietary intake data from the 2011 to 2012 National Nutrition and Physical Activity Survey were used. Usual water, fluid and food and nutrient intakes were estimated from two days of dietary recalls. Total water includes plain drinking water and moisture from all food and beverage sources; total fluids include plain drinking water and other beverages, but not food moisture. Results: The mean (SD) daily total water intakes for children and adolescents aged 2-18 years were 1.7 (0.6) L for males and 1.5 (0.4) L for females, and for adults aged 19 years and over were 2.6 (0.9) L for males and 2.3 (0.7) L for females. The majority of the population failed to meet the Adequate Intake (AI) values for total water intake (82%) and total fluids intake (78%) with the elderly at highest risk (90%-95%). The contributions of plain drinking water, other beverages and food moisture to total water intake were 44%, 27%, and 29%, respectively, among children and adolescents, and 37%, 37% and 25% among adults. The main sources of other beverages were full-fat plain milk and regular soft drinks for children and adolescents, and tea, coffee, and alcoholic drinks for adults. For adults, higher total water intake was associated with lower percent energy from fat, saturated fat, and free sugars, lower sodium and energy-dense nutrient poor food intakes but higher dietary fibre, fruit, vegetable, caffeine, and alcohol intakes. No associations were found between total water consumption and body mass index (BMI) for adults and BMI z-score for children and adolescents. Conclusion: Reported water consumption was below recommendations. Higher water intakes were suggestive of better diet quality.
C1 [Sui, Zhixian; Zheng, Miaobing; Zhang, Man; Rangan, Anna] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.
C3 University of Sydney
RP Sui, ZX (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.
EM zhixian.sui@sydney.edu.au; miaobing.zheng@sydney.edu.au; mzha7338@uni.sydney.edu.au; anna.rangan@sydney.edu.au
CR Ali A, 2015, INT J SPORTS MED, V36, P433, DOI 10.1055/s-0034-1398580
   An R, 2016, J HUM NUTR DIET, V29, P624, DOI 10.1111/jhn.12368
   An RP, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050263
   Unknown -, 2013, AUSTR GUID HLTH EAT, V0, P0
   Unknown -, 2014, AUSTRALIAN FOOD, V0, P0
   Armstrong LE, 2012, NUTR REV, V70, PS121, DOI 10.1111/j.1753-4887.2012.00539.x
   Australian Bureau of Statistics, 2013, AUSTRALIAN HEALTH SURVEY: USERS GUIDE, V0, P0
   Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971
   Börnhorst C, 2014, CLIN NUTR, V33, P79, DOI 10.1016/j.clnu.2013.03.018
   Drewnowski A, 2013, NUTR J, V12, P0
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1068
   Frangeskou M, 2015, J NUTR HEALTH AGING, V19, P619, DOI 10.1007/s12603-015-0491-2
   Gemming L, 2014, EUR J CLIN NUTR, V68, P259, DOI 10.1038/ejcn.2013.242
   Harttig U, 2011, EUR J CLIN NUTR, V65, PS87, DOI 10.1038/ejcn.2011.92
   Jayalath VH, 2015, AM J CLIN NUTR, V102, P914, DOI 10.3945/ajcn.115.107243
   Jéquier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111
   Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Millar L, 2014, OBESITY, V22, PE96, DOI 10.1002/oby.20665
   National Health and Medical Research Council, 2013, EAT HEALTHEDUCATOR G, V0, P0
   OConnor L, 2014, J HUM NUTR DIET, V27, P550, DOI 10.1111/jhn.12189
   Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150
   Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93
   Perrier E, 2013, BRIT J NUTR, V109, P1678, DOI 10.1017/S0007114512003601
   Rangan A, 2014, J HUM NUTR DIET, V27, P450, DOI 10.1111/jhn.12182
   Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003
   Vanrullen IB, 2014, BRIT J NUTR, V111, P1292, DOI 10.1017/S0007114513003759
   Vieux F, 2016, PUBLIC HEALTH NUTR, V19, P2305, DOI 10.1017/S1368980015003614
   Wang J, 2008, DIABETES CARE, V31, P2120, DOI 10.2337/dc08-1085
   WHO, 2006, LENGTH HEIGHT AG WEI, V0, P0
   Zheng MB, 2015, BRIT J NUTR, V114, P1448, DOI 10.1017/S0007114515002974
   Zheng MB, 2015, NUTRITION, V31, P38, DOI 10.1016/j.nut.2014.04.017
NR 39
TC 41
Z9 43
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV 15
PY 2016
VL 8
IS 11
BP 
EP 
DI 10.3390/nu8110678
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA ED2IE
UT WOS:000388666400014
PM 27792184
DA 2025-04-28
ER

PT J
AU Wang, J
   Engler-Stringer, R
   Muhajarine, N
AF Wang, Jin
   Engler-Stringer, Rachel
   Muhajarine, Nazeem
TI Assessing the Consumer Food Environment in Restaurants by Neighbourhood Distress Level across Saskatoon, Saskatchewan
SO CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH
LA English
DT Article
ID nutrition information; public-health; deprivation; disparity; obesity; access; index
AB Purpose: To assess the consumer food environment in restaurants in Saskatoon, using the Nutrition Environment Measures Survey for Restaurants (NEMS-R), to examine differences by neighbourhood distress level and to reflect on the need for further refinement of the assessment of restaurant consumer food environments. Methods: Neighbourhoods were classified as low, middle, or high distress level based on the socioeconomic indicators (income, employment, and education) in the Material Deprivation Index. Differences in restaurant consumer food environments, indicated by mean NEMS-R total and sub-scores, were examined by various restaurant categories and by varying neighbourhood distress levels. Results: Chain coffee shops and pita and sandwich restaurants had higher NEMS-R totals and "Healthy Entrees" sub-scores; however, burger and chicken restaurants and pizza restaurants had more barriers to healthful eating. Although restaurants in lower distress level neighbourhoods generally rated healthier (higher NEMS-R scores), only a few measures (such as "Facilitators" and "Barriers") significantly differed by neighbourhood distress level. Conclusions: The findings highlight the importance of developing interventions to improve restaurant consumer food environments, especially in neighbourhoods with higher distress levels. The results suggest that reliable measures of the consumer food environment could be developed beginning with what can be measured by NEMS-R.
C1 [Wang, Jin; Engler-Stringer, Rachel; Muhajarine, Nazeem] Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK S7N 0W0, Canada.
C3 University of Saskatchewan
RP Wang, J (corresponding author), Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK S7N 0W0, Canada.
FU Canadian Institutes for Health Research [106643]
CR Unknown -, 2008, REDUCING GAPS IN HEALTH: A FOCUS ON SOCIOECONOMIC STATUS IN URBAN CANADA, V0, P0
   Unknown -, 2013, MEAS FOOD ENV CAN, V0, P0
   Auchincloss AH, 2013, PUBLIC HEALTH NUTR, V16, P2138, DOI 10.1017/S1368980013000104
   Azagba S, 2012, J PRIM CARE COMMUNIT, V3, P57, DOI 10.1177/2150131911417445
   Bader MDM, 2010, ECON GEOGR, V86, P409, DOI 10.1111/j.1944-8287.2010.01084.x
   Black C, 2014, HEALTH PLACE, V27, P229, DOI 10.1016/j.healthplace.2013.09.015
   Buckeridge DL, 2014, ANN NY ACAD SCI, V1331, P270, DOI 10.1111/nyas.12332
   Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973
   Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006
   City of Saskatoon, 2012, CIT SASK NEIGHB PROF, V0, P0
   De Vogli R, 2014, B WORLD HEALTH ORGAN, V92, P99, DOI 10.2471/BLT.13.120287
   Drouin S, 2009, CAN J PUBLIC HEALTH, V100, P361, DOI 10.1007/BF03405271
   Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520
   Engler-Stringer R, 2014, CHARACTERIZATION FOO, V0, P0
   Engler-Stringer R, 2014, SPAT SPATIO-TEMPORAL, V11, P23, DOI 10.1016/j.sste.2014.07.001
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Hobin E, 2015, CAN J DIET PRACT RES, V76, P44, DOI 10.3148/cjdpr-2014-026
   Hollands S, 2014, CAN J PUBLIC HEALTH, V105, PE172, DOI 10.17269/cjph.105.4287
   Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267
   Institut national de santei publique du Queibec, 2008, IND CAN DEIF, V0, P0
   Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059
   Jones J, 2009, CAN J PUBLIC HEALTH, V100, P32, DOI 10.1007/BF03405489
   Kershaw T, 2010, FOOD ACCESS SASKATOO, V0, P0
   Krieger JW, 2013, AM J PREV MED, V44, P595, DOI 10.1016/j.amepre.2013.01.031
   Larsen K, 2008, INT J HEALTH GEOGR, V7, P0, DOI 10.1186/1476-072X-7-16
   Longacre MR, 2012, AM J PREV MED, V42, P579, DOI 10.1016/j.amepre.2012.02.017
   Lytle LA, 2009, AM J PREV MED, V36, PS134, DOI 10.1016/j.amepre.2009.01.018
   McKinnon RA, 2009, AM J PREV MED, V36, PS124, DOI 10.1016/j.amepre.2009.01.012
   Minaker LM, 2009, CAN J PUBLIC HEALTH, V100, P421, DOI 10.1007/BF03404337
   Pampalon R, 2014, CHRON DIS INJ CAN, V34, P12
   Peters EJ, 2008, CANADIAN JOURNAL OF URBAN RESEARCH, V71, P78
   Rehm CD, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103543
   Robitaille E, 2010, 1092 I NAT SANT PUBL, V0, P0
   Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022
   Saelens BE, 2012, AM J PREV MED, V43, P505, DOI 10.1016/j.amepre.2012.07.025
   Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017
   Statistics Canada, 2010, CAN HLTH MEAS SURV, V0, P0
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
NR 39
TC 5
Z9 7
U1 0
U2 7
PU DIETITIANS CANADA
PI TORONTO
PA 480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA
SN 1486-3847
EI 2292-9592
J9 CAN J DIET PRACT RES
JI Can. J. Diet. Pract. Res.
PD MAR 15
PY 2016
VL 77
IS 1
BP 9
EP 16
DI 10.3148/cjdpr-2015-031
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DN0QI
UT WOS:000376768100004
PM 26450080
DA 2025-04-28
ER

PT J
AU Maghsoudi, Z
   Ghiasvand, R
   Salehi-Abargouei, A
AF Maghsoudi, Zahra
   Ghiasvand, Reza
   Salehi-Abargouei, Amin
TI Empirically derived dietary patterns and incident type 2 diabetes mellitus: a systematic review and meta-analysis on prospective observational studies
SO PUBLIC HEALTH NUTRITION
LA English
DT Review
DE Dietary patterns; Type 2 diabetes mellitus; Systematic review; Meta-analysis
ID coffee consumption; risk; women; men; association; obesity; index; fruit
AB Objective To systematically review prospective cohort studies about the association between dietary patterns and type 2 diabetes mellitus (T2DM) incidence, and to quantify the effects using a meta-analysis. Design Databases such as PubMed, ISI Web of Science, SCOPUS and Google Scholar were searched up to 15 January 2015. Cohort studies which tried to examine the association between empirically derived dietary patterns and incident T2DM were selected. The relative risks (RR) and their 95 % confidence intervals for diabetes among participants with highest v. lowest adherence to derived dietary patterns were incorporated into meta-analysis using random-effects models. Results Ten studies (n 404 528) were enrolled in the systematic review and meta-analysis; our analysis revealed that adherence to the healthy' dietary patterns significantly reduced the risk of T2DM (RR=086; 95 % CI 082, 090), while the unhealthy' dietary patterns adversely affected diabetes risk (RR=130; 95 % CI 118, 143). Subgroup analysis showed that unhealthy dietary patterns in which foods with high phytochemical content were also loaded did not significantly increase T2DM risk (RR=106; 95 % CI 087, 130). Conclusions Healthy' dietary patterns containing vegetables, fruits and whole grains can lower diabetes risk by 14 %. Consuming higher amounts of red and processed meats, high-fat dairy and refined grains in the context of unhealthy' dietary patterns will increase diabetes risk by 30 %; while including foods with high phytochemical content in these patterns can modify this effect.
C1 [Maghsoudi, Zahra; Ghiasvand, Reza] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran.
   [Maghsoudi, Zahra; Ghiasvand, Reza] Isfahan Univ Med Sci, Sch Food & Nutr Sci, Dept Community Nutr, Esfahan, Iran.
   [Salehi-Abargouei, Amin] Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran.
   [Salehi-Abargouei, Amin] Shahid Sadoughi Univ Med Sci, Fac Hlth, Dept Nutr, POB 887-89165, Yazd, Iran.
C3 Isfahan University of Medical Sciences; Isfahan University of Medical Sciences
RP Salehi-Abargouei, A (corresponding author), Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran.; Salehi-Abargouei, A (corresponding author), Shahid Sadoughi Univ Med Sci, Fac Hlth, Dept Nutr, POB 887-89165, Yazd, Iran.
EM abargouei@hlth.mui.ac.ir
CR Alhazmi A, 2014, J HUM NUTR DIET, V27, P251, DOI 10.1111/jhn.12139
   Unknown -, 2008, SYSTEMATIC REV HLTH, V0, P0
   Bauer F, 2013, EUR J NUTR, V52, P1127, DOI 10.1007/s00394-012-0423-4
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erber E, 2010, DIABETES CARE, V33, P532, DOI 10.2337/dc09-1621
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jacobs DR, 2003, AM J CLIN NUTR, V78, P508S, DOI 10.1093/ajcn/78.3.508S
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Kuhad A, 2008, LIFE SCI, V83, P128, DOI 10.1016/j.lfs.2008.05.013
   Kuhad A, 2008, EUR J PAIN, V12, P624, DOI 10.1016/j.ejpain.2007.10.008
   Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528
   Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039
   Morimoto A, 2012, ASIA PAC J CLIN NUTR, V21, P601
   Nanri A, 2013, EUR J CLIN NUTR, V67, P18, DOI 10.1038/ejcn.2012.171
   Nettleton JA, 2008, DIABETES CARE, V31, P1777, DOI 10.2337/dc08-0760
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350
   Palli D, 2013, DIABETOLOGIA, V56, P47, DOI 10.1007/s00125-012-2718-7
   Sahyoun NR, 2008, AM J CLIN NUTR, V87, P126, DOI 10.1093/ajcn/87.1.126
   Seidell JC, 2000, BRIT J NUTR, V83, PS5, DOI 10.1017/S000711450000088X
   Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321
   Smith B, 2006, DIABETES CARE, V29, P2385, DOI 10.2337/dc06-1084
   Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109
   Thompson S, 2011, THESIS ARIZONA STATE, V0, P0
   Thompson SV, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-23
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574
   Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008
   Wells GA, 2016, BORRERO V. WELLS, V0, P0
   Winham D, 2008, NUTRITION TODAY, V43, P201, DOI 10.1097/01.NT.0000303354.21347.45
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 41
TC 46
Z9 54
U1 2
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD FEB 15
PY 2016
VL 19
IS 2
BP 230
EP 241
DI 10.1017/S1368980015001251
PG 12
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA DH2TR
UT WOS:000372639900005
PM 25917191
DA 2025-04-28
ER

PT J
AU Rocha, A
   Bolin, AP
   Cardoso, CAL
   Otton, R
AF Rocha, Andrea
   Bolin, Anaysa Paola
   Lima Cardoso, Claudia Andrea
   Otton, Rosemari
TI Green tea extract activates AMPK and ameliorates white adipose tissue metabolic dysfunction induced by obesity
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Obesity; Flavonoids; Metabolism; Gene expression; Polyphenols
ID protein-kinase; antioxidant capacity; adiponectin; thermogenesis; polyphenols; inhibition; mechanisms; caffeine; catechin; synthase
AB Beneficial effects of green tea (GT) polyphenols against obesity have been reported. However, until this moment the molecular mechanisms of how green tea can modulate obesity and regulates fat metabolism, particularly in adipose tissue, remain poorly understood. The aim of this study was to evaluate the role of GT extract in the adipose tissue of obese animals and its effect on weight gain, metabolism and function (de novo lipogenesis and lipolysis), and the involvement of AMP-activated protein kinase (AMPK). Male Wistar rats were treated with GT by gavage (12 weeks/5 days/week; 500 mg/kg of body weight), and obesity was induced by cafeteria diet (8 weeks). Here, we show that obese rats treated with GT showed a significant reduction in indicators of obesity such as hyperlipidemia, fat synthesis, body weight, and fat depots as compared to those treated with standard control diet. AMPK was induced in adipose tissue in rats that were treated with GT and likely restored insulin sensitivity, increased mRNA expression of GLUT4, reducing the concentrations of plasma and liver lipid content, also stimulating fatty acid oxidation in the same tissue. Importantly, repression of de novo lipogenesis in the adipose tissue, reduced lipid droplets in the liver, and the development of insulin resistance in diet-induced obese rats were accompanied by AMPK activation. Our study identified that metabolic changes caused by GT intake induced AMPK activation and modulate the expression of genes involved in metabolism, particularly in adipose tissue, thus offering a therapeutic strategy to combat insulin resistance, dyslipidemia, and obesity in rats.
C1 [Rocha, Andrea; Bolin, Anaysa Paola; Otton, Rosemari] Cruzeiro do Sul Univ, Sci Inst Phys Act & Sports, Human Movement Sci, Ave Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.
   [Bolin, Anaysa Paola; Otton, Rosemari] Univ Sao Paulo, Postgrad Program Pharmacol, Sao Paulo, SP, Brazil.
   [Lima Cardoso, Claudia Andrea] Mato Grosso do Sul Univ, Rodovia Ithaum,Km 12 Cidade Univ, BR-79804970 Dourados, MS, Brazil.
C3 Universidade de Sao Paulo
RP Otton, R (corresponding author), Cruzeiro do Sul Univ, Sci Inst Phys Act & Sports, Human Movement Sci, Ave Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.; Otton, R (corresponding author), Univ Sao Paulo, Postgrad Program Pharmacol, Sao Paulo, SP, Brazil.
EM rosemari.otton@cruzeirodosul.edu.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2011/19216-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [139307/2012-5]; Universidade Cruzeiro do Sul; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/19216-8] Funding Source: FAPESP
CR Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002
   Anesini C, 2008, J AGR FOOD CHEM, V56, P9225, DOI 10.1021/jf8022782
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x
   Hong MH, 2007, LIFE SCI, V80, P1957, DOI 10.1016/j.lfs.2007.02.024
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B
   Kadowaki T, 2011, CELL METAB, V13, P123, DOI 10.1016/j.cmet.2011.01.012
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lee H, 2013, J NUTR BIOCHEM, V24, P1232, DOI 10.1016/j.jnutbio.2012.09.007
   Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357
NR 27
TC 73
Z9 78
U1 4
U2 68
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2016
VL 55
IS 7
BP 2231
EP 2244
DI 10.1007/s00394-015-1033-8
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DX7EV
UT WOS:000384550300005
PM 26361764
DA 2025-04-28
ER

PT J
AU Stohs, SJ
   Badmaev, V
AF Stohs, Sidney J.
   Badmaev, Vladimir
TI A Review of Natural Stimulant and Non-stimulant Thermogenic Agents
SO PHYTOTHERAPY RESEARCH
LA English
DT Review
DE thermogenesis; stimulant; non-stimulant; caffeine; ephedra; chlorogenic acid; p-synephrine; forskolin; green tea; capsaicin; flavonoids; carotenoids
ID aurantium bitter orange; brown adipose-tissue; p-synephrine; green tea; salacia-reticulata; insulin-resistance; metabolic syndrome; citrus flavonoids; potential target; down-regulation
AB Obesity and overweight are major health issues. Exercise and calorie intake control are recognized as the primary mechanisms for addressing excess body weight. Naturally occurring thermogenic plant constituents offer adjunct means for assisting in weight management. The controlling mechanisms for thermogenesis offer many intervention points. Thermogenic agents can act through stimulation of the central nervous system with associated adverse cardiovascular effects and through metabolic mechanisms that are non-stimulatory or a combination thereof. Examples of stimulatory thermogenic agents that will be discussed include ephedrine and caffeine. Examples of non-stimulatory thermogenic agents include p-synephrine (bitter orange extract), capsaicin, forskolin (Coleus root extract), and chlorogenic acid (green coffee bean extract). Green tea is an example of a thermogenic with the potential to produce mild but clinically insignificant undesirable stimulatory effects. The use of the aforementioned thermogenic agents in combination with other extracts such as those derived from Salacia reticulata, Sesamum indicum, Lagerstroemia speciosa, Cissus quadrangularis, and Moringa olifera, as well as the use of the carotenoids as lutein and fucoxanthin, and flavonoids as naringin and hesperidin can further facilitate energy metabolism and weight management as well as sports performance without adverse side effects. (c) 2016 The Authors Phytotherapy Research published by John Wiley & Sons Ltd.
C1 [Stohs, Sidney J.] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA.
   [Badmaev, Vladimir] Amer Med Holdings Inc, Staten Isl, NY 10314 USA.
C3 Creighton University
RP Stohs, SJ (corresponding author), 7068 Maumee Valley Court, Frisco, TX 75034 USA.
EM sid.stohs9@gmail.com
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Andraws R, 2005, PROG CARDIOVASC DIS, V47, P217, DOI 10.1016/j.pcad.2004.07.006
   Arao K, 2004, BIOSCI BIOTECH BIOCH, V68, P2643, DOI 10.1271/bbb.68.2643
   Arao Keisuke, 2004, LIPIDS HEALTH DIS, V3, P24, DOI 10.1186/1476-511X-3-24
   Asgary S, 2013, SCI WORLD J, V0, P0, DOI DOI 10.1155/2013.365892eCollection
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   Badmaev V, 2002, NUTRACOS, V1, P1
   Badmaev V, 2015, J FUNCT FOODS, V15, P44, DOI 10.1016/j.jff.2015.03.007
   Bahmani M, 2015, J EVID COMPL ALTERN, V0, P0
   BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425
   Biswas A, 2010, J FOOD SCI, V75, PH274, DOI 10.1111/j.1750-3841.2010.01821.x
   Bruckbauer A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0089166
   Carey AL, 2015, DIABETOLOGIA, V58, P1045, DOI 10.1007/s00125-015-3543-6
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Carpene MA, 2014, TRENDS ENDOCRIN MET, V26, P238
   Celi FS, 2015, TRENDS ENDOCRIN MET, V26, P238, DOI 10.1016/j.tem.2015.03.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clapham JC, 2012, NEUROPHARMACOLOGY, V63, P111, DOI 10.1016/j.neuropharm.2011.10.014
   Copeland S, 2013, INT J OCCUP ENV MED, V4, P211
   Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x
   De Matteis R, 2002, INT J OBESITY, V26, P1442, DOI 10.1038/sj.ijo.0802148
   de Oliveira AL, 2014, MOL CELL BIOCHEM, V388, P135, DOI 10.1007/s11010-013-1905-2
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Donovan J L, 2001, PSYCHOPHARMACOL BULL, V35, P30
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   European Food Safety Authority, 2015, EFSA J, V13, P120, DOI 10.2903/j.efsa.2015.4120
   Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010
   Franke AA, 2014, ARCH BIOCHEM BIOPHYS, V559, P24, DOI 10.1016/j.abb.2014.06.007
   Godard MP, 2005, OBES RES, V13, P1335, DOI 10.1038/oby.2005.162
   Goldwasser J, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012399
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hong NY, 2012, BIOCHEM BIOPH RES CO, V418, P720, DOI 10.1016/j.bbrc.2012.01.085
   Inchiosa MA, 2011, J OBES, V2011, P0, DOI 10.1155/2011/764584
   INSEL PA, 1982, J BIOL CHEM, V257, P7485
   Janssens PLHR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067786
   Jitomir J, 2008, J INT SOC SPORT NUTR, V5, P0, DOI 10.1186/1550-2783-5-23
   Kaats GR, 2013, FOOD CHEM TOXICOL, V55, P358, DOI 10.1016/j.fct.2013.01.013
   Kamiya Tomoyasu, 2012, GLOB J HEALTH SCI, V4, P147, DOI 10.5539/gjhs.v4n5p147
   Kassis O, 2013, ISRAELI MED ASS, V15, P487
   Lai CS, 2012, J AGR FOOD CHEM, V60, P1094, DOI 10.1021/jf204862d
   Landsberg L, 1996, BLOOD PRESS SUPPL, V1, P25
   Li PB, 2013, FOOD CHEM TOXICOL, V60, P1, DOI 10.1016/j.fct.2013.07.019
   LIU YL, 1995, INT J OBESITY, V19, P678
   Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maeda H, 2015, J OLEO SCI, V64, P125, DOI 10.5650/jos.ess14226
   Matsumura Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112180
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   McCarty MF, 2015, OPEN HEART, V2, P0, DOI 10.1136/openhrt-2015-000162eCollection.
   McNulty H, 2008, AM J CARDIOL, V101, P20D, DOI 10.1016/j.amjcard.2008.02.004
   Mercader J, 2011, J PHYSIOL BIOCHEM, V67, P443, DOI 10.1007/s13105-011-0078-2
   Montoya GA, 2014, BRIT J NUTR, V112, P1427, DOI 10.1017/S0007114514002232
   Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634
   Mund RA, 2013, CARDIOL REV, V21, P265, DOI 10.1097/CRD.0b013e31829cabff
   Muriach M, 2008, J PHYSIOL BIOCHEM, V64, P149, DOI 10.1007/BF03168243
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nunes AR, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00406
   Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Osakabe N, 2014, LIFE SCI, V114, P51, DOI 10.1016/j.lfs.2014.07.041
   Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256
   Peixoto JS, 2012, MOLECULES, V17, P5854, DOI 10.3390/molecules17055854
   Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015
   Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339
   Ratamess NA, 2015, J INT SOC SPORT NUTR, V12, P0, DOI 10.1186/s12970-015-0096-5
   Ray S, 2005, ARCH TOXICOL, V79, P330, DOI 10.1007/s00204-005-0672-6
   Reinbach HC, 2010, FOOD QUAL PREFER, V21, P655, DOI 10.1016/j.foodqual.2010.04.003
   Rosenbaum M, 2010, AM J CLIN NUTR, V88, P906
   Sayin MR, 2012, WIEN KLIN WOCHENSCHR, V124, P285, DOI 10.1007/s00508-012-0163-8
   Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897
   Srinivasan K, 2015, CRIT REV FOOD SCI NU, V0, P0, DOI DOI 10.1080/10408398.772090
   Stohs SJ, 2015, PHYTOTHER RES, V29, P986, DOI 10.1002/ptr.5382
   Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325
   Stohs SJ, 2013, PHYTOTHER RES, V27, P1107, DOI 10.1002/ptr.4846
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, OXID MED CELL LONGEV, V2011, P0, DOI 10.1155/2011/482973
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westfall TC, 2014, GOODMAN AND GILMANS, V0, P0
   Yoneshiro T, 2013, CURR OPIN CLIN NUTR, V16, P625, DOI 10.1097/MCO.0b013e3283653ee1
   Zhao J, 1997, J BIOL CHEM, V272, P32847, DOI 10.1074/jbc.272.52.32847
   Zheng Weijiang, 2013, WEISHENGWU XUEBAO, V53, P1251
NR 91
TC 86
Z9 90
U1 1
U2 71
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD MAY 15
PY 2016
VL 30
IS 5
BP 732
EP 740
DI 10.1002/ptr.5583
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DL6YY
UT WOS:000375787200003
PM 26856274
DA 2025-04-28
ER

PT J
AU Alderete, E
   Bejarano, I
   Rodríguez, A
AF Alderete, E.
   Bejarano, I.
   Rodriguez, A.
TI Beverage intake and obesity in early childhood: evidence form primary health care clients in Northwest Argentina
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Article
DE beverages; dietary sugar; latin America; pediatric obesity; water
ID body-mass index; sugar-sweetened beverages; income preschool-children; soft drink consumption; latin-america; juice intake; overweight; weight; prevalence; nutrition
AB Sugar sweetened beverages (SSB) are thought to play an important role in weight gain. We examined the relationship between the intake of caloric and noncaloric beverages (SSB and water) and the nutritional status of children. In 2014, we randomly selected 16 public health clinics in four cities of Northwest Argentina and conducted a survey among mothers of children 0-6 years of age. Children's beverage intake was ascertained by 24-h dietary recall provided by the mothers. Children's weight and height measures were obtained from clinic's registries. We calculated the body mass index using the International Obesity Task Force standards. The analysis included 562 children 25 months to 6 years of age with normal or above normal nutritional status. Children's beverage consumption was as follows, water 81.8%, carbonated soft drinks (CSD) 49.7%, coffee/tea/cocoa 44.0%, artificial fruit drinks 35.6%, flavored water 17.9%, natural fruit juice 14.5%. In multivariate logistic regression models the likelihood of being obese v. being overweight or having normal weight doubled with an intake of one to five glasses of CSD (OR = 2.2) and increased by more than three-fold with an intake of more than five glasses (OR = 3.5). Drinking more than five glasses of water decreased the likelihood of being obese by less than half (OR = 0.3). The percentage of children drinking more than five glasses of other beverages was low (3.3-0.9%) and regression models did not yield significant results. The study contributed evidence for reducing children's CSD intake and for promoting water consumption, together with the implementation of comprehensive regulatory public health policies.
C1 [Alderete, E.] Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, CONICET, El Hornero 468, RA-4600 San Salvador De Jujuy, Jujuy, Argentina.
   [Bejarano, I.; Rodriguez, A.] Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, San Salvador De Jujuy, Jujuy, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
RP Alderete, E (corresponding author), Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, CONICET, El Hornero 468, RA-4600 San Salvador De Jujuy, Jujuy, Argentina.
EM alderetew@gmail.com
FU Secretaria de Ciencia y Tecnica y Estudios Regionales, Universidad Nacional de Jujuy, Argentina, Resolucion CS [081/2015]; Salud Investiga, Ministerio de Salud de la Nacion Argentina, Becas de Investigacion Carrillo-Onativia
CR Abeya Gilardon EO, 2009, EVALUACION ESTADO NU, V0, P0
   Albrecht SS, 2014, AM J HUM BIOL, V26, P627, DOI 10.1002/ajhb.22573
   Almiron-Roig E, 2003, OBES REV, V4, P201, DOI 10.1046/j.1467-789X.2003.00112.x
   Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   Unknown -, 2006, WHO MULTICENTRE GROWTH REFERENCE STUDY GROUP: WHO CHILD GROWTH STANDARDS: LENGTH/ HEIGHT-FOR-AGE, V0, P0
   Unknown -, 2000, GUIDE MEASURING HOUS, V0, P0
   Unknown -, 2005, DIET REF INT WAT POT, V0, P0
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   BARKER DJP, 1986, LANCET, V1, P1077
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bejarano Ignacio, 2005, ARCH. ARGENT. PEDIATR., V103, P101
   Bolzán Andrés, 2005, ARCH. ARGENT. PEDIATR., V103, P545
   Bray GA, 2014, HANDBOOK OF OBESITY: CLINICAL APPLICATIONS, V2, P0
   Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   de Onis M, 2000, AM J CLIN NUTR, V72, P1032
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Deckelbaum RJ, 2001, OBES RES, V9, P239S, DOI 10.1038/oby.2001.125
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Dietz WH, 1998, J PEDIATR-US, V132, P191
   Dietz WH, 2009, MILBANK Q, V87, P215, DOI 10.1111/j.1468-0009.2009.00553.x
   Drewnowski A, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-85
   Dubois L, 2007, J AM DIET ASSOC, V107, P924, DOI 10.1016/j.jada.2007.03.004
   Durán P, 2009, ARCH ARGENT PEDIATR, V107, P397, DOI 10.1590/S0325-00752009000500005
   Faith MS, 2006, PEDIATRICS, V118, P2066, DOI 10.1542/peds.2006-1117
   Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623
   Frazier CRM, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003221
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Institute of Medicine of the National Academies, 2009, LOC GOV ACT PREV CHI, V0, P0
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kain J, 2009, CAD SAUDE PUBLICA, V19, P0
   King V, 2014, REPROD BIOL ENDOCRIN, V12, P0, DOI 10.1186/1477-7827-12-73
   Kral TVE, 2008, OBESITY, V16, P1802, DOI 10.1038/oby.2008.287
   Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738
   Lim S, 2009, OBESITY, V17, P1262, DOI 10.1038/oby.2008.656
   Lobstein BT, 2005, EU BRIEFING PAPER, V0, P0
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Meyer E, 2013, ARCH ARGENT PEDIATR, V111, P516, DOI 10.5546/aap.2013.516
   Muckelbauer R, 2014, OBESITY, V22, P2462, DOI 10.1002/oby.20911
   Muckelbauer R, 2009, PEDIATRICS, V123, PE661, DOI 10.1542/peds.2008-2186
   Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020
   OConnor TM, 2006, PEDIATRICS, V118, PE1010, DOI 10.1542/peds.2005-2348
   ODonnell A, 2003, ARCH ARGENT PEDIATR, V101, P57
   Padula G, 2008, ARCH LATINOAM NUTR, V58, P330
   PAHO/WHO, 2014, PLAN ACT PREV OB CHI, V0, P0
   Pérez-Morales E, 2013, NUTR HOSP, V28, P47, DOI 10.3305/nh.2013.28.1.6247
   Piernas C, 2014, AM J CLIN NUTR, V99, P567, DOI 10.3945/ajcn.113.072132
   Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1207, DOI 10.1136/bmj.39048.503750.BE
   Romaguera D, 2008, PUBLIC HEALTH NUTR, V11, P606, DOI 10.1017/S1368980007001061
   Skinner JD, 2001, J AM DIET ASSOC, V101, P432, DOI 10.1016/S0002-8223(01)00111-0
   Uauy R, 2001, J NUTR, V131, P893S, DOI 10.1093/jn/131.3.893S
   UNDP, 2014, HUMAN DEV REPORT 201, V0, P0
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X
   Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792
   Welsh JA, 2005, PEDIATRICS, V115, PE223, DOI 10.1542/peds.2004-1148
   WHO, 2014, REPORT OF THE FIRST, V0, P0
   WHOWorld Health Statistics, 2014, THE WHO DOCUMENT PRO, V0, P0
   World Health Organization, 1998, OBESITY PREVENTING A, V0, P0
NR 71
TC 3
Z9 3
U1 0
U2 11
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
EI 2040-1752
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD JUN 15
PY 2016
VL 7
IS 3
BP 244
EP 252
DI 10.1017/S204017441500793X
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR3CT
UT WOS:000379780900005
PM 26639571
DA 2025-04-28
ER

PT J
AU Alam, MA
   Subhan, N
   Hossain, H
   Hossain, M
   Reza, HM
   Rahman, MM
   Ullah, MO
AF Alam, Md Ashraful
   Subhan, Nusrat
   Hossain, Hemayet
   Hossain, Murad
   Reza, Hasan Mahmud
   Rahman, Md Mahbubur
   Ullah, M. Obayed
TI Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity
SO NUTRITION & METABOLISM
LA English
DT Review
DE Hydroxycinnamic acid; Obesity; Diabetes; Dyslipidemia; Inflammation
ID activated protein-kinase; high-fat diet; necrosis-factor-alpha; phenethyl ester cape; nf-kappa-b; ferulic acid; caffeic acid; ppar-gamma; chlorogenic acid; cinnamic acid
AB Hydroxycinnamic acid derivatives are important class of polyphenolic compounds originated from the Mavolanate-Shikimate biosynthesis pathways in plants. Several simple phenolic compounds such as cinnamic acid, p-coumaric acid, ferulic acid, caffeic acid, chlorgenic acid, and rosmarinic acid belong to this class. These phenolic compounds possess potent antioxidant and anti-inflammatory properties. These compounds were also showed potential therapeutic benefit in experimental diabetes and hyperlipidemia. Recent evidences also suggest that they may serve as valuable molecule for the treatment of obesity related health complications. In adipose tissues, hydroxycinnamic acid derivatives inhibit macrophage infiltration and nuclear factor kappa B (NF-kappa B) activation in obese animals. Hydroxycinnamic acid derivatives also reduce the expression of the potent proinflammatory adipokines tumor necrosis factor-alpha (TNF alpha), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor type-1 (PAI-1), and they increase the secretion of an anti-inflammatory agent adiponectin from adipocytes. Furthermore, hydroxycinnamic acid derivatives also prevent adipocyte differentiation and lower lipid profile in experimental animals. Through these diverse mechanisms hydroxycinnamic acid derivatives reduce obesity and curtail associated adverse health complications.
C1 [Alam, Md Ashraful; Hossain, Murad; Reza, Hasan Mahmud; Rahman, Md Mahbubur; Ullah, M. Obayed] North South Univ Bangladesh, Dept Pharmaceut Sci, Dhaka, Bangladesh.
   [Subhan, Nusrat] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.
   [Hossain, Hemayet] Bangladesh Council Sci & Ind Res, BCSIR Labs, Dhaka, Bangladesh.
C3 North South University (NSU); Charles Sturt University; Bangladesh Council of Scientific & Industrial Research (BCSIR); BCSIR Laboratories Dhaka
RP Ullah, MO (corresponding author), North South Univ Bangladesh, Dept Pharmaceut Sci, Dhaka, Bangladesh.
EM obayed.obhi@yahoo.com
CR Ardiansyah, 2008, J AGR FOOD CHEM, V56, P2825, DOI 10.1021/jf072896y
   Ardiansyah, 2007, BRIT J NUTR, V97, P67, DOI 10.1017/S000711450721013X
   Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759
   Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440
   Balasubashini MS, 2003, ACTA DIABETOL, V40, P118, DOI 10.1007/s00592-003-0099-6
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Celik S, 2009, PHARMACOL RES, V60, P270, DOI 10.1016/j.phrs.2009.03.017
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Chao PC, 2009, NUTR METAB, V6, P0, DOI 10.1186/1743-7075-6-33
   CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082
   Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Eid HM, 2012, PLANTA MED, V78, P0
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Ferdowsian HR, 2009, AM J CARDIOL, V104, P947, DOI 10.1016/j.amjcard.2009.05.032
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200
   Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994
   Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028
   Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100
   Herman CP, 2011, SOC ISS POLICY REV, V5, P37, DOI 10.1111/j.1751-2409.2011.01025.x
   Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956
   Hey-Mogensen M, 2012, ACTA PHYSIOL, V204, P354, DOI 10.1111/j.1748-1716.2011.02347.x
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hole AS, 2012, FOOD CHEM, V133, P969, DOI 10.1016/j.foodchem.2012.02.017
   Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Huang DW, 2012, J FUNCT FOODS, V4, P358, DOI 10.1016/j.jff.2012.01.005
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008
   Juman S, 2011, BIOL PHARM BULL, V34, P490, DOI 10.1248/bpb.34.490
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Jung KJ, 2009, J NUTR BIOCHEM, V20, P378, DOI 10.1016/j.jnutbio.2008.04.008
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasetti RB, 2012, FOOD CHEM TOXICOL, V50, P1425, DOI 10.1016/j.fct.2012.02.003
   Kim EO, 2012, FOOD CHEM TOXICOL, V50, P1309, DOI 10.1016/j.fct.2012.02.011
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kopp C, 2014, INT J MOL SCI, V15, P2906, DOI 10.3390/ijms15022906
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Kwon EY, 2010, FOOD CHEM TOXICOL, V48, P2298, DOI 10.1016/j.fct.2010.05.063
   Kwon EY, 2009, J MED FOOD, V12, P996, DOI 10.1089/jmf.2009.0105
   Lafay Sophie, 2008, PHYTOCHEMISTRY REVIEWS, V7, P301, DOI 10.1007/s11101-007-9077-x
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lazarou C, 2012, CRIT REV FOOD SCI, V52, P382, DOI 10.1080/10408398.2010.500258
   Lee MK, 2007, CHEM-BIOL INTERACT, V170, P9, DOI 10.1016/j.cbi.2007.06.037
   Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011
   LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006
   Long YC, 2005, DIABETOLOGIA, V48, P2354, DOI 10.1007/s00125-005-1962-5
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031
   McGowan MP, 2009, CURR ATHEROSCLER REP, V11, P470, DOI 10.1007/s11883-009-0070-2
   Michaluart P, 1999, CANCER RES, V59, P2347
   Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538
   Mnafgui K, 2015, J FOOD SCI TECH MYS, V52, P4378, DOI 10.1007/s13197-014-1488-2
   Narasimhan A, 2015, EUR J PHARMACOL, V761, P391, DOI 10.1016/j.ejphar.2015.04.043
   Narasimhan A, 2015, APPL PHYSIOL NUTR ME, V40, P769, DOI 10.1139/apnm-2015-0002
   Bezerra RMN, 2012, METABOLISM, V61, P1606, DOI 10.1016/j.metabol.2012.04.006
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003
   Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7
   Pignatelli P, 2006, ATHEROSCLEROSIS, V188, P77, DOI 10.1016/j.atherosclerosis.2005.10.025
   Pistollato F, 2014, TRENDS FOOD SCI TECH, V0, P0
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Pragasam S, 2012, INFLAMMATION, V0, P1
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907
   Racette SB, 2003, PHYS THER, V83, P276, DOI 10.1093/ptj/83.3.276
   Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0
   Rodríguez-Hernández H, 2013, INT J ENDOCRINOL, V2013, P0, DOI 10.1155/2013/678159
   Sakai S, 1997, CYTOKINE, V9, P242, DOI 10.1006/cyto.1996.0160
   Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shashirekha MN, 2015, CRIT REV FOOD SCI, V55, P1324, DOI 10.1080/10408398.2012.692736
   Son MJ, 2011, J FOOD SCI, V76, PH7, DOI 10.1111/j.1750-3841.2010.01907.x
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003
   Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015
   TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wilson TA, 2007, J NUTR BIOCHEM, V18, P105, DOI 10.1016/j.jnutbio.2006.03.006
   WOLFFRAM S, 1995, J NUTR, V125, P1300
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992
   Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 132
TC 251
Z9 278
U1 17
U2 181
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD APR 11
PY 2016
VL 13
IS 
BP 
EP 
DI 10.1186/s12986-016-0080-3
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DI7JK
UT WOS:000373675300001
PM 27069498
DA 2025-04-28
ER

PT J
AU Kourouniotis, S
   Keast, RSJ
   Riddell, LJ
   Lacy, K
   Thorpe, MG
   Cicerale, S
AF Kourouniotis, S.
   Keast, R. S. J.
   Riddell, L. J.
   Lacy, K.
   Thorpe, M. G.
   Cicerale, S.
TI The importance of taste on dietary choice, behaviour and intake in a group of young adults
SO APPETITE
LA English
DT Article
DE Taste importance; Taste; Food choice; Influences; Nutrition; Young adults
ID energy density; food; students; obesity; habits; health; consumption; preferences; attitudes; nutrition
AB The 'taste of food' plays an important role in food choice. Furthermore, foods high in fat, sugar and salt are highly palatable and associated with increased food consumption. Research exploring taste importance on dietary choice, behaviour and intake is limited, particularly in young adults. Therefore, in this study a total of 1306 Australian university students completed questionnaires assessing dietary behaviors (such as how important taste was on food choice) and frequency of food consumption over the prior month. Diet quality was also assessed using a dietary guideline index. Participants had a mean age of 20 +/- 5 years, Body Mass Index (BMI) of 22 +/- 3 kg/m(2), 79% were female and 84% Australian. Taste was rated as being a very or extremely important factor for food choice by 82% of participants. Participants who rated taste as highly important, had a poorer diet quality (p = 0.001) and were more likely to consume less fruit (p = 0.03) and vegetables (p = 0.05). Furthermore, they were significantly more likely to consume foods high in fat, sugar and salt, including chocolate and confectionary, cakes and puddings, sweet pastries, biscuits, meat pies, pizza, hot chips, potato chips, takeaway meals, soft drink, cordial and fruit juice (p = 0.001-0.02). They were also more likely to consider avoiding adding salt to cooking (p = 0.02) and adding sugar to tea or coffee (p = 0.01) as less important for health. These findings suggest that the importance individuals place on taste plays an important role in influencing food choice, dietary behaviors and intake. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Kourouniotis, S.; Keast, R. S. J.; Cicerale, S.] Deakin Univ, Ctr Adv Sensory Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Riddell, L. J.; Lacy, K.; Thorpe, M. G.] Deakin Univ, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
C3 Deakin University; Deakin University
RP Cicerale, S (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM sara.cicerale@deakin.edu.au
CR Anderson Drew A, 2003, EAT BEHAV, V4, P363, DOI 10.1016/S1471-0153(03)00030-8
   Unknown -, 2013, AUSTR DIET GUID, V0, P0
   Unknown -, 2013, NUTR 1 RES FOODS NUT, V0, P0
   Unknown -, 2013, 4364 0 55 003 AUSTR, V0, P0
   Unknown -, 1998, J AM DIET ASSOC, V0, P0
   Ansari WE, 2012, NUTR J, V11, P1
   Bagordo F, 2013, J FOOD NUTR RES-SLOV, V52, P164
   Barclay AW, 2011, NUTRIENTS, V3, P491, DOI 10.3390/nu3040491
   BEAUCHAMP GK, 1987, AM SCI, V75, P27
   BERTINO M, 1986, PHYSIOL BEHAV, V38, P203, DOI 10.1016/0031-9384(86)90155-1
   Biloukha OO, 2001, PUBLIC HEALTH NUTR, V4, P207, DOI 10.1079/PHN200059
   BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x
   DeBate RD, 2001, ADOLESCENCE, V36, P819
   Deliens T, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-162
   Drewnowski A, 1997, J AM DIET ASSOC, V97, P266, DOI 10.1016/S0002-8223(97)00070-9
   Drewnowski A, 2005, AM J CLIN NUTR, V82, P265S, DOI 10.1093/ajcn/82.1.265S
   DREWNOWSKI A, 1983, PHYSIOL BEHAV, V30, P629, DOI 10.1016/0031-9384(83)90232-9
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S
   Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019
   Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031
   Garnweidner LM, 2012, J NUTR EDUC BEHAV, V44, P335, DOI 10.1016/j.jneb.2011.08.005
   Georgiou CC, 1997, J AM DIET ASSOC, V97, P754, DOI 10.1016/S0002-8223(97)00187-9
   Gokhan I, 2014, ONLINE INTERNATIONAL INTERDISCIPLINARY RESEARCH JOURNAL, V4, P341
   Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628
   Hennekens CH, 1987, EPIDEMIOLOGY MED, V0, P0
   Ireland P, 1994, ASIA PAC J CLIN NUTR, V3, P19
   Lennernas M, 1997, EUR J CLIN NUTR, V51, P0
   McCrory MA, 2006, PHYSIOL BEHAV, V87, P451, DOI 10.1016/j.physbeh.2004.10.025
   McNaughton SA, 2008, J NUTR, V138, P86, DOI 10.1093/jn/138.1.86
   National Health and Medical Research Council, 2005, FOOD FOR HLTH, V0, P0
   Noble AC, 1996, TRENDS FOOD SCI TECH, V7, P439, DOI 10.1016/S0924-2244(96)10044-3
   Olsen NV, 2012, FOOD QUAL PREFER, V24, P171, DOI 10.1016/j.foodqual.2011.11.001
   Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008
   Riddell LJ, 2011, APPETITE, V56, P726, DOI 10.1016/j.appet.2011.02.010
   SHEPHERD R, 1986, APPETITE, V7, P343, DOI 10.1016/S0195-6663(86)80003-4
   Silliman K, 2004, CALIFORNIAN JOURNAL OF HEALTH PROMOTION, V2, P10
   Soriano JM, 2000, NUTR RES, V20, P1249, DOI 10.1016/S0271-5317(00)00217-7
   Vadiveloo M, 2013, APPETITE, V71, P349, DOI 10.1016/j.appet.2013.09.005
   WARDLE J, 1991, SOC SCI MED, V33, P925, DOI 10.1016/0277-9536(91)90263-C
NR 41
TC 106
Z9 120
U1 3
U2 113
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD AUG 1
PY 2016
VL 103
IS 
BP 1
EP 7
DI 10.1016/j.appet.2016.03.015
PG 7
WC Behavioral Sciences; Nutrition & Dietetics
SC Behavioral Sciences; Nutrition & Dietetics
GA DP7GF
UT WOS:000378666500001
PM 26972352
DA 2025-04-28
ER

PT J
AU Choi, JY
   Kim, YJ
   Ryu, R
   Cho, SJ
   Kwon, EY
   Choi, MS
AF Choi, Ji-Young
   Kim, Ye Jin
   Ryu, Ri
   Cho, Su-Jung
   Kwon, Eun-Young
   Choi, Myung-Sook
TI Effect of Green Tea Extract on Systemic Metabolic Homeostasis in Diet-Induced Obese Mice Determined via RNA-Seq Transcriptome Profiles
SO NUTRIENTS
LA English
DT Article
DE energy expenditure; green tea extract; obesity; RNA-seq; transcriptome
ID activated protein-kinase; amino-acid catabolism; insulin-resistance; adipose-tissue; energy-expenditure; fat oxidation; caffeine; liver; (-)-epigallocatechin-3-gallate; supplementation
AB Green tea (GT) has various health effects, including anti-obesity properties. However, the multiple molecular mechanisms of the effects have not been fully determined. The aim of this study was to elucidate the anti-obesity effects of GT via the analysis of its metabolic and transcriptional responses based on RNA-seq profiles. C57BL/6J mice were fed a normal, high-fat (60% energy as fat), or high-fat + 0.25% (w/w) GT diet for 12 weeks. The GT extract ameliorated obesity, hepatic steatosis, dyslipidemia, and insulin resistance in diet-induced obesity (DIO) mice. GT supplementation resulted in body weight gain reduction than mice fed high-fat through enhanced energy expenditure, and reduced adiposity. The transcriptome profiles of epididymal white adipose tissue (eWAT) suggested that GT augments transcriptional responses to the degradation of branched chain amino acids (BCAAs), as well as AMP-activated protein kinase (AMPK) signaling, which suggests enhanced energy homeostasis. Our findings provide some significant insights into the effects of GT for the prevention of obesity and its comorbidities. We demonstrated that the GT extract contributed to the regulation of systemic metabolic homeostasis via transcriptional responses to not only lipid and glucose metabolism, but also amino acid metabolism via BCAA degradation in the adipose tissue of DIO mice.
C1 [Choi, Ji-Young; Kim, Ye Jin; Ryu, Ri; Cho, Su-Jung; Kwon, Eun-Young; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, 1370 Sankyuk Dong, Daegu 702701, South Korea.
   [Choi, Ji-Young; Kim, Ye Jin; Ryu, Ri; Cho, Su-Jung; Kwon, Eun-Young; Choi, Myung-Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, 1370 Sankyuk Dong, Daegu 702701, South Korea.
C3 Kyungpook National University (KNU); Kyungpook National University (KNU)
RP Choi, MS (corresponding author), Kyungpook Natl Univ, Dept Food Sci & Nutr, 1370 Sankyuk Dong, Daegu 702701, South Korea.; Choi, MS (corresponding author), Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, 1370 Sankyuk Dong, Daegu 702701, South Korea.
EM jyjy31@hanmail.net; freewilly59@hanmail.net; sangsang0119@gmail.com; chocrystalhihi@hanmail.net; savage20@naver.com; mschoi@knu.ac.kr
FU Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [NRF-2012M3A9C4048818]; Science Research Center Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [NRF-2015R1A5A6001906]
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Forester SC, 2011, MOL NUTR FOOD RES, V55, P844, DOI 10.1002/mnfr.201000641
   Freudenberg A, 2013, AMINO ACIDS, V44, P519, DOI 10.1007/s00726-012-1363-2
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001
   Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428
   Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, PE1175, DOI 10.1152/ajpendo.00630.2012
   Lazarow P B, 1981, METHODS ENZYMOL, V72, P315
   Lian K, 2015, DIABETES, V64, P49, DOI 10.2337/db14-0312
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151
   Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171
   Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   OCHOA S, 1955, METHOD ENZYMOL, V1, P735, DOI 10.1016/0076-6879(55)01128-2
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Peng XL, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06251
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Santamarina AB, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0141227
   SEIFTER S, 1950, ARCH BIOCHEM, V25, P191
   SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9
   She PX, 2007, AM J PHYSIOL-ENDOC M, V293, PE1552, DOI 10.1152/ajpendo.00134.2007
   Sun JQ, 2013, BMC BIOINFORMATICS, V14, P0, DOI 10.1186/1471-2105-14-219
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007
NR 42
TC 17
Z9 20
U1 1
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
EI 
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2016
VL 8
IS 10
BP 
EP 
DI 10.3390/nu8100640
PG 16
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA ED2HT
UT WOS:000388665300057
PM 27754422
DA 2025-04-28
ER

PT J
AU Yahya, HM
   Day, A
   Lawton, C
   Myrissa, K
   Croden, F
   Dye, L
   Williamson, G
AF Yahya, Hanis Mastura
   Day, Andrea
   Lawton, Clare
   Myrissa, Kyriaki
   Croden, Fiona
   Dye, Louise
   Williamson, Gary
TI Dietary intake of 20 polyphenol subclasses in a cohort of UK women
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Polyphenols; Flavonoids; Phenolic acids; Food diary; Phenol-Explorer
ID major food sources; recall cohort; cancer; adults; flavonoids; population; vegetables; country; disease; risk
AB Establishing and linking the proposed health benefits of dietary polyphenols to their consumption requires measurement of polyphenol intake in appropriate samples and an understanding of factors that influence their intake in the general population. This study examined polyphenol intake estimated from 3- and 7-day food diaries in a sample of 246 UK women aged 18-50 years. Estimation of the intake of 20 polyphenol subclasses commonly present in foods consumed by the sample studied was done using Phenol-Explorer(A (R)) and USDA polyphenol databases. Women were participants in the Leeds Women's Wellbeing Study (LWW) (n = 143), a dietary intervention study aimed at overweight women (mean age 37.2 +/- 9.4 years; mean BMI 30.8 +/- 3.1 kg/m(2)), and the Diet and Health Study (DH) (n = 103) which aimed to examine the relationship between polyphenol intake and cognitive function (mean age 25.0 +/- 9.0 years; mean BMI 24.5 +/- 4.6 kg/m(2)). The estimated intake of polyphenol subclasses was significantly different between the two samples (p < 0.01) with consumption of 1292 +/- 844 and 808 +/- 680 mg/day for the LWW and DH groups, respectively. Flavanols and hydroxycinnamic acids were the most important contributors to the polyphenols consumed by both groups, owing to tea and coffee consumption. Other major polyphenol food sources included fruits, vegetables and processed foods. Older women consumed more polyphenol-containing foods and beverages, which was due to the higher coffee and tea consumption amongst the LWW participants.
C1 [Yahya, Hanis Mastura; Day, Andrea; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
   [Yahya, Hanis Mastura] Univ Kebangsaan Malaysia, Sch Healthcare Sci, Fac Hlth Sci, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
   [Lawton, Clare; Myrissa, Kyriaki; Croden, Fiona; Dye, Louise] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England.
C3 University of Leeds; Universiti Kebangsaan Malaysia; University of Leeds
RP Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
EM hanis.yahya@ukm.edu.my; G.Williamson@leeds.ac.uk
FU Ministry of Education Malaysia; Universiti Kebangsaan Malaysia; Kellogg's Sales and Marketing UK
CR Bhagwat S, 2011, USDA DATABASE FLAVON, V0, P0
   Cheyette C, 2010, CARBS CALS PROTEIN F, V0, P0
   Cieslik E, 2006, FOOD CHEM, V94, P135, DOI 10.1016/j.foodchem.2004.11.015
   Dummer Trevor J B, 2012, J OBES, V2012, P934895, DOI 10.1155/2012/934895
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489
   Johnson CM, 2011, APPETITE, V57, P220, DOI 10.1016/j.appet.2011.04.025
   Kuhnert N, 2010, ARCH BIOCHEM BIOPHYS, V501, P37, DOI 10.1016/j.abb.2010.04.013
   Li GL, 2013, J ACAD NUTR DIET, V113, P786, DOI 10.1016/j.jand.2013.01.018
   Mahabir S, 2006, EUR J CLIN NUTR, V60, P561, DOI 10.1038/sj.ejcn.1602359
   Neveu V, 2010, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bap024
   Oakes ME, 2005, APPETITE, V44, P317, DOI 10.1016/j.appet.2005.03.010
   Oakes ME, 2001, PSYCHOL HEALTH, V16, P57, DOI 10.1080/08870440108405489
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Schofield W N, 1985, HUM NUTR CLIN NUTR, V39 Suppl 1, P5
   Sohrab G, 2013, INT J FOOD SCI NUTR, V64, P661, DOI 10.3109/09637486.2013.787397
   Somerset SM, 2008, NUTR CANCER, V60, P442, DOI 10.1080/01635580802143836
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050
   Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481
   Zamora-Ros R, 2013, EUR J CLIN NUTR, V67, P779, DOI 10.1038/ejcn.2013.89
   Zamora-Ros R, 2012, EUR J CLIN NUTR, V66, P932, DOI 10.1038/ejcn.2012.36
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
   Zamora-Ros R, 2013, BREAST CANCER RES TR, V139, P163, DOI 10.1007/s10549-013-2483-4
   Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273
   Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X
   Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI 10.1017/S0007114511001437
NR 28
TC 16
Z9 17
U1 0
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG 15
PY 2016
VL 55
IS 5
BP 1839
EP 1847
DI 10.1007/s00394-015-1001-3
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DR8CI
UT WOS:000380125600004
PM 26210882
DA 2025-04-28
ER

PT J
AU Shaikh, NI
   Patil, SS
   Halli, S
   Ramakrishnan, U
   Cunningham, SA
AF Shaikh, Nida I.
   Patil, Shailaja S.
   Halli, Shiva
   Ramakrishnan, Usha
   Cunningham, Solveig A.
TI Going global: Indian adolescents' eating patterns
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Adolescents; Food; Nutrition transition; Globalization; India
ID nutrition transition; dietary-intake; children; burden; schoolchildren; overnutrition; country; diseases; obesity; trends
AB Objective: To describe adolescents' eating patterns of traditional, global/non-local and mixed foods, and the factors that may influence food consumption, access and preferences, in a globalizing city. Design: A representative sample of school-going adolescents completed a cross-sectional survey including an FFQ designed to identify traditional and global foods. Student's t test and ordinal logistic regression were used to examine weekly food intake, including differences between boys and girls and between adolescents attending private and public schools. Setting: Vijayapura city, Karnataka State, India. Subjects: Adolescents (n 399) aged 13-16 years. Results: Compared with dietary guidelines, adolescents consumed fruit, green leafy vegetables, non-green leafy vegetables and dairy less frequently than recommended and consumed energy-dense foods more frequently than recommended. Traditional but expensive foods (fruits, dairy, homemade sweets and added fat) were more frequently consumed by private-school students, generally from wealthier, more connected families, than by public-school students; the latter more frequently consumed both traditional (tea, coffee, eggs) and mixed foods (snack and street foods; P <= 0.05). Girls reported more frequent consumption of global/non-local packaged and ready-to-eat foods, non-green leafy vegetables and added fat than boys (P <= 0.05). Boys reported more frequent consumption of eggs and street foods than girls (P <= 0.05). Conclusions: Adolescents' eating patterns in a globalizing city reflect a combination of global/non-local and traditional foods, access and preferences. As global foods continue to appear in low-and middle-income countries, understanding dietary patterns and preferences can inform efforts to promote diversity and healthfulness of foods.
C1 [Shaikh, Nida I.; Ramakrishnan, Usha; Cunningham, Solveig A.] Emory Univ, Laney Grad Sch, Doctoral Program Nutr & Hlth Sci, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
   [Patil, Shailaja S.] BLDE Univ, Shri BM Patil Med Coll Hosp & Res Ctr, Dept Community Med, Vijayapura, Karnataka, India.
   [Halli, Shiva] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Ramakrishnan, Usha; Cunningham, Solveig A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
   [Cunningham, Solveig A.] Emory Univ, Dept Sociol, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
C3 Emory University; BLDE (Deemed to be University); University of Manitoba; Emory University; Rollins School Public Health; Emory University
RP Shaikh, NI (corresponding author), Emory Univ, Laney Grad Sch, Doctoral Program Nutr & Hlth Sci, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
EM nida.shaikh@emory.edu
FU Eunice Kennedy Shriver National Institute of Child Health & Human Development [3D43HD065249-03S1]; Fogarty International Center at the National Institutes of Health [1-R25 TW009337-01]
CR AGARWAL B, 1994, J PEASANT STUD, V22, P81, DOI 10.1080/03066159408438567
   Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5
   Unknown -, 1990, J AM DIET ASSOC, V0, P0
   Unknown -, 2007, EUR J CLIN NUTR, V0, P0
   Baker P, 2014, OBES REV, V15, P564, DOI 10.1111/obr.12174
   Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952
   Dasen PR, 2000, INT J GROUP TENS, V29, P17, DOI 10.1023/A:1005126629553
   Davidson JA, 2003, JOURNAL OF THE ADVENTIST THEOLOGICAL SOCIETY, V14, P114
   Eckhardt GM, 2012, J MACROMARKETING, V32, P280, DOI 10.1177/0276146712440708
   Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692
   Gulati S, 2013, ANN NUTR METAB, V62, P279, DOI 10.1159/000346554
   Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820
   Gupta R, 2003, J ASSOC PHYSICIANS INDIA, V51, P470
   Hannerz Ulf, 2000, TRANSNATIONAL CONNECTIONS: CULTURE, V0, P0
   Hoefling A, 2010, APPETITE, V54, P603, DOI 10.1016/j.appet.2010.02.016
   Jatrana S, 2003, EXPLAINING GENDER DISPARITY IN CHILD HEALTH IN HARYANA STATE OF INDIA, V0, P0
   Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168
   Kapil Umesh, 2012, INDIAN J COMMUNITY MED, V37, P207, DOI 10.4103/0970-0218.103465
   Kotecha PV, 2013, J HEALTH POPUL NUTR, V31, P490
   Livingstone MBE, 2004, BRIT J NUTR, V92, PS213, DOI 10.1079/BJN20041169
   Misra A, 2011, J DIABETES, V3, P278, DOI 10.1111/j.1753-0407.2011.00139.x
   Misra A, 2011, ANN NUTR METAB, V58, P203, DOI 10.1159/000329431
   Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433
   Patel SA, 2015, ANN EPIDEMIOL, V25, P336, DOI 10.1016/j.annepidem.2015.02.009
   Pingali P, 2004, ESA WORKING PAPER NO. 04-05, V0, P0
   Plüss C, 2005, INT SOCIOL, V20, P201, DOI 10.1177/0268580905052369
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x
   Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180
   Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7
   Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022
   Shaw A, 1993, INDIAN FOOD PACKER, V47, P29
   Shetty P, 2013, INDIAN J PEDIATR, V80, PS21, DOI 10.1007/s12098-013-0971-5
   Singh PN, 2014, AM J CLIN NUTR, V100, P359S, DOI 10.3945/ajcn.113.071571
   Spear BA, 2002, J AM DIET ASSOC, V102, PS23, DOI 10.1016/S0002-8223(02)90418-9
   Stigler MH, 2011, INT J BEHAV NUTR PHY, V8, P0, DOI 10.1186/1479-5868-8-9
   Swaminathan S, 2007, INDIAN PEDIATR, V44, P593
   THIMMAYAMMA BV, 1973, INDIAN J NUTR DIET, V10, P8
   Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210
   UNICEF, 2011, STAT WORLDS CHILDR 2, V0, P0
   Vaz M, 2005, SAJCN - SOUTH AFRICAN JOURNAL OF CLINICAL NUTRITION, V18, P198
   Venkaiah K, 2002, EUR J CLIN NUTR, V56, P1119, DOI 10.1038/sj.ejcn.1601457
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   Vijayapushpam T, 2003, PUBLIC HEALTH NUTR, V6, P683, DOI 10.1079/PHN2003478
   WHO, 2003, WHO TECHN REP SER, V0, P0
   WOODWARD DR, 1986, HUM NUTR-APPL NUTR, V40A, P185
   Zollo Peter, 1995, AMERICAN DEMOGRAPHICS, V17, P22
NR 50
TC 21
Z9 22
U1 3
U2 8
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD OCT 15
PY 2016
VL 19
IS 15
BP 2799
EP 2807
DI 10.1017/S1368980016001087
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FH5ZG
UT WOS:000411250600014
PM 27170203
DA 2025-04-28
ER

PT J
AU Ayseli, MT
   Ipek Ayseli, Y
AF Ayseli, Mehmet Turan
   Ipek Ayseli, Yasemin
TI Flavors of the future: Health benefits of flavor precursors and volatile compounds in plant foods
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review
DE Volatile compounds; Antimicrobial activity; Health benefits; Functional foods
ID antimicrobial activity; raspberry ketone; aroma compounds; bioactive compounds; chlorogenic acid; stem-cells; coffee; beans; differentiation; phytonutrients
AB Background: Consumers' food production requirements have changed considerably during the last decade. This includes growing interest in the use of aroma compounds to develop functional foods for providing health benefits and reducing chemically synthesized additives. More recently, beyond their flavoring properties, various reports have shown the potential role of volatile compounds in human health, including their antioxidant, anti-inflammatory, anti-cancer and anti-obesity activities. Thus, investigation into the pharmacological activities of flavor and volatile compounds has been increased. Scope and approach: To our knowledge, no single review article is available that provides an overview of the health benefits and antimicrobial properties of volatile compounds. To address this, here it was aimed to review the current knowledge of the health benefit and antimicrobial properties of volatile compounds. Key findings and conclusions: There are many plant or food products with health benefits and antimicrobial activities. However, existing literature indicates that terpenoids, phenolics and alkaloids are among natural taste compounds, which are the most attractive sources in terms of developing new antimicrobial agents and health-promoting ingredients. Future investigation is required to demonstrate key properties of volatiles/non-volatile taste compounds such as synergic actions, organoleptic impacts, process stability and efficacy dosage, particularly in cooperation with different research disciplines. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ayseli, Mehmet Turan] Genetris Consultancy, Kisikli Caddesi 28 Kat 2-226, TR-34662 Istanbul, Turkey.
   [Ipek Ayseli, Yasemin] Kosuyolu Family Hlth Ctr, TR-34718 Istanbul, Turkey.
RP Ayseli, MT (corresponding author), Genetris Consultancy, Kisikli Caddesi 28 Kat 2-226, TR-34662 Istanbul, Turkey.
EM tayseli@genetris.com; yaseminipek@ymail.com
CR Akowuah AG, 2014, J NAT PRODUCTS, V0, P05
   Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Amanpour A, 2015, FOOD CHEM, V182, P251, DOI 10.1016/j.foodchem.2015.03.005
   Antonio AG, 2010, FOOD CHEM, V118, P782, DOI 10.1016/j.foodchem.2009.05.063
   Anuradha K, 2013, CRIT REV FOOD SCI, V53, P1250, DOI 10.1080/10408398.2011.563879
   Aprea E, 2015, MOLECULES, V20, P2445, DOI 10.3390/molecules20022445
   Arathi BP, 2015, TRENDS FOOD SCI TECH, V45, P105, DOI 10.1016/j.tifs.2015.06.003
   Arroyo FT, 2007, J AGR FOOD CHEM, V55, P5701, DOI 10.1021/jf0703957
   Arumugam M, 2012, NAT PROD RES, V26, P1942, DOI 10.1080/14786419.2011.622277
   Augustin MA, 2015, ANNU REV FOOD SCI T, V6, P463, DOI 10.1146/annurev-food-022814-015507
   Belletti N, 2007, APPL ENVIRON MICROB, V73, P5580, DOI 10.1128/AEM.00351-07
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Boulogne I, 2012, ENVIRON CHEM LETT, V10, P325, DOI 10.1007/s10311-012-0359-1
   Buffo RA, 2004, FLAVOUR FRAG J, V19, P99, DOI 10.1002/ffj.1325
   Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006
   Chiu SS, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092914
   Cordero-Herrera I, 2015, MOL NUTR FOOD RES, V59, P597, DOI 10.1002/mnfr.201400492
   Crozier A, 2011, TEAS COCOA COFFEE PL, V0, P252
   Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312
   Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424
   Fadida T, 2015, FOOD HYDROCOLLOID, V48, P213, DOI 10.1016/j.foodhyd.2015.02.033
   Fan JF, 2015, MOL MED REP, V12, P4759, DOI 10.3892/mmr.2015.3996
   Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305
   Ayala-Zavala JF, 2009, J FOOD SCI, V74, PR84, DOI 10.1111/j.1750-3841.2009.01294.x
   Fitzgerald DJ, 2004, J APPL MICROBIOL, V97, P104, DOI 10.1111/j.1365-2672.2004.02275.x
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Frauendorfer F, 2008, J AGR FOOD CHEM, V56, P10244, DOI 10.1021/jf802098f
   Gonzalez-Rios O, 2007, J FOOD COMPOS ANAL, V20, P289, DOI 10.1016/j.jfca.2006.07.009
   Goswami T, 2012, J FOOD PROCESS TECHN, V3, P1, DOI 10.4172/2157-7110.1000181
   Hannemann A, 2014, BLOOD CELL MOL DIS, V53, P21, DOI 10.1016/j.bcmd.2014.02.004
   Holzapfel NP, 2013, INT J MOL SCI, V14, P14620, DOI 10.3390/ijms140714620
   Hosseinzadeh H, 2013, PHYTOTHER RES, V27, P475, DOI 10.1002/ptr.4784
   Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471
   Jelen H, 2011, FOOD FLAVORS CHEM SE, V0, P0
   Kabir F, 2014, J KOREAN SOC APPL BI, V57, P359, DOI 10.1007/s13765-014-4056-6
   Kalaska B, 2014, J AGR FOOD CHEM, V62, P2853, DOI 10.1021/jf5008538
   Keiler AM, 2013, PLANTA MED, V79, P576, DOI 10.1055/s-0032-1328330
   Kreppenhofer S, 2011, FOOD CHEM, V126, P441, DOI 10.1016/j.foodchem.2010.11.008
   Lanciotti R, 2004, TRENDS FOOD SCI TECH, V15, P201, DOI 10.1016/j.tifs.2003.10.004
   Lanciotti R, 2003, J AGR FOOD CHEM, V51, P2958, DOI 10.1021/jf026143h
   Laroui H, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032084
   Li Y, 2015, NEUROCHEM RES, V40, P1520, DOI 10.1007/s11064-015-1629-7
   Linnewiel-Hermoni K, 2015, ARCH BIOCHEM BIOPHYS, V572, P28, DOI 10.1016/j.abb.2015.02.018
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-22
   Ludwig IA, 2014, FOOD RES INT, V61, P67, DOI 10.1016/j.foodres.2014.03.045
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martinez-Mayorga K, 2014, FOOD INFORMATICS, V0, P97
   Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005
   Mestdagh F, 2014, FOOD RES INT, V63, P271, DOI 10.1016/j.foodres.2014.03.011
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5823, DOI 10.1021/jf901136e
   Özçelik B, 2011, PHARM BIOL, V49, P396, DOI 10.3109/13880209.2010.519390
   Park KS, 2015, PHARM BIOL, V53, P870, DOI 10.3109/13880209.2014.946059
   Park SN, 2012, ANAEROBE, V18, P369, DOI 10.1016/j.anaerobe.2012.04.001
   Petisca C, 2013, FOOD BIOPROD PROCESS, V91, P233, DOI 10.1016/j.fbp.2012.10.003
   Poisson L, 2009, J AGR FOOD CHEM, V57, P9923, DOI 10.1021/jf901683v
   Rahaiee S, 2015, J FOOD SCI TECH MYS, V52, P1881, DOI 10.1007/s13197-013-1238-x
   Rekha KR, 2013, J MOL NEUROSCI, V51, P851, DOI 10.1007/s12031-013-0074-9
   Rempe CS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0123925
   Rodriguez-Mateos A, 2014, MOL NUTR FOOD RES, V58, P1952, DOI 10.1002/mnfr.201400231
   Sai V, 2011, J MED PLANTS RES, V5, P2110
   Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x
   Selli S, 2014, FOOD CHEM, V165, P540, DOI 10.1016/j.foodchem.2014.05.147
   Sharma BR, 2015, AM J CHINESE MED, V43, P681, DOI 10.1142/S0192415X15500421
   Sharma Shruti, 2009, DRUG DISCOV TODAY DIS MECH, V6, P0
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Singh CK, 2015, ANN NY ACAD SCI, V0, P1
   Soto-Vaca A, 2012, J AGR FOOD CHEM, V60, P6658, DOI 10.1021/jf300861c
   Sun-Waterhouse D, 2013, FOOD BIOPROCESS TECH, V6, P607, DOI 10.1007/s11947-012-0829-2
   Takata T, 2014, J MED FOOD, V17, P332, DOI 10.1089/jmf.2013.2763
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   Tzeng TF, 2014, PHYTOTHER RES, V28, P187, DOI 10.1002/ptr.4976
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Wagenstaller M, 2014, METABOLOMICS, V10, P225, DOI 10.1007/s11306-013-0581-2
   Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717
   Xavier JR, 2015, APPL BIOCHEM BIOTECH, V176, P1498, DOI 10.1007/s12010-015-1660-9
   Xie W, 2014, EVID-BASED COMPL ALT, V2014, P1
   Younesi E, 2014, FUNCT FOODS HEALTH D, V4, P362
   Younesi E, 2015, TRENDS FOOD SCI TECH, V41, P95, DOI 10.1016/j.tifs.2014.09.006
   Zang LY, 2000, AM J PHYSIOL-CELL PH, V279, PC954, DOI 10.1152/ajpcell.2000.279.4.C954
NR 82
TC 96
Z9 105
U1 9
U2 162
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
EI 
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD FEB 15
PY 2016
VL 48
IS 
BP 69
EP 77
DI 10.1016/j.tifs.2015.11.005
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA DD7NH
UT WOS:000370110900007
DA 2025-04-28
ER

PT J
AU Ramirez, G
   Zamilpa, A
   Zavala, M
   Perez, J
   Morales, D
   Tortoriello, J
AF Ramirez, Guillermo
   Zamilpa, Alejandro
   Zavala, Miguel
   Perez, Julia
   Morales, Dulce
   Tortoriello, Jaime
TI Chrysoeriol and other polyphenols from Tecoma stuns with lipase inhibitory activity
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Tecoma stuns; Diabetes; Obesity; Chrysoeriol; Luteolin; Verbascoside; Chlorogenic acid
ID plants; ethnobotany; extract; fat
AB Ethnopharmacological relevance: Tecoma stans is traditionally used by several ethnical groups in Mexico and Central America to treat diabetes. This species is mentioned in the majority of the ethnopharmacological studies compiled in Mexico focused in medicinal plants used as anti-diabetic treatment. Aim of the study: Recently, this plant was found to display a high level of pancreatic lipase inhibitory activity, in addition to the several action mechanisms already described. Here we show the phytochemical and in vitro pharmacological characterization of some of the compounds responsible for the antilipase activity. Materials and methods: Starting with a hydroalcoholic extract, fractions were obtained by liquid-liquid separation and successive processes of column chromatography purifications. Lipase inhibitory activity was measured employing a spectrophotometric analysis. For structural elucidation H-1 and C-13 NMR experiments were used. HPLC was used to quantify and confirm the identity of the bioactive compounds. Results: Bio-guided chemical purification of the hydroalcoholic extract produced an organic fraction (ethyl acetate, TsEA), flavone fractions (TsC1F13), (TsC1F15), (TsC1F16) and isolated compounds (chrysoeriol, apigenin, luteolin, and verbascoside) with the capability to inhibit the activity of pancreatic lipase. The most active fraction (TsC2F6B) was constituted by a mixture of Chrysoeriol (5,7-dihydroxy-2-[4-hydroxy-3-methoxyphenyl]chromen-4-one, 96%) and Apigenin (4%). This flavone mixture displayed a percentage of inhibition of 85% when it was eavaluated at 0.25 mg/mL. Luteolin and chrysoeriol produced a noncompetitive and mixed inhibition with values of IC50 = 63 and 158 mu M respectively. The content of chrysoeriol was also quantified in the hydroalcoholic extract (TsHAE) and organic fraction (TsEA) as 1% and 7% respectively. All of this confirms that high proportion of both flavones produce an increase of the biological activity due to they show the highest inhibition of lipase enzyme in a concentration dependant way. Conclusions: These results evidence that the medicinal use of T. stans could be in part because of its lipase inhibitory activity allowing to adapt the administration of this plant before meals. Also this data could help to develop a novel phytopharmaceutical drug (standardized in luteolin, chrysoeriol, and apigenin) auxiliary for the Type 2 Diabetes mellitus. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Ramirez, Guillermo; Zamilpa, Alejandro; Morales, Dulce; Tortoriello, Jaime] IMSS, Ctr Invest Biomed Sur, Argentina 1, Xochitepec 62790, Morelos, Mexico.
   [Zavala, Miguel; Perez, Julia] UAM Xochimilco, Dept Syst Biol, Calzada Hueso 1100, Mexico City 04960, DF, Mexico.
C3 Universidad Autonoma Metropolitana - Mexico; University Autonoma Metropolitana Xochimilco
RP Zamilpa, A (corresponding author), Mexican Inst Social Secur, Southern Biomed Res, Argentina 1, Xochitepec 62790, Morelos, Mexico.
EM azamilpa_2000@yahoo.com.mx
CR Abdel-Mageed WM, 2012, FITOTERAPIA, V83, P500, DOI 10.1016/j.fitote.2011.12.025
   Aguilar-Santamaría L, 2009, J ETHNOPHARMACOL, V124, P284, DOI 10.1016/j.jep.2009.04.033
   Al-Azzawi AM, 2012, CANADIAN JOURNAL OF PURE & APPLIED SCIENCES, V6, P1809
   Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Andrade-Cetto A, 2006, J ETHNOPHARMACOL, V107, P199, DOI 10.1016/j.jep.2006.03.005
   ANDRADECETTO A, 1995, THESIS UNAM MEXICO, V0, P93
   BIANCO A, 1981, PHYTOCHEMISTRY, V20, P1871, DOI 10.1016/0031-9422(81)84024-1
   Cruz EC, 2015, J ETHNOPHARMACOL, V159, P238, DOI 10.1016/j.jep.2014.11.021
   Cheng N, 2014, CHINESE CHEM LETT, V25, P1094, DOI 10.1016/j.cclet.2014.05.021
   Choi JS, 2014, FOOD CHEM TOXICOL, V64, P27, DOI 10.1016/j.fct.2013.11.020
   Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P417
   Costantino Luca, 2003, FARMACO, V58, P781
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   De la Paz J, 2003, REV CUB MED MILITAR, V32, P13
   Juárez-Vázquez MD, 2013, J ETHNOPHARMACOL, V148, P521, DOI 10.1016/j.jep.2013.04.048
   Ding L, 2010, J NUTR BIOCHEM, V21, P941, DOI 10.1016/j.jnutbio.2009.07.009
   Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8
   Ganapaty S, 2008, ASIAN J CHEM, V20, P4493
   Garcia Mesa M, 2014, PHARM ONLINE ARCH, V1, P52
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hu B, 2015, INT J BIOL MACROMOL, V80, P529, DOI 10.1016/j.ijbiomac.2015.07.031
   Johnson L, 2006, PHYTOTHER RES, V20, P250, DOI 10.1002/ptr.1820
   Alonso-Castro AJ, 2010, J ETHNOPHARMACOL, V127, P1, DOI 10.1016/j.jep.2009.09.060
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Liu Y, 2014, BEHAV BRAIN RES, V267, P178, DOI 10.1016/j.bbr.2014.02.040
   Liu Y, 2013, BRAIN RES BULL, V94, P23, DOI 10.1016/j.brainresbull.2013.02.001
   LOZOYAMECKES M, 1985, J ETHNOPHARMACOL, V14, P1, DOI 10.1016/0378-8741(85)90022-4
   Mabry TJ, 2012, SYSTEMATIC IDENTIFIC, V0, P0
   Nickavar B, 2013, IRAN J PHARM RES, V12, P57
   Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736
   Park Y, 2007, MAGN RESON CHEM, V45, P1072, DOI 10.1002/mrc.2063
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Ramírez G, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/701261
   Rauter AP, 2010, PHYTOTHER RES, V24, PS133, DOI 10.1002/ptr.3017
   Rivellese AA, 2008, CLIN NUTR, V27, P133, DOI 10.1016/j.clnu.2007.07.005
   Roman-Ramos R, 1991, ARCH INVEST MED (MEX), V22, P87
   Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005
   Singh LKVijay, 2011, JAPHR, V1, P75
   SRIVASTAVA BK, 1995, ASIAN J CHEM, V7, P679
   VANLOO P, 1986, MAGN RESON CHEM, V24, P879, DOI 10.1002/mrc.1260241007
   Wagner H, 2001, PLANT DRUG ANAL THIN, V0, PP349, DOI 10.1016/s0031-9422(97)80771-6
   Winkelman M, 1989, MED ANTHROPOL, V11, P255
   Wu XL, 2014, FOOD CHEM, V142, P306, DOI 10.1016/j.foodchem.2013.07.071
   Yan JK, 2014, INT J BIOL MACROMOL, V64, P213, DOI 10.1016/j.ijbiomac.2013.12.007
   Yang RM, 2015, J ETHNOPHARMACOL, V169, P459, DOI 10.1016/j.jep.2014.12.066
NR 49
TC 42
Z9 45
U1 1
U2 43
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JUN 5
PY 2016
VL 185
IS 
BP 1
EP 8
DI 10.1016/j.jep.2016.03.014
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA DM9OV
UT WOS:000376696500001
PM 26970570
DA 2025-04-28
ER

PT J
AU Watson, WL
   Piazza, S
   Wellard, L
   Hughes, C
   Chapman, K
AF Watson, Wendy L.
   Piazza, Sarah
   Wellard, Lyndal
   Hughes, Clare
   Chapman, Kathy
TI Energy and nutrient composition of menu items at Australian coffee chains
SO NUTRITION & DIETETICS
LA English
DT Article
DE Australia; fast food; food industry; menu labelling; nutrition information
ID body-mass index; fast-food; nutrition information; consumption; children; obesity; choices
AB AimWorldwide, there are concerns about the link between fast food and overall poor dietary quality and weight gain. Beverages and snack foods purchased from coffee chains may contribute excess energy and nutrients to the diet if they are consumed in addition to usual meals. The present study investigated the energy, saturated fat and sugar content of beverages and sweet snacks from major coffee chains and compared the nutrient content to daily intake (DI) reference values for adults. MethodsNutrition information per serve was sourced from the Australian websites of five coffee chains with the largest number of outlets in New South Wales and compared to DI reference values for adults for energy, saturated fat and sugars. Energy per serve was compared to 600kJ, the Australian Dietary Guidelines recommendation for one serve of a discretionary food. ResultsEighty-four per cent (n=238) of sweet snacks and 65% (n=79) of cold beverages provided more than two equivalent serves (1200kJ) of a discretionary food. Sixteen (13%) cold beverages and 47 (16%) sweet snacks provided over 50% DI of saturated fat. Sixty-six (54%) cold beverages and 47 (16%) sweet snacks had more than half the DI of sugars. ConclusionsFood and beverage items from coffee chains may contribute to excess intake of energy and other nutrients of public health concern if consumed in addition to meals. To assist consumers to make informed and healthier fast food choices, accessible detailed nutrition information should be available along with reductions in portion sizes and reformulation to more nutritious menu items.
C1 [Watson, Wendy L.; Wellard, Lyndal; Hughes, Clare; Chapman, Kathy] NSW Canc Council, Canc Programs Div, Sydney, NSW, Australia.
   [Piazza, Sarah] Univ Sydney, Sch Mol Biosci, Discipline Nutr & Dietet, Fac Sci, Sydney, NSW 2006, Australia.
C3 Cancer Council New South Wales; University of Sydney
RP Watson, WL (corresponding author), NSW Canc Council, Canc Programs Div, 153 Dowling St, Woolloomooloo, NSW 2011, Australia.
EM wendyw@nswcc.org.au
CR Unknown -, 2013, AUSTR DIET GUID, V0, P0
   Unknown -, 2012, 4364 0 055 001 AUSTR, V0, P0
   Unknown -, 2014, NOTICE, V79, P0
   Unknown -, 2009, AUSTRALIA: THE HEALTHIEST COUNTRY BY 2020, V0, P0
   Australian Bureau of Statistics, 2014, 4364 0 55 007 AUSTR, V0, P0
   Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020
   Bollinger B, 2010, CALORIE POSTING IN CHAIN RESTAURANTS, V0, P0
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Burns C, 2002, PUBLIC HEALTH NUTR, V5, P441, DOI 10.1079/PHN2001316
   Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973
   Dunn KI, 2008, APPETITE, V51, P331, DOI 10.1016/j.appet.2008.03.003
   ESPINEL P, 2010, APPARENT CONSUMPTION, V0, P0
   Fayet F, 2012, NUTR DIET, V69, P102, DOI 10.1111/j.1747-0080.2012.01582.x
   Kozup JC, 2003, J MARKETING, V67, P19, DOI 10.1509/jmkg.67.2.19.18608
   National Health & Medical Research Council, 2013, EAT HLTH EDUCATOR GU, V0, P0
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839
   Rangan AM, 2009, EUR J CLIN NUTR, V63, P865, DOI 10.1038/ejcn.2008.51
   Sinclair SE, 2014, J ACAD NUTR DIET, V114, P1375, DOI 10.1016/j.jand.2014.05.014
   Tandon PS, 2010, PEDIATRICS, V125, P244, DOI 10.1542/peds.2009-1117
   Watson WL, 2013, PUBLIC HEALTH NUTR, V16, P409, DOI 10.1017/S1368980012000900
   WHO, 2013, GLOB ACT PLAN PREV C, V0, P0
   Young LR, 2012, AM J PREV MED, V43, P565, DOI 10.1016/j.amepre.2012.07.024
NR 36
TC 4
Z9 5
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1446-6368
EI 1747-0080
J9 NUTR DIET
JI Nutr. Diet.
PD FEB 15
PY 2016
VL 73
IS 1
BP 81
EP 87
DI 10.1111/1747-0080.12226
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DD3NT
UT WOS:000369829800011
DA 2025-04-28
ER

PT J
AU Truthmann, J
   Schienkiewitz, A
   Busch, MA
   Mensink, GBM
   Du, Y
   Bosy-Westphal, A
   Knopf, H
   Scheidt-Nave, C
AF Truthmann, Julia
   Schienkiewitz, Anja
   Busch, Markus A.
   Mensink, Gert B. M.
   Du, Yong
   Bosy-Westphal, Anja
   Knopf, Hildtraud
   Scheidt-Nave, Christa
TI Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Total cholesterol; Triglycerides; High density lipoprotein-cholesterol; Lifestyle; Lipid-lowering medication
ID heart-disease; alcohol-consumption; cholesterol levels; lowering drugs; time trends; interview; determinants; lipoproteins; population; food
AB Background: Monitoring of serum lipid concentrations at the population level is an important public health tool to describe progress in cardiovascular disease risk control and prevention. Using data from two nationally representative health surveys of adults 18-79 years, this study identified changes in mean serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in relation to changes in potential determinants of serum lipids between 1997-99 and 2008-11 in Germany. Methods: Sex-specific multivariable linear regression analyses were performed with serum lipids as dependent variables and survey wave as independent variable and adjusted for the following covariables: age, fasting duration, educational status, lifestyle, and use of medication. Results: Mean TC declined between the two survey periods by 13 % (5.97 mmol/l vs. 5.19 mmol/l) among men and by 12 % (6.03 mmol/l vs. 5.30 mmol/l) among women. Geometric mean TG decreased by 14 % (1.66 mmol/l vs. 1.42 mmol/l) among men and by 8 % (1.20 mmol/l vs. 1.10 mmol/l) among women. Mean HDL-C remained unchanged among men (1.29 mmol/l vs. 1.27 mmol/l), but decreased by 5 % among women (1.66 mmol/l vs. 1.58 mmol/l). Sports activity and coffee consumption increased, while smoking and high alcohol consumption decreased only in men. Processed food consumption increased and wholegrain bread consumption decreased in both sexes, and obesity increased among men. The use of lipid-lowering medication, in particular statins nearly doubled over time in both sexes. Among women, hormonal contraceptive use increased and postmenopausal hormone therapy halved over time. The changes in lipid levels between surveys remained significant after adjusting for covariables. Conclusion: Serum TC and TG considerably declined over one decade in Germany, which can be partly explained by increased use of lipid-lowering medication and improved lifestyle among men. The decline in serum lipids among women, however, remains unexplained.
C1 [Truthmann, Julia; Schienkiewitz, Anja; Busch, Markus A.; Mensink, Gert B. M.; Du, Yong; Knopf, Hildtraud; Scheidt-Nave, Christa] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
   [Bosy-Westphal, Anja] Univ Hohenheim, Inst Nutr Med, Stuttgart, Germany.
C3 Robert Koch Institute; University Hohenheim
RP Truthmann, J (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
EM TruthmannJ@rki.de
FU German Ministry of Health (BMG)
CR Adams SP, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008226.pub3
   Bellach B M, 1998, GESUNDHEITSWESEN, V60 Suppl 2, P0
   Brauns H, 1999, ZUMA-NACHRICHTEN, V44, P7
   Brien SE, 2011, BMJ-BRIT MED J, V342, P0, DOI 10.1136/bmj.d636
   Brown L, 1999, AM J CLIN NUTR, V69, P30
   Burger M, 2004, PUBLIC HEALTH NUTR, V7, P879, DOI 10.1079/PHN2004631
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Craig-Schmidt MC, 2006, ATHEROSCLEROSIS SUPP, V7, P1, DOI 10.1016/j.atherosclerosissup.2006.04.001
   Du Yong, 2007, BMC WOMENS HEALTH, V7, P19, DOI 10.1186/1472-6874-7-19
   Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002
   Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x
   Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   Ferrières J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002
   Ford ES, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065228
   Jansson JH, 2003, SCAND J PUBLIC HEALT, V31, P43, DOI 10.1080/14034950310001397
   Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9
   Klose G, 2014, ARZNEIMITTELVERORDNU, V0, P0
   Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8
   Krachler B, 2005, PUBLIC HEALTH NUTR, V8, P628, DOI 10.1079/PHN2004710
   Laaser U, 2006, TRENDS RISK FACTOR C, V2, P0
   Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4
   LAW MR, 1994, EUR J CLIN NUTR, V48, P305
   Libuda L, 2014, BRIT J NUTR, V111, P141, DOI 10.1017/S0007114513002031
   Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P779, DOI 10.1007/s00103-012-1651-8
   Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923
   Mozaffarian D, 2009, EUR J CLIN NUTR, V63, PS22, DOI 10.1038/sj.ejcn.1602976
   Mozaffarian D, 2009, EUR J CLIN NUTR, V63, PS5, DOI 10.1038/sj.ejcn.1602973
   Naz F, 2012, PAK J BIOL SCI, V15, P947
   Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6
   Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092
   Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4
   Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001
   Rehm J, 2000, EUR J EPIDEMIOL, V16, P669, DOI 10.1023/A:1007693009604
   Reiner Z, 2011, ESC EAS GUIDELINES M, V14, P0
   Rubner-Institut Max, 2008, NATL VERZEHRSSTUDI 2, V0, P0
   Sai AJ, 2011, MENOPAUSE, V18, P1101, DOI 10.1097/gme.0b013e318217d41d
   Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, P0, DOI 10.1186/1471-2458-12-730
   Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285
   Stender S, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2012-000859
   STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126
   Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x
   WHO, 2003, WHO TECHN REP SER, V0, P0
   WHO, 2000, WHO TECHN REP SER, V894, P0
NR 48
TC 19
Z9 21
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
EI 
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 8
PY 2016
VL 16
IS 
BP 
EP 
DI 10.1186/s12889-016-2826-2
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DG2DS
UT WOS:000371877000001
PM 26956524
DA 2025-04-28
ER

PT J
AU Visvanathan, R
   Jayathilake, C
   Jayawardana, BC
   Liyanage, R
AF Visvanathan, Rizliya
   Jayathilake, Chathuni
   Jayawardana, Barana Chaminda
   Liyanage, Ruvini
TI Health-beneficial properties of potato and compounds of interest
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Review
DE potatoes; consumption; functional compounds; antinutritional compounds; beneficial effects
ID solanum-tuberosum l.; in-vitro binding; nf-kappa-b; antioxidant activity; glycemic index; dietary fiber; food-intake; chlorogenic acid; human colon; cholecystokinin secretion
AB Potatoes have shown promising health-promoting properties in human cell culture, experimental animal and human clinical studies, including antioxidant, hypocholesterolemic, anti-inflammatory, antiobesity, anticancer and antidiabetic effects. Compounds present such as phenolics, fiber, starch and proteins as well as compounds considered antinutritional such as glycoalkaloids, lectins and proteinase inhibitors are believed to contribute to the health benefits of potatoes. However, epidemiological studies exploring the role of potatoes in human health have been inconclusive. Some studies support a protective effect of potato consumption in weight management and diabetes, while other studies demonstrate no effect and a few suggest a negative effect. As there are many biological activities attributed to the compounds present in potato, some of which could be beneficial or detrimental depending on specific circumstances, a long-term study investigating the association between potato consumption and diabetes, obesity, cardiovascular disease and cancer while controlling for fat intake is needed. (C) 2016 Society of Chemical Industry
C1 [Visvanathan, Rizliya; Jayathilake, Chathuni; Liyanage, Ruvini] Natl Inst Fundamental Studies, Div Nutr Biochem, Kandy, Sri Lanka.
   [Jayawardana, Barana Chaminda] Univ Peradeniya, Dept Anim Sci, Fac Agr, Peradeniya, Sri Lanka.
C3 National Institute of Fundamental Studies (NIFS); University of Peradeniya
RP Liyanage, R (corresponding author), Natl Inst Fundamental Studies, Nutr Biochem, Kandy, Sri Lanka.
EM ruvinill@yahoo.com
CR Al-Weshahy A, 2009, FOOD RES INT, V42, P1062, DOI 10.1016/j.foodres.2009.05.011
   ALSAIKHAN MS, 1995, J FOOD SCI, V60, P341, DOI 10.1111/j.1365-2621.1995.tb05668.x
   Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583
   Arcan I, 2007, FOOD CHEM, V103, P301, DOI 10.1016/j.foodchem.2006.07.050
   Valiñas MA, 2015, J AGR FOOD CHEM, V63, P4902, DOI 10.1021/jf505777p
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4
   Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654
   Brown CR, 2005, J AM SOC HORTIC SCI, V130, P174, DOI 10.21273/JASHS.130.2.174
   Buttriss JL, 2008, NUTR BULL, V33, P186, DOI 10.1111/j.1467-3010.2008.00705.x
   Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996
   CAMIRE ME, 1995, J AGR FOOD CHEM, V43, P970, DOI 10.1021/jf00052a024
   CAMIRE ME, 1993, J AGR FOOD CHEM, V41, P2391, DOI 10.1021/jf00036a033
   Carpenter MA, 2015, FRONT PLANT SCI, V6, P0, DOI 10.3389/fpls2015.00143
   Chen WY, 2012, BIOSCI BIOTECH BIOCH, V76, P1104, DOI 10.1271/bbb.110936
   Choi E, 2005, FOOD AGR IMMUNOL, V16, P29, DOI 10.1080/09540100500064320
   Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5<561::AID-JSFA574>3.0.CO;2-#
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   CordierBussat M, 1997, ENDOCRINOLOGY, V138, P1137, DOI 10.1210/en.138.3.1137
   Dana S, 2005, OPEN LABEL CLIN TRIA, V0, P0
   De Mejía EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445
   Deusser H, 2012, FOOD CHEM, V135, P2814, DOI 10.1016/j.foodchem.2012.07.028
   Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5
   Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011
   ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423
   Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Fernandes G, 2005, J AM DIET ASSOC, V105, P557, DOI 10.1016/j.jada.2005.01.003
   Foltz M, 2008, J AGR FOOD CHEM, V56, P837, DOI 10.1021/jf072611h
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s
   Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Geng F, 2010, BIOMED CHROMATOGR, V24, P312, DOI 10.1002/bmc.1291
   Gumul D, 2011, ACTA SCI POLON-TECHN, V10, P73
   Habeebullah SFK, 2010, J AM OIL CHEM SOC, V87, P1319, DOI 10.1007/s11746-010-1611-0
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Hamouz K, 2011, PLANT SOIL ENVIRON, V57, P478, DOI 10.17221/265/2011-PSE
   Han KH, 2007, BRIT J NUTR, V98, P914, DOI 10.1017/S0007114507761792
   Han KH, 2007, BIOSCI BIOTECH BIOCH, V71, P1356, DOI 10.1271/bbb.70060
   Han KH, 2006, BIOSCI BIOTECH BIOCH, V70, P1432, DOI 10.1271/bbb.50670
   HARRIS PJ, 1991, MUTAT RES, V260, P203, DOI 10.1016/0165-1218(91)90009-B
   Hashimoto N, 2006, J NUTR SCI VITAMINOL, V52, P445, DOI 10.3177/jnsv.52.445
   Hayashi K, 2006, FOOD SCI TECHNOL RES, V12, P22, DOI 10.3136/fstr.12.22
   He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754
   Henry CJK, 2005, BRIT J NUTR, V94, P917, DOI 10.1079/BJN20051571
   Hickling S, 2008, PREV MED, V47, P71, DOI 10.1016/j.ypmed.2008.02.007
   HILL AJ, 1990, PHYSIOL BEHAV, V48, P241, DOI 10.1016/0031-9384(90)90307-P
   Hira T, 2009, EUR J NUTR, V48, P124, DOI 10.1007/s00394-008-0764-1
   Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701
   HOLM J, 1988, AM J CLIN NUTR, V47, P1010, DOI 10.1093/ajcn/47.6.1010
   Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957
   Jacobsen HB, 1998, POTATO RES, V41, P109, DOI 10.1007/BF02358433
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Kanatt SR, 2005, J AGR FOOD CHEM, V53, P1499, DOI 10.1021/jf048270e
   Kanazawa T, 2008, J OLEO SCI, V57, P335, DOI 10.5650/jos.57.335
   Kaspar KL, 2013, FOOD AND NUTRITION SCIENCES, V4, P77
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Kenny OM, 2013, JOURNAL OF AGRICULTURAL SCIENCE AND APPLICATIONS, V2, P184, DOI 10.14511/jasa.2013.020401
   Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006
   Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860
   King JC, 2013, ADV NUTR, V4, P393S, DOI 10.3945/an.112.003525
   Komarnytsky S, 2011, INT J OBESITY, V35, P236, DOI 10.1038/ijo.2010.192
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Kudo K, 2009, J FUNCT FOODS, V1, P170, DOI 10.1016/j.jff.2009.01.006
   Kudoh K, 2003, J NUTR SCI VITAMINOL, V49, P451, DOI 10.3177/jnsv.49.451
   Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE
   Lachman J, 2001, ROST VYROBA, V47, P181
   Lærke HN, 2007, NUTR RES, V27, P152, DOI 10.1016/j.nutres.2007.01.003
   Langner E, 2009, JOURNAL OF PRE-CLINICAL AND CLINICAL RESEARCH, V3, P036
   Lazarov K, 1996, MED SCI RES, V24, P581
   Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d
   Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S
   Liese AD, 2009, DIABETES CARE, V32, P263, DOI 10.2337/dc08-1325
   Lightowler HJ, 2009, NUTR RES, V29, P551, DOI 10.1016/j.nutres.2009.06.004
   Lipsky LM, 2012, NUTR RES, V32, P251, DOI 10.1016/j.nutres.2012.03.005
   Lister CE, 2000, 143 NZ I CROP FOOD R, V0, P0
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Liu YW, 2003, J AGR FOOD CHEM, V51, P4389, DOI 10.1021/jf030016j
   Liyanage R, 2008, BIOSCI BIOTECH BIOCH, V72, P943, DOI 10.1271/bbb.70593
   Liyanage R, 2009, EUR J LIPID SCI TECH, V111, P884, DOI 10.1002/ejlt.200800264
   Lu MK, 2010, BIOL PHARM BULL, V33, P1685, DOI 10.1248/bpb.33.1685
   Madiwale GP, 2011, J AGR FOOD CHEM, V59, P8155, DOI 10.1021/jf201073g
   Mäkinen S, 2008, J AGR FOOD CHEM, V56, P9875, DOI 10.1021/jf8016817
   McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633
   Mohdaly AAA, 2010, J SCI FOOD AGR, V90, P218, DOI 10.1002/jsfa.3796
   Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039
   Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, PG183, DOI 10.1152/ajpgi.00434.2003
   Morimoto A, 2012, ASIA PAC J CLIN NUTR, V21, P601
   Morita T, 1997, J NUTR, V127, P470, DOI 10.1093/jn/127.3.470
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Naito K, 1998, PHYTOCHEMISTRY, V47, P109, DOI 10.1016/S0031-9422(97)00520-7
   Nakajima S, 2011, J AGR FOOD CHEM, V59, P9491, DOI 10.1021/jf200988f
   Navarre DA, 2011, FOOD CHEM, V127, P34, DOI 10.1016/j.foodchem.2010.12.080
   Nayak B, 2014, FOOD RES INT, V56, P35, DOI 10.1016/j.foodres.2013.12.020
   Némoz-Gaillard E, 1998, ENDOCRINOLOGY, V139, P932, DOI 10.1210/en.139.3.932
   Noda T, 2006, FOOD CHEM, V95, P632, DOI 10.1016/j.foodchem.2005.02.002
   Nunn N, 2011, Q J ECON, V126, P593, DOI 10.1093/qje/qjr009
   Nzaramba MN, 2009, J AGR FOOD CHEM, V57, P8308, DOI 10.1021/jf901567k
   Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631
   Panagiotakos DB, 2007, PREV MED, V44, P335, DOI 10.1016/j.ypmed.2006.12.009
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Pihlanto A, 2013, BIOACTIVE FOOD PEPTIDES IN HEALTH AND DISEASE, V0, P145
   Pihlanto A, 2008, FOOD CHEM, V109, P104, DOI 10.1016/j.foodchem.2007.12.023
   Pouvreau L, 2001, J AGR FOOD CHEM, V49, P2864, DOI 10.1021/jf010126v
   Reddivari L, 2007, CARCINOGENESIS, V28, P2227, DOI 10.1093/carcin/bgm117
   Reddivari L, 2007, AM J POTATO RES, V84, P275, DOI 10.1007/BF02986239
   Reddivari L, 2010, NUTR CANCER, V62, P601, DOI 10.1080/01635580903532358
   Rehman ZU, 2004, FOOD CHEM, V85, P215, DOI 10.1016/j.foodchem.2003.06.015
   Robert L, 2006, EUR J NUTR, V45, P267, DOI 10.1007/s00394-006-0594-y
   Robert L, 2008, J AM COLL NUTR, V27, P109, DOI 10.1080/07315724.2008.10719682
   Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x
   Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164
   SCHWARTZ JG, 1994, DIABETES CARE, V17, P255, DOI 10.2337/diacare.17.4.255
   Shih YW, 2007, J AGR FOOD CHEM, V55, P11035, DOI 10.1021/jf072423r
   Singh N, 2005, CLIN CHIM ACTA, V353, P165, DOI 10.1016/j.cccn.2004.10.016
   Singh N, 2004, FOOD CHEM, V85, P611, DOI 10.1016/j.foodchem.2003.07.003
   Singh N, 2008, CHEM-BIOL INTERACT, V173, P97, DOI 10.1016/j.cbi.2008.03.008
   Soh NL, 1999, EUR J CLIN NUTR, V53, P249, DOI 10.1038/sj.ejcn.1600713
   Spiegel TA, 1999, N AM ASS STUD OB NAA, V0, P0
   Spielmann J, 2009, J ANIM PHYSIOL AN N, V93, P400, DOI 10.1111/j.1439-0396.2008.00819.x
   Storey ML, 2013, ADV NUTR, V4, P335S, DOI 10.3945/an.112.003541
   Stushnoff C, 2008, AM J POTATO RES, V85, P267, DOI 10.1007/s12230-008-9032-4
   Sun Y, 2013, FOOD FUNCT, V4, P1502, DOI 10.1039/c3fo60248f
   Sweitzer NK, 2003, CIRCULATION, V108, PE16, DOI 10.1161/01.CIR.0000075957.16003.07
   THED ST, 1995, FOOD CHEM, V52, P301, DOI 10.1016/0308-8146(95)92828-8
   Thomassen LV, 2011, APPL MICROBIOL BIOT, V90, P873, DOI 10.1007/s00253-011-3092-y
   Thompson MD, 2009, J FOOD COMPOS ANAL, V22, P571, DOI 10.1016/j.jfca.2008.09.002
   VARO P, 1983, J ASSOC OFF ANA CHEM, V66, P933
   Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310
   Vinson JA, 1998, J AGR FOOD CHEM, V46, P3630, DOI 10.1021/jf980295o
   Vinson JA, 2012, J AGR FOOD CHEM, V60, P6749, DOI 10.1021/jf2045262
   Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2
   Wang LL, 2008, J FOOD SCI, V73, PC482, DOI 10.1111/j.1750-3841.2008.00802.x
   Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538
   Williams DEM, 1999, J CLIN EPIDEMIOL, V52, P329, DOI 10.1016/S0895-4356(99)00006-2
   Xu XY, 2009, J AGR FOOD CHEM, V57, P10231, DOI 10.1021/jf902532q
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Yang SA, 2006, FOOD CHEM TOXICOL, V44, P839, DOI 10.1016/j.fct.2005.11.007
   Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014
   Younes H, 2001, BRIT J NUTR, V86, P479, DOI 10.1079/BJN2001430
   YUNES H, 1995, LIPIDS, V30, P847, DOI 10.1007/BF02533961
   Zhang C, 2009, J AGR FOOD CHEM, V57, P9503, DOI 10.1021/jf901550u
NR 143
TC 58
Z9 67
U1 1
U2 81
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD DEC 15
PY 2016
VL 96
IS 15
BP 4850
EP 4860
DI 10.1002/jsfa.7848
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA EB4OL
UT WOS:000387351200003
PM 27301296
DA 2025-04-28
ER

PT J
AU Choi, BK
   Park, SB
   Lee, DR
   Lee, HJ
   Jin, YY
   Yang, SH
   Suh, JW
AF Choi, Bong-Keun
   Park, Sung-Bum
   Lee, Dong-Ryung
   Lee, Hae Jin
   Jin, Ying-Yu
   Yang, Seung Hwan
   Suh, Joo-Won
TI Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Green coffee bean extract; High-fat diet induced obese mice; Adipogenesis; Body fat; Dual energy X-ray absorptiometry
ID ppar-gamma; chlorogenic acid; energy-balance; risk; ampk; metabolism; lipolysis; alpha; cell
AB Objective: To evaluate possible lipid catabolism and body fat regulation effects of 3-caffeoylquinic acid in Green coffee bean extract (GCBE) in high-fat diet (HFD)-induced obese mice. Methods: Obesity was induced in mice using a HFD for four weeks. Then, mice were fed only HFD or HFD with GCBE at 50, 100, and 200 mg/kg. Fatty acid synthesis mechanism regulation of body fat was investigated through real-time PCR and Western blot assay. Body fat reduction was measured through dual- energy X-ray absorptiometry. Results: In HFD-induced obese mice, GCBE treatment significantly decreased body weight gain, liver weight and white adipose tissue weights with regulation of adipose tissue lipolysis hormones, like adiponectin and leptin. GCBE treatment decreased mRNA expression levels of adipogenesis and adipocyte metabolism related genes in adipose tissues and the liver, and decreased the corresponding protein expression. Dual energy X-ray absorptiometry measurements were used to compare body fat between mice on high-fat and those treated with GCBE. GCBE treated mice had a lower fat mass compared to HFD alone fed mice and relative body weight and fat mass were markedly decreased. Conclusions: GCBE has a potential anti-obesity effect with lowering body fat accumulation by regulating adipogenesis and lipid metabolism-related genes and proteins in WAT and liver.
C1 [Choi, Bong-Keun; Lee, Dong-Ryung] Nutra Pharm Tech, Yongin 446916, Gyeonggi, South Korea.
   [Park, Sung-Bum; Lee, Hae Jin; Yang, Seung Hwan] Myongji Univ, Interdisciplinary Program Biomodulat, Yongin 446728, Gyeonggi, South Korea.
   [Jin, Ying-Yu; Yang, Seung Hwan; Suh, Joo-Won] Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 446728, Gyeonggi, South Korea.
C3 Myongji University; Myongji University
RP Yang, SH; Suh, JW (corresponding author), Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 446728, Gyeonggi, South Korea.
EM ymtehigan@mju.ac.kr; jwsuh@mju.ac.kr
FU Cooperative Research Program for Agriculture Science & Technology Development [PJ01134802]
CR Arch JRS, 2005, P NUTR SOC, V64, P39, DOI 10.1079/PNS2004407
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Blum J, 2007, NUTRAFOODS, V6, P13
   Chen WY, 2012, AM J PHYSIOL-ENDOC M, V303, PE635, DOI 10.1152/ajpendo.00078.2012
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Dickson JC, 2015, BMC GASTROENTEROL, V15, P0, DOI 10.1186/s12876-015-0321-3
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Farmer SR, 2005, INT J OBESITY, V29, PS13, DOI 10.1038/sj.ijo.0802907
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Jin SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0120842
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Martin ASG, 2006, AM J CLIN NUTR, V83, P461S, DOI 10.1093/ajcn/83.2.461s
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Pietrobelli A, 2005, INT J OBESITY, V29, PS97, DOI 10.1038/sj.ijo.0803079
   Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Wedellova Z, 2011, PHYSIOL RES, V60, P139, DOI 10.33549/physiolres.931863
   Xiaoping Zhao, 2012, SHENG WU WU LI HSUEH BAO, V28, P287
NR 38
TC 90
Z9 91
U1 1
U2 41
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL 15
PY 2016
VL 9
IS 7
BP 616
EP 624
DI 10.1016/j.apjtm.2016.05.017
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500004
PM 27393090
DA 2025-04-28
ER

PT J
AU Kobayashi, M
   Kawano, T
   Ukawa, Y
   Sagesaka, YM
   Fukuhara, I
AF Kobayashi, Makoto
   Kawano, Takanori
   Ukawa, Yuuichi
   Sagesaka, Yuko M.
   Fukuhara, Ikuo
TI Green tea beverages enriched with catechins with a galloyl moiety reduce body fat in moderately obese adults: a randomized double-blind placebo-controlled trial
SO FOOD & FUNCTION
LA English
DT Article
ID micellar solubility; lipid-peroxidation; energy-expenditure; postprandial fat; dietary-fat; cholesterol; weight; absorption; oxidation; caffeine
AB Objective To determine whether ingesting a green tea beverage enriched with catechins with a galloyl moiety during a meal reduces body fat in moderately obese adults. Design Randomized double-blind placebo-controlled study. Subjects A total of 126 obese subjects (25 <= body mass index < 30 kg m(-2)) were randomly assigned to a group receiving green tea beverages without catechins (placebo), or a group receiving green tea beverages with a low or high content of catechins with a galloyl moiety. Each subject ingested 500 mL bottled green tea beverages containing 25, 180, or 279.5 mg green tea catechins (0, 149.5, or 246.5 mg catechins with a galloyl moiety, respectively), at mealtimes for 12 weeks; the subjects were instructed to ingest the beverage during the meal that had the highest fat content on that day. Methods Anthropometric measurements and blood chemistry analysis were performed during the run-in period; at weeks 0, 4, 8, and 12 of the intake period; and at the end of the withdrawal period. Abdominal fat area was measured by computed tomography at weeks 0, 8, and 12 of the intake period and at the end of the withdrawal period. Results Both the low-and high-dose groups exhibited significant reductions in visceral and subcutaneous fat areas compared to the control group at 12 weeks post-intervention. Conclusion Ingestion of a green tea beverage enriched with catechins with a galloyl moiety during a high-fat meal reduces body fat in moderately obese adults.
C1 [Kobayashi, Makoto; Kawano, Takanori; Ukawa, Yuuichi; Sagesaka, Yuko M.] ITO EN Ltd, Cent Res Inst, Shizuoka 4210516, Japan.
   [Fukuhara, Ikuo] Fukuhara Hosp, Fukuhara, Hokkaido 0611351, Japan.
RP Kobayashi, M (corresponding author), ITO EN Ltd, Cent Res Inst, Shizuoka 4210516, Japan.
EM m-kobayasi@itoen.co.jp
CR Asaka M, 2000, J JPN SOC FOOD SCI, V47, P708, DOI 10.3136/nskkk.47.708
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Cohn JS, 2010, NUTRIENTS, V2, P116, DOI 10.3390/nu2020116
   Després JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fujiki H, 1998, MUTAT RES-FUND MOL M, V402, P307, DOI 10.1016/S0027-5107(97)00310-2
   GORDON DJ, 1988, J CLIN EPIDEMIOL, V41, P679, DOI 10.1016/0895-4356(88)90120-5
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Gutiérrez-Salmeán G, 2014, FOOD FUNCT, V5, P521, DOI 10.1039/c3fo60416k
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kajimoto O, 2003, J CLIN BIOCHEM NUTR, V33, P101
   Kajimoto O, 2006, HLTH SCI, V22, P60
   Kobayashi M, 2014, J AGR FOOD CHEM, V62, P2881, DOI 10.1021/jf405591g
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   OKUDA T, 1983, CHEM PHARM BULL, V31, P1625
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   Ukawa Y, 2013, JPN PHARM THER, V41, P919
   Unno T, 2005, BRIT J NUTR, V93, P543, DOI 10.1079/BJN20041379
   Unno T, 2005, JPN J NUTR ASSESS, V22, P207
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wu CD, 2002, NUTRITION, V18, P443, DOI 10.1016/S0899-9007(02)00763-3
   YOSHINO K, 1994, AGE, V17, P79, DOI 10.1007/BF02435010
NR 47
TC 26
Z9 27
U1 0
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 15
PY 2016
VL 7
IS 1
BP 498
EP 507
DI 10.1039/c5fo00750j
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA DB9TO
UT WOS:000368860000050
PM 26569165
DA 2025-04-28
ER

PT J
AU Franklin, JL
   Mirzaei, M
   Wearne, TA
   Homewood, J
   Goodchild, AK
   Haynes, PA
   Cornish, JL
AF Franklin, Jane L.
   Mirzaei, Mehdi
   Wearne, Travis A.
   Homewood, Judi
   Goodchild, Ann K.
   Haynes, Paul A.
   Cornish, Jennifer L.
TI Extended exposure to sugar and/or caffeine produces distinct behavioral and neurochemical profiles in the orbitofrontal cortex of rats: Implications for neural function
SO PROTEOMICS
LA English
DT Article
DE Animal proteomics; Caffeine; Hyperactivity; Neurological disease; Orbitofrontal cortex; Sugar
ID prefrontal cortex; gene-expression; parkinsons-disease; alzheimers-disease; locomotor-activity; proteomic analysis; monoamine-oxidase; nervous-system; consumption; brain
AB Caffeine is a psychostimulant commonly consumed with high levels of sugar. The increased availability of highly caffeinated, high sugar energy drinks could put some consumers at risk of being exposed to high doses of caffeine and sugar. Notably, research that has examined the consequences of this combination is limited. Here, we explored the effect of chronic exposure to caffeine and/or sugar on behavior and protein levels in the orbitofrontal cortex (OFC) of rats. The OFC brain region has been implicated in neuropsychiatric conditions, including obesity and addiction behaviors. Adultmale Sprague-Dawley rats were treated for 26 days with control, caffeine (0.6 g/L), 10% sugar, or combination of both. Locomotor behavior was measured on the first and last day of treatment, then 1 week after treatment. Two hours following final behavioral testing, brains were rapidly removed and prepared for proteomic analysis of the OFC. Label-free quantitative shotgun analysis revealed that 21, 12, and 23% of proteins identified in the OFC were differentially expressed by sugar and/or caffeine. The results demonstrate that the intake of high levels of sugar and/or low to moderate levels of caffeine has different behavioral consequences. Moreover, each treatment results in a unique proteomic profile with different implications for neural health.
C1 [Franklin, Jane L.; Wearne, Travis A.; Cornish, Jennifer L.] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia.
   [Mirzaei, Mehdi; Haynes, Paul A.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.
   [Homewood, Judi] Macquarie Univ, Fac Human Sci, Sydney, NSW, Australia.
   [Goodchild, Ann K.] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia.
C3 Macquarie University; Macquarie University; Macquarie University; Macquarie University
RP Cornish, JL (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.
EM jennifer.cornish@mq.edu.au
FU Australian Postgraduate Award (APA); Macquarie University in the form of the Psychology Department Higher Degree Research Grant; Australian Research Council in the form of an Industrial Transformation Training Centre grant; Hillcrest Foundation
CR Ahmed SSSJ, 2009, J BIOMED SCI, V16, P0, DOI 10.1186/1423-0127-16-63
   Alia-Klein N, 2011, ARCH GEN PSYCHIAT, V68, P283, DOI 10.1001/archgenpsychiatry.2011.10
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008
   Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584
   Begcevic I, 2013, CLIN PROTEOM, V10, P0, DOI 10.1186/1559-0275-10-5
   Bélanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964
   Bortolato M, 2013, INT J NEUROPSYCHOPH, V16, P869, DOI 10.1017/S1461145712000715
   Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723
   CALVINO AM, 1990, CHEM SENSES, V15, P505, DOI 10.1093/chemse/15.5.505
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Carlson JS, 2007, J APPL SCH PSYCHOL, V24, P127, DOI 10.1300/J370v24n01_07
   Ciavardelli D, 2010, CELL DEATH DIS, V1, P0, DOI 10.1038/cddis.2010.68
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Correia SC, 2012, BRAIN RES, V1441, P64, DOI 10.1016/j.brainres.2011.12.063
   Daniello Allison, 2012, BIOMED SCI INSTRUM, V48, P73
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Enns GM, 2003, MOL GENET METAB, V80, P11, DOI 10.1016/j.ymgme.2003.08.009
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, PS167, DOI 10.3233/JAD-2010-1404
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   FLEMMER DD, 1989, PHARMACOL BIOCHEM BE, V34, P261, DOI 10.1016/0091-3057(89)90309-2
   Francis HM, 2013, PROTEOMICS, V13, P3076, DOI 10.1002/pmic.201300124
   Franklin JL, 2016, J PROTEOME RES, V15, P1455, DOI 10.1021/acs.jproteome.5b01043
   Franklin JL, 2016, PROTEOMICS, V16, P657, DOI 10.1002/pmic.201500126
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gammulla CG, 2010, PROTEOMICS, V10, P3001, DOI 10.1002/pmic.201000054
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   GRIFFITHS RR, 1988, PSYCHOPHARMACOLOGY, V94, P437, DOI 10.1007/BF00212836
   Guo XG, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094715
   Hajnal A, 2004, AM J PHYSIOL-REG I, V286, PR31, DOI 10.1152/ajpregu.00282.2003
   HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Herrmann AG, 2013, J CEREBR BLOOD F MET, V33, P673, DOI 10.1038/jcbfm.2012.204
   Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x
   Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531, DOI 10.55782/ane-2000-1374
   Himmel Herbert M, 2008, JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, V58, P129, DOI 10.1016/j.vascn.2008.06.001
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   KAPLAN GB, 1993, J PHARMACOL EXP THER, V266, P1563
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052
   Ko JH, 2013, HUM BRAIN MAPP, V34, P1591, DOI 10.1002/hbm.22006
   Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552
   KOLB B, 1974, BEHAV BIOL, V10, P329, DOI 10.1016/S0091-6773(74)91924-5
   Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z
   Lien L, 2006, AM J PUBLIC HEALTH, V96, P1815, DOI 10.2105/AJPH.2004.059477
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766
   Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x
   McDonald JH, 2009, HANDBOOK OF BIOLOGICAL STATISTICS, V3rd, P0
   Mémet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003
   Millichap JG, 2012, PEDIATRICS, V129, P330, DOI 10.1542/peds.2011-2199
   Mirzaei M, 2012, PROTEOMICS, V12, P864, DOI 10.1002/pmic.201100389
   Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, PC670, DOI 10.1152/ajpcell.00213.2006
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   NEHLIG A, 1986, EUR J PHARMACOL, V129, P93, DOI 10.1016/0014-2999(86)90340-7
   Neilson Karlie A, 2013, METHODS MOL BIOL, V1002, P205, DOI 10.1007/978-1-62703-360-2_17
   Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553
   NIKODIJEVIC O, 1993, PHARMACOL BIOCHEM BE, V44, P199, DOI 10.1016/0091-3057(93)90299-9
   ODoherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315
   Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Palou A, 2009, OBES REV, V10, P1, DOI 10.1111/j.1467-789X.2008.00560.x
   Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, V0, P0
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Rabilloud T, 2003, NAT BIOTECHNOL, V21, P508, DOI 10.1038/nbt0503-508
   Reissig JE, 2005, ANN PHARMACOTHER, V39, P727, DOI 10.1345/aph.1E309
   Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748
   Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001
   Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031
   Scott TR, 2001, APPETITE, V37, P111, DOI 10.1006/appe.2001.0413
   Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197
   Singer CA, 1999, J NEUROSCI, V19, P2455
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Svenningsson P, 1999, J NEUROSCI, V19, P4011
   Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294
   Unal CT, 2009, EUR J NEUROSCI, V29, P1615, DOI 10.1111/j.1460-9568.2009.06691.x
   Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005
   Volkow Nora D, 2012, ANNU REV PHARMACOL TOXICOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625
   Wearne TA, 2015, J PROTEOME RES, V14, P397, DOI 10.1021/pr500719f
   Yamamoto T, 2003, NUTR REV, V61, PS5, DOI 10.1301/nr.2003.may.S5-S9
   Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313
   Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887
NR 96
TC 1
Z9 2
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV 15
PY 2016
VL 16
IS 22
BP 2894
EP 2910
DI 10.1002/pmic.201600032
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ED9US
UT WOS:000389219200009
PM 27588558
DA 2025-04-28
ER

